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env     envelope; gene encoding glycoprotein160 
ER     endoplasmic reticulum 
ERK     extracellular signal-regulated kinase 
F(ab')2     bivalent antigen-binding fragment 
FACS     fluorescence-activated cell sorter 
Fc     fragment crystalline 
FcR     Fc receptor 
FCS     fetal calf serum 
FITC     fluorescein-5-isothiocyanate 
Fluo-3-AM glycine, N-[4-[6-[(acetyloxy)methoxy]-2,7-dichloro-3-oxo-
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[(acetyloxy)methoxy]-2-oxyethyl]-, (acetyloxy)methyl ester 
FRIP     IL-four receptor interacting protein 
Fyn     fgr/yes-related novel PTK 
Gab     Grb2-associated binder 
Gads     Grb2-related adaptor downstream of Shc 
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HEK     human embryonic kidney 
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HIV     human immunodeficiency virus 
HPK1     hematopoietic progenitor kinase 1 
HRPO     horseradish peroxidase  
IB     immunoblot 
ICRAC     Ca2+ release activated Ca2+ current 
Ig     immunoglobulin 
IgH chain     Ig heavy chain 
IgL chain    Ig light chain 
IHF     integration host factor 
IL     interleukin 
Indo-1 1H-indole-6-carboxylic acid, 2-[4-[bis[2-
[(acetyloxy)methoxy]-2-oxoethyl]amino]-3-[2-[2-[bis[2-
[(acetyloxy)methoxy]-2-oxoethyl]amino]-5-
methylphenoxy]ethoxy]phenyl]-, (acetyloxy)methyl ester 
INS     insertion 
Int     integrase 
IP     immunoprecipitation 
IP3     inositol 1,4,5-trisphosphate 
IP3R     IP3 receptor 
IPTG     isopropyl-β-D-thiogalactopyranoside 
IRES     internal ribosome entry site 
IRS     insulin receptor substrate 
ITAM     immunoreceptor tyrosine-based activation motif 
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Itk     IL-2-inducible T-cell kinase 
JNK     c-Jun N-terminal kinase 
Kan     kanamycin 
KAR     killer activating receptor 
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LIME     Lck-interacting molecule 
 
Lyn     lck/yes-related novel PTK 
mAb     monoclonal antibody 
MAPK     mitogen-activated protein kinase 
mIg     membrane Ig 
MMLV     moloney murine leukemia virus  
MS     mass spectrometry 
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Nck     non-catalytic region of tyrosine kinase  
NCR     natural cytotoxicity receptor 
NEF     negative factor 
neo     neomycin 
NFAT     nuclear factor of activated T cells 
NFκB     nuclear factor for κ gene in B lymphocytes 
NK cells    natural killer cells 
NTAL     non-T cell activation linker 
OD     optical density 
p protein 
P phosphate 
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PAGE     polyacrylamide gel electrophoresis 
PBL     peripheral blood leukocyte 
PBS     phosphate-buffered saline 
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PCR     polymerase chain reaction 
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PI(3,4)P2    phosphatidylinositol 3,4-bisphosphate 
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PTB domain    phosphotyrosine binding domain 
PTK      protein tyrosine kinase 
PTP     protein tyrosine phosphatase 
pTyr     phosphotyrosine 
pY     phosphotyrosine 
RA      right arm 
Rac     Ras-related C3 botulinum toxin substrate 
RACC     receptor-activated Ca2+ channel 
Ras     abbreviation originated from rat sarcoma 
RasGAP    Ras GTPase-activating protein 
RasGRP    Ras guanine nucleotide releasing protein 
REP     replacement 
Ret     rearranged during transfection 
Rho     Ras homology 
RNA     ribonucleic acid 
RNAi     RNA interference 
RNase     ribonuclease 
ROC     receptor-operated channel 
rpm     rounds per minute 
RPMI     Roswell Park Memorial Institute 
RT     reverse transcription/transcriptase or room temperature 
RTK      receptor tyrosine kinase 
RYR     ryanodine receptor 
SDS     sodium dodecylsulfate  
SERCA    sarcoplasmic/endoplasmic reticulum Ca2+-ATPase 
Shc     SH2-containing sequence 
SH domain    Src homology domain 
SHIP     SH2 domain-containing inositol 5’-phosphatase 
SHP-1/2 SH2 domain-containing protein tyrosine phosphatases 1/2 
SIT     SHP-2 interacting transmembrane adaptor protein 
SLC     surrogate light chain 
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SNP     single nucleotide polymorphism 
SOC     store-operated channel 
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SR     sarcoplasmic reticulum 
src     Rous sarcoma oncogene 
STIM1     stromal interaction molecule 1 
Syk     Spleen tyrosine kinase 
t     time 
T     temperature 
TAE     Tris acetate EDTA buffer 
TBE     Tris borate EDTA buffer 
TBS     Tris-buffered saline 
TCR     T cell antigen receptor 
 Tec                                                          Tyrosine kinase expressed in hepatocellular carcinoma 
TEMED    N,N,N’,N’-tetramethylethylene-diamine  
Tm     melting temperature 
TM     transmembrane 
TRIM     T-cell receptor interacting molecule 
Tris     Tris-(hydroxymethyl)-aminomethane 
Triton X-100 4-(2’,2’,4’,4’-tetramethylbutyl)phenyldecaethylene-glycol-
ether 
TRP transient receptor potential 
Tween-20    polyoxyethylene sorbitan monolaurate 
U     Units 
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UTR     untranslated region 
UV     ultraviolet  
Vav six (Hebrew); adapter protein with GEF activity 
VOCC     voltage-operated Ca2+ channel 
VSV-G      vesicular stomatitis virus glycoprotein 
v/v     volume per volume 
w/o     without 
w/v     weight per volume 
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X-Gal     5-bromo-4-chloro-3-indoxyl-β-D-galactopyranoside 
Xis     excisionase  
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III  Deoxyribonucleotides 
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    °C degree Celsius 
   g acceleration of gravity    
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1
1.  Summary 
The generation of antigen-specific B lymphocytes is essential for the humoral immune 
response. B cell activation depends on signals generated upon engagement of the B cell 
antigen receptor (BCR). Proximal BCR effector proteins are cytoplasmic protein tyrosine 
kinases (PTKs) which phosphorylate cytoplasmic and transmembrane adaptor proteins such 
as SLP-65 or NTAL, respectively. Phosphorylated SLP-65 forms the scaffold for the 
assembly and activation of a protein complex which initiates Ca2+ release from intracellular 
stores. This Ca2+ initiation complex is composed of at least Bruton’s tyrosine kinase (Btk) 
and phospholipase C-γ2 (PLC-γ2). BCR-induced Ca2+ mobilization arises by both release 
from intracellular Ca2+ stores, and Ca2+ influx through plasma membrane channels. The 
extent of Ca2+ mobilization from these two sources varies depending on the developmental 
stage of the B lymphocyte. Shaping Ca2+ profiles in the dimensions of space and time can 
determine different B cell responses, i.e. proliferation, differentiation, anergy or apoptosis. 
Currently, central questions of BCR-induced Ca2+ mobilization are: (1) how the Ca2+ 
initiation complex is targeted to the plasma membrane, (2) what is the exact mechanism of 
BCR-triggered PLC-γ2 activation, (3) how the intracellular Ca2+ release is connected to Ca2+ 
influx across the plasma membrane, and (4) how Ca2+ mobilization is differentially 
regulated during B cell lymphopoiesis. In this study, these questions were addressed by gene 
targeting experiments and subsequent reconstitutions in the chicken B cell line DT40. It was 
demonstrated that the SH2/SH3 adaptor Grb2 negatively regulates Ca2+ mobilization from 
intra- and extracellular sources. This function depends on the central SH2 and the              
C-terminal SH3 domain. Tyrosine-phosphorylated NTAL counter-acts Grb2 by recruiting it 
into lipid rafts. It was further shown that the NTAL/Grb2 module does not affect the 
phosphorylation state of the central components of the Ca2+ initiation complex, i.e. SLP-65 
or PLC-γ2. However, it appeared that PLC-γ2 activation and/or retention at the plasma 
membrane are controlled by NTAL/Grb2. The downstream effector of Grb2 was determined 
to be the major tyrosine phosphorylated protein in DT40 B cells, and was subsequently 
identified as the cytosolic adaptor Dok-3. Phosphorylation of Dok-3 by Lyn depends on 
Grb2 and requires its central SH2 and C-terminal SH3 domain. Collectively, Grb2 seems to 
be a molecular switch in BCR-induced Ca2+ mobilization. The SH2 domain-dependent 
binding of Grb2 to either tyrosine phosphorylated NTAL or Dok-3 ultimately leads to 
positive or negative modulation of antigen receptor-induced Ca2+ mobilization in B cells. 
Thus, in this study a novel Ca2+ regulation pathway in B lymphocytes was identified. The 
adaptor-mediated modulation of Ca2+ mobilization may critically influence B cell signalling 
by supporting either activation or tolerance induction. 
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1.1. Zusammenfassung 
Die Generierung Antigen-spezifischer B-Lymphozyten ist essentiell für die humorale 
Immunantwort. Die Aktivierung von B-Zellen ist von Signalen abhängig, die über den       
B-Zell-Antigenrezeptor (BCR) vermittelt werden. Cytoplasmatische Protein-Tyrosinkinasen 
(PTKs) sind BCR-proximale Effektorproteine, die cytoplasmatische und transmembrane 
Adapterproteine wie SLP-65 oder NTAL phosphorylieren. Phosphoryliertes SLP-65 bildet 
das Gerüst für die Assemblierung und Aktivierung eines Proteinkomplexes, der die Ca2+-
Freisetzung aus intrazellulären Speichern initiiert. Dieser Ca2+-Initiationskomplex besteht 
mindestens aus Brutons Tyrosinkinase (Btk) und Phospholipase  C-γ2 (PLC-γ2). Die BCR-
induzierte Ca2+-Mobilisierung beinhaltet sowohl die Freisetzung aus intrazellulären Ca2+-
Speichern als auch den Einstrom über die Plasmamembran. Das Ausmaß der Ca2+-
Mobilisierung aus diesen beiden Speichern hängt von dem Entwicklungsstadium des         
B-Lymphozyten ab. Die räumliche und zeitliche Veränderung von Ca2+-Profilen kann zu 
verschiedenen B-Zell-Antworten führen, d.h. Proliferation, Differenzierung, Anergie oder 
Apoptose. Gegenwärtig sind zentrale Fragen in der BCR-induzierten Ca2+-Mobilisierung: 
(1) wie wird der Ca2+-Initiationskomplex an die Membran rekrutiert, (2) was ist der exakte 
Mechanismus der BCR-vermittelten PLC-γ2 Aktivierung, (3) wie ist die intrazelluläre Ca2+-
Freisetzung mit dem Ca2+-Einstrom über die Plasmamembran verbunden, und (4) wie 
erfolgt die differentielle Regulierung der Ca2+-Mobilisierung während der B-Zell-
Lymphopoese? In dieser Studie wurden diese Fragen mittels zielgerichteter Gen-
Inaktivierung und nachfolgenden Rekonstitutionen analysiert. Es konnte gezeigt werden, 
dass der SH2/SH3-Adapter Grb2 die Ca2+-Mobilisierung aus intra- und extrazellulären 
Quellen negativ reguliert. Diese Funktion ist von der zentralen SH2- und der C-terminalen 
SH3-Domäne abhängig. Tyrosin-phosphoryliertes NTAL wirkt dieser Funktion durch die 
Grb2-Rekrutierung in lipid rafts entgegen. Es konnte des weiteren gezeigt werden, dass das 
NTAL/Grb2-Modul nicht den Phosphorylierungsgrad der zentralen Komponenten des Ca2+-
Initiationskomplexes, d.h. SLP-65 oder PLC-γ2, beeinflusst. Allerdings scheinen 
NTAL/Grb2 die PLC-γ2-Aktivierung und/oder dessen Retention an der Plasmamembran zu 
kontrollieren. Es konnte im Rahmen dieser Arbeit herausgefunden werden, dass das 
Hauptphosphoprotein in DT40 das Grb2-Effektorprotein ist. Nachfolgend wurde dieses als 
das cytosolische Adapterprotein Dok-3 identifiziert. Die Phosphorylierung von Dok-3 durch 
Lyn ist abhängig von Grb2 und benötigt dessen zentrale SH2- und die C-terminale SH3-
Domäne. Zusammenfassend deuten diese Studien darauf hin, dass Grb2 ein molekularer 
Schalter in der BCR-induzierten Ca2+-Mobilisierung ist. Die SH2-Domänen-abhängige 
Bindung von Grb2 an entweder Tyrosin-phosphoryliertes NTAL oder Dok-3 führt 
letztendlich zur positiven bzw. negativen Modulation der Antigenrezeptor-induzierten Ca2+-
Mobilisierung in B-Zellen. In dieser Studie wurde ein neuer Ca2+-Regulationsmechanismus 
identifiziert. Die Adapter-vermittelte Modulation der Ca2+-Mobilisierung könnte durch die 
Unterstützung von entweder Aktivierung oder Toleranzinduktion die B-Zell-
Signaltransduktion kritisch beeinflussen. 
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2. Introduction 
Immune responses are mediated by leukocytes, which originate from pluripotent 
hematopoietic stem cells in the bone marrow. These stem cells give rise to myeloid cell 
lineages including granulocytes, macrophages, dendritic cells and mast cells, as well as 
lymphoid cell lineages such as B lymphocytes, T lymphocytes and natural killer (NK) cells. 
B lymphocytes (B cells) mature in the bone marrow or in the avian Bursa of Fabricius, 
whereas T lymphocytes (T cells) mature in the thymus. Lymphocytes represent the 
foundation for the adaptive immune response which specifically recognizes all pathogens 
and guarantees protective immunity against re-infection. This is accomplished by mature 
lymphocytes each bearing a monospecific variant of a prototype antigen receptor on its 
surface. 
 
2.1. Structure and functions of the antigen receptors on B lymphocytes 
The B cell antigen receptor (BCR) is composed of several subunits with separate functions 
for signal reception and signal transduction (RETH, 1992; NEUBERGER et al., 1993). 
Membrane-bound immunoglobulins (mIgs) recognize and bind extracellular antigen. 
Immunoglobulins (Igs) are tetrameric proteins consisting of two Ig heavy (IgH) chains and 
two Ig light (IgL) chains. One IgL chain is covalently associated with one IgH chain by a 
disulfide bond, and the two IgH chains are connected by disulfide bonds. The juxtaposition 
of the IgH and IgL complementarity-determining regions (CDRs) form the antigen binding 
region (RETH, 1992; WIENANDS, 2000a), and each individual B cell carries BCRs of a single 
antigen specificity. According to the Ig heavy chain, Igs are divided into five isotypes: IgM, 
IgD, IgG, IgA, and IgE (RETH, 1992). In pre-B cells, the pre-BCR is generated by the 
association of the µm-heavy chain (m = membrane) with the surrogate light chain (SLC) 
which is composed of the invariant polypeptides λ5 and VpreB (RETH, 1992). BCR signal 
transduction is mediated through the transmembrane proteins Ig-α (CD79a, mb-1 gene 
product) and Ig-β (CD79b, B29 gene product). A disulfide-linked Ig-α/Ig-β heterodimer is 
non-covalently associated with the mIg in a 1:1 complex (RETH et al., 2000; SCHAMEL and 
RETH, 2000). 
The main function of B lymphocytes is to contribute to the elimination of foreign antigens 
by producing soluble antibodies. However, the BCR does not only play a central role in the 
antigen-induced activation of mature B lymphocytes during adaptive humoral immune 
responses, but also in B cell development, B cell maintenance, and in the apoptotic 
elimination of B cells reactive to self-antigens (reviewed in WIENANDS, 2000a).  
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2.2.  BCR-mediated signalling 
2.2.1.  Signalling via the Ig-α/Ig-β heterodimer 
Ig-α and Ig-β each contain in their cytoplasmic tail a single copy of a specific amino acid 
motif which is necessary for the signalling functions of both the pre-BCR and the BCR 
(RETH, 1989; CAMBIER, 1995). This motif is called the immunoreceptor tyrosine-based 
activation motif (ITAM) and is characterized by the consensus amino acid sequence 
D/Ex7D/ExxYxxI/Lx7YxxI/L (single-letter amino acid code, x denotes any residue) (RETH, 
1989). Upon BCR engagement, the two tyrosine residues of the ITAM become 
phosphorylated by intracellular protein tyrosine kinases (PTKs). ITAM phosphorylation is 
initiated by Src family PTKs (Lyn, Fyn and/or Blk), which can be found in close association 
with unligated BCRs (YAMANASHI et al., 1991; CAMPBELL and SEFTON, 1992). A 
phosphorylated ITAM-tyrosine provides a binding motif for proteins containing a Src 
homology 2 (SH2) domain. SH2 domains bind sequence-specifically to tyrosine-
phosphorylated proteins (SONGYANG et al., 1993). A doubly phosphorylated ITAM is bound 
by the tandemly arranged SH2 domains of the cytoplasmic PTK Syk (see figure 2.1) 
(KUROSAKI et al., 1995; WIENANDS et al., 1995; FUTTERER et al., 1998). Syk is expressed in 
most hematopoietic cells, and forms together with ZAP-70 that is expressed in                     
T lymphocytes and NK cells the Syk family PTKs (reviewed in TURNER et al., 2000). The 
kinase activity of Syk is activated by a combination of SH2-mediated recruitment, 
transphosphorylation through Src family PTKs, and autophosphorylation processes 
(KUROSAKI et al., 1994; KUROSAKI et al., 1995; ROWLEY et al., 1995; KIMURA et al., 1996). 
The phosphorylation of a tyrosine residue in the activation loop of the kinase domain (Y520) 
is central to Syk activation, whereas phosphorylation of Y317 in the linker region between  
C-terminal SH2 domain and kinase domain inhibits Syk function (HIKIDA and KUROSAKI, 
2005).  
PTKs of the Src family and Syk couple the BCR to multiple signal transduction pathways 
including the mobilization of Ca2+ ions, activation of protein kinase C (PKC), and activation 
of small G proteins (Ras and Rho/Rac/Cdc42), and mitogen-activated protein kinases 
(MAPKs) such as extracellular signal-regulated kinase (Erk), c-Jun N-terminal kinase (Jnk), 
or p38. Ultimately, antigen recognition leads to the activation of transcription factors (e.g. 
nuclear factor of activated T cells, NFAT; nuclear factor for κ gene in B lymphocytes,     
NF-κB; activating protein-1, AP-1) and subsequent changes in gene expression (see also 
section 2.6).     
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Figure 2.1: Signalling molecules in B lymphocytes 
A selection of signalling molecules found in B lymphocytes is schematically depicted to visualize their 
modular structure and their protein-protein and protein-lipid interaction domains. In this figure murine 
orthologs are illustrated. SH2 and PTB domains bind to phosphotyrosines (shown as Y), SH3 domains 
bind to proline-rich peptide motifs (illustrated as black semi-ellipses), and PH domains associate with 
phospholipids. Binding sites for the Grb2 SH2 domain are designated as YxN. Intramolecular 
interactions in PTK Lyn are illustrated as black doubleheaded arrows. The relative size of the molecules 
is scaled down. Btk, Bruton’s tyrosine kinase; Csk, C-terminal Src kinase; Dok-3, downstream of kinase 
3; Grb2, growth factor receptor bound protein 2; LAT, linker for activation of T cells; Lyn, Lck/Yes-
related novel tyrosine kinase; NTAL, non-T cell activation linker; PH, pleckstrin homology domain; 
PI3K, phosphatidylinositol 3’-kinase; PLC-γ2, phospholipase C-γ2; PTB, phosphotyrosine binding 
domain; PTK, protein tyrosine kinase; SH2, Src homology domain 2; SH3, Src homology domain 3; 
SHIP, SH2 domain-containing inositol 5’-phosphatase; SLP-65, SH2-domain-containing leukocyte 
protein of 65 kDa; Syk, spleen tyrosine kinase; TH, tec homology domain (modified from KUROSAKI, 
2002).  
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2.2.2.  Negative regulation of BCR signalling 
The intracellular signalling machinery leading to cell activation is shared not only by the 
BCR and T cell antigen receptor (TCR), but also by receptors for the Fc portion of 
immunolgobulins (FcRs; e.g. FcεRI, FcγRI, FcγRIIA, FcγRIII), natural cytotoxicity 
receptors (NCRs) on NK cells, and killer activating receptors (KARs) (VEILLETTE et al., 
2002). In order to counterbalance this cell activation machinery, immune cells possess an 
equally complex machinery aimed at restricting the duration and/or intensity of signalling. 
This inhibitory machinery includes receptors containing immunoreceptor tyrosine-based 
inhibitory motifs (ITIMs) (e.g. FcγRIIB; killer inhibitory receptors, KIRs; CD22; CD72; 
paired immunoglobulin-like receptor B, PIR-B), tyrosine kinases (e.g. C-terminal Src 
kinase, Csk), tyrosine phosphatases (e.g. SH2 domain-containing protein tyrosine 
phosphatases 1/2, SHP-1/2), lipid phosphatases (e.g. SH2 domain-containing inositol        
5’-phosphatase, SHIP; phosphatase and tensin homolog, PTEN), adaptors (e.g. downstream 
of tyrosine kinase, Dok), and ubiquitin ligases (e.g. c-Cbl, Cbl-b) (reviewed in VEILLETTE et 
al., 2002).   
The regulation of the activity of Src family PTKs is an example for the interplay between 
activating and inhibitory machinery. Src family PTKs contain a unique region at the          
N-terminus, followed by a Src homology 3 (SH3) domain, an SH2 domain, and a kinase 
domain (also known as SH1 domain) (see figure 2.1). SH3 domains bind to short proline 
rich sequences with a core PxxP motif (SPARKS et al., 1996, 1998; MAYER, 2001). The 
activity of Src family PTKs is controlled by two tyrosine phosphorylation sites. 
Autophosphorylation of a conserved tyrosine in the kinase domain (Y397 in murine Lyn) 
results in activation. In contrast, phosphorylation of the regulatory tyrosine near the           
C-terminus (Y508 in murine Lyn) by Csk leads to intramolecular interactions which stabilize 
the inactive conformation (NADA et al., 1993; CHONG et al., 2005a, 2005b). These inhibitory 
intramolecular interactions include the binding of phospho-Y508 to the SH2 domain and the 
association of a polyproline type II helical structure in the SH2-kinase interdomain with the 
SH3 domain (see figure 2.1) (CHONG et al., 2005a, 2005b). Thus, it has been proposed that 
Src family PTKs are active upon: (1) interference with the inhibitory intramolecular 
interactions, (2) autophosphorylation of Y397, and (3) dephosphorylation of Y508 (CHONG et 
al., 2005a, 2005b). CD45 is the phosphatase responsible for the dephosphorylation of both 
the autophosphorylation and the regulatory tyrosine (YANAGI et al., 1996). Indeed, the 
regulatory tyrosine of Lyn is hyperphosphorylated in CD45-deficient B cells and 
hypophosphorylated in Csk-deficient   B cells (HATA et al., 1994; YANAGI et al., 1996). Csk 
is recruited to the plasma membrane via the phosphoprotein associated with 
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glycosphingolipid-enriched microdomains (PAG; also known as Csk-interacting protein, 
Cbp) (BRDICKA et al., 2000; KAWABUCHI et al., 2000). Ligands which bind to the SH3 
domain of Src family PTKs can efficiently activate them by disrupting the polyproline-SH3 
interaction. Examples of these SH3 ligands are the human immunodeficiency virus (HIV)-1 
accessory protein Nef (BRIGGS et al., 1997; MOAREFI et al., 1997), SHP-2 (WALTER et al., 
1999), and UNC119 (CEN et al., 2003; GORSKA et al., 2004).  
 
2.2.3.  BCR complexes and lipid rafts 
Upon crosslinking, BCR complexes can be detected in low-density detergent-resistant 
microdomains called lipid rafts (CHENG et al., 1999; AMAN and RAVICHANDRAN, 2000; 
DILLON et al., 2000; PETRIE et al., 2000; WEINTRAUB et al., 2000). Lipid rafts (also known 
as detergent-resistant membranes, DRMs, glycophospholipid-enriched microdomains, 
GEMs, or detergent insoluble glycolipid-rich membranes, DIGs) are lateral heterogeneities 
in the plasma membrane which are highly dynamic submicroscopic assemblies that float 
freely like a raft in the lipid bilayer of cell membranes (reviewed in BROWN and LONDON, 
2000; LANGLET et al., 2000; SIMONS and TOOMRE, 2000; RAJENDRAN and SIMONS, 2005). 
Lipid rafts are enriched in cholesterol as well as glycosphingolipids with saturated fatty acid 
side chains. Phosphatidyl-4,5-bisphosphate [PI(4,5)P2], the major substrate of activated 
phospholipase C-γ (PLC-γ) or phosphatidylinositol 3’-kinase (PI3K) (see below), is also a 
major component of lipid rafts (HOPE and PIKE, 1996; XAVIER et al., 1998). Whereas most 
transmembrane proteins are excluded from these microdomains, several signalling proteins 
partition into the lipid rafts upon modification with hydrophobic side chains, e.g. the doubly 
acylated Src family PTKs or the linker for activation of T cells (LAT, see below) (ZHANG et 
al., 1998a; LIN et al., 1999; BROWN and LONDON, 2000; LANGLET et al., 2000; SIMONS and 
TOOMRE, 2000). In mature B cells, few BCR complexes are present in lipid rafts before 
antigen recognition. It has been postulated that the recruitment of crosslinked BCRs within 
lipid rafts initiates signalling by co-localizing the BCR with proximal signalling molecules 
such as Lyn (CHENG et al., 1999) and by exclusion of negative regulators of BCR signalling 
such as CD22 (WEINTRAUB et al., 2000). However, recent reports question the importance 
of lipid rafts. The first definition of lipid rafts was biochemical and based on the resistance 
of lipid rafts to extraction with Triton X-100 at 4 °C (BROWN and ROSE, 1992). It is now 
accepted that DRMs do not accurately reflect the native state of the lipid microdomains 
(MUNRO, 2003; LICHTENBERG et al., 2005). Douglass and Vale recently demonstrated that 
the key regulator of plasma membrane microdomains is a protein-protein network and not 
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lipid rafts (DOUGLASS and VALE, 2005). Thus, defining the role of membrane microdomains 
definitely requires further investigation. 
 
2.3.  Adaptor proteins in lymphocyte signalling 
2.3.1.  Cytosolic adaptor proteins 
In addition to cell-surface receptors, it is now clear that adaptor molecules participate in the 
modulation of signal transduction. Adaptor molecules exert their function by mediating 
protein-protein or protein-lipid interactions via modular interaction domains, without 
intrinsic enzymatic or transcriptional activities. However, many enzymes also contain 
protein- or lipid-binding modules and can therefore be considered adaptors (see figure 2.1).  
The SH2-domain-containing leukocyte protein of 65 kDa (SLP-65, also known as BLNK, 
BASH, and BCA) is the central adaptor protein in B cells (FU et al., 1998; GANGI-PETERSON 
et al., 1998; GOITSUKA et al., 1998; WIENANDS et al., 1998). It is the immediate downstream 
substrate of Syk and was cloned on the basis of its tyrosine phosphorylation after BCR 
engagement. SLP-65 is composed of an N-terminal leucine-zipper motif (KOHLER et al., 
2005), followed by an acidic region with five tyrosine phosphorylation motifs and several 
putative recognition motifs for SH3 domains, and a C-terminal SH2 domain (figure 2.1). 
SLP-65 is mainly expressed in B cells and macrophages and its domain structure is similar 
to its T-cell paralog SLP-76 (FU et al., 1998; GANGI-PETERSON et al., 1998; GOITSUKA et 
al., 1998; WIENANDS et al., 1998; BONILLA et al., 2000). The N-terminal tyrosine residues 
mediate phosphorylation-dependent interactions with the guanine-nucleotide exchange 
factor (GEF) Vav1, the adaptor non-catalytic region of tyrosine kinase (Nck), the Tec family 
PTK Bruton`s tyrosine kinase (Btk), and PLC-γ2 (FU et al., 1998; WIENANDS et al., 1998; 
HASHIMOTO et al., 1999; ISHIAI et al., 1999a; SU et al., 1999). The adaptor molecule growth 
factor receptor bound protein 2 (Grb2) binds to proline rich regions of SLP-65 (FU et al., 
1998; WIENANDS et al., 1998; FUSAKI et al., 2000), and the SLP-65 SH2 domain was shown 
to interact with hematopoietic progenitor kinase 1 (HPK1) and Ig-α (SAUER et al., 2001; 
ENGELS et al., 2001; KABAK et al., 2002). One of SLP-65’s central tasks in B cell signalling 
is the organization of the Ca2+ initiation complex consisting of SLP-65, Btk, and PLC-γ2 
(see below) (reviewed in KORETZKY et al., 2006).   
Grb2 is a prototypic adaptor protein containing a central SH2 domain flanked by two SH3 
domains (figure 2.1) (CLARK et al., 1992; LOWENSTEIN et al., 1992; OLIVIER et al., 1993). 
Grb2 is ubiquitously expressed in mutliple tissues and cell lines (OLIVIER et al., 1993), and 
since its discovery a plethora of Grb2-interacting proteins have been identified (for an 
overview see: www.signaling-gateway.org). Although the C-terminal SH3 domain of Grb2 
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can bind to SLP-65 it was shown that these two molecules translocate to lipid rafts 
independently of each other following BCR engagement (JOHMURA et al., 2003). Both SH3 
domains were demonstrated to bind the GEF son of sevenless (SOS) homolog (BUDAY and 
DOWNWARD, 1993; CHARDIN et al., 1993; EGAN et al., 1993; LI et al., 1993; ROZAKIS-
ADCOCK et al., 1993). The Grb2 SH2 domain preferentially binds to the phosphotyrosine 
(pY)-containing motif pYxN (KESSELS et al., 2002). Ligation of growth-factor receptors 
leads to tyrosine phosphorylation in the cytoplasmic tail of the receptor tyrosine kinases 
(RTKs) and subsequent binding of Grb2 via its SH2 domain. Thereby, the Grb2-SOS 
complex is recruited to the membrane, where SOS can activate membrane-localized Ras 
(ROGGE et al., 1991; EGAN et al., 1993; GALE et al., 1993; LI et al., 1993; ROZAKIS-ADCOCK 
et al., 1993; SKOLNIK et al., 1993; DOWNWARD, 1994; MARGOLIS and SKOLNIK, 1994). In 
BCR signalling, the adaptor protein Shc has been implicated in the recruitment of the 
Grb2/SOS complex to the membrane (SAXTON et al., 1994; HARMER and DEFRANCO, 1997). 
Upon BCR stimulation, Shc is recruited to the plasma membrane and becomes tyrosine 
phosphorylated, thereby creating binding sites for Grb2 (SALCINI et al., 1994; SAXTON et al., 
1994; VAN DER GEER et al., 1996; HARMER and DEFRANCO, 1997). Shc/Grb2/SOS 
complexes were detected in the membrane-enriched particulate fraction of stimulated          
B cells (SAXTON et al., 1994). However, Oh-hora et al. demonstrated that the BCR activates 
Ras through Ras guanine nucleotide releasing protein 3 (RasGRP3) rather than via the 
Grb2/SOS complex (OH-HORA et al., 2003). Thus, the exact role of Grb2 in BCR signal 
transduction remains to be determined. 
Cytosolic adaptor proteins not only serve as scaffolds for the assembly of cell activation 
complexes, but also play an important role in inhibitory pathways. Members of one adaptor 
family may sometimes exert both activating and inhibitory functions as exemplified by 
members of the Dok family. Structural characteristics of this adaptor family make them 
most similar to the insulin receptor substrate (IRS) family of proteins (CONG et al., 1999). 
All Dok proteins contain an N-terminal pleckstrin homology (PH) domain, a central 
phosphotyrosine binding (PTB) domain, and a C-terminal region containing proline-rich 
regions and tyrosine-based signalling motifs (VEILLETTE et al., 2002).  
To date, six members of the Dok-family have been identified. Dok-1 (also known as p62dok) 
was originally shown to be a substrate of activated PTKs and to associate with p120 Ras 
GTPase-activating protein (p120 RasGAP) when phosphorylated (ELLIS et al., 1990; 
CARPINO et al., 1997; YAMANASHI and BALTIMORE, 1997). Dok-2 (also known as Dok-R, 
FRIP, or p56dok) has also been shown to inducibly interact with p120 RasGAP (DI 
CRISTOFANO et al., 1998; JONES and DUMONT, 1998; NELMS et al., 1998). Dok-3 (figure2.1; 
also known as Dok-L) was reported to play a role in the negative regulation of BCR 
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signalling, but unlike Dok-1 and Dok-2, Dok-3 cannot bind p120 RasGAP (CONG et al., 
1999; LEMAY et al., 2000). 
Dok-1, Dok-2, and Dok-3 have all been shown to primarily mediate negative signalling 
downstream of various receptor and non-receptor kinases (NELMS et al., 1998; CONG et al., 
1999; JONES and DUMONT, 1999; LEMAY et al., 2000; YAMANASHI et al., 2000; ZHAO et al., 
2001; ROBSON et al., 2004), and all three inducibly interact with both SHIP and Csk 
(LEMAY et al., 2000; TAMIR et al., 2000; LATOUR and VEILLETTE, 2001; OTT et al., 2002; 
VAN SLYKE et al., 2005). In contrast, Dok-4, Dok-5 and Dok-6 were identified as targets of 
Ret and the insulin receptor, and positively regulate RTK signalling pathways (GRIMM et al., 
2001; CAI et al., 2003; FAVRE et al., 2003; CROWDER et al., 2004). Dok-1-3 are 
predominantly expressed in tissues of hematopoietic origin, whereas the other three 
members are highly expressed in non-hematopoietic tissues, and particularly in the nervous 
system (LEMAY et al., 2000; GRIMM et al., 2001; CROWDER et al., 2004). 
Dok proteins function as scaffolding molecules with regulated membrane-targeting 
properties (WHITE and YENUSH, 1998; VAN DIJK et al., 2000; JACOBS et al., 2001; ZHAO et 
al., 2001). PH domains bind phospholipids and therefore serve as membrane-targeting 
domains (LEMMON and FERGUSON, 1998; LEMMON, 2004). Since most PH domains bind 
phospholipids with low affinity and specificity, it has been postulated that either post-
translational modifications or oligomerization might enable PH domains to bind membranes 
with greater avidity (LEMMON and FERGUSON, 2000). PTB domains are structurally related 
to PH domains (BORG and MARGOLIS, 1998; BLOMBERG et al., 1999). Some PTB domains 
may bind phospholipids (RAVICHANDRAN et al., 1997; HOWELL et al., 1999), but essentially 
they serve as protein-protein interaction modules (FORMAN-KAY and PAWSON, 1999; 
SCHLESSINGER and LEMMON, 2003). Recently it was discovered that many PTB domains 
can bind peptide sequences in a phosphorylation-independent (BORG et al., 1996) or in a 
tyrosine-independent manner (CHAREST et al., 1996; CHIEN et al., 1998; MEYER et al., 1999; 
ONG et al., 2000). In IRS and Dok proteins, PH and PTB domains co-exist (BEDIRIAN et al., 
2004). So far it seems that recruitment of the Dok family proteins to the plasma membrane 
can occur by various mechanisms, and is dependent on either the PH domain or the PTB 
domain or both. Although the interaction of Dok-1-3 with various negative regulators of 
BCR signalling and their recruitment to the membrane was reported by several groups, the 
physiologic processes regulated by Dok-1-3 in B lymphocytes remain poorly understood.  
 
2.3.2.  Transmembrane adaptor proteins 
The second large group of adaptors are integral membrane proteins. They lack modular 
protein-protein interaction domains present in cytosolic adaptors but contain mutiple 
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tyrosine-based signalling motifs, which are phosphorylated upon antigen receptor triggering. 
Based on these structural properties, transmembrane adaptors serve as anchors for SH2- and 
PTB-domain containing signalling molecules and recruit them to the plasma membrane. 
Transmembrane adaptor proteins can be further divided into lipid raft-associated and lipid 
raft-excluded molecules.  
To date, four lipid-raft associated transmembrane adaptors have been identified and cloned: 
LAT, the non-T cell activation linker (NTAL; also called linker for activation of B cells, 
LAB), PAG/Cbp, and the Lck-interacting molecule (LIME) (ZHANG et al., 1998b; BRDICKA 
et al., 2002; JANSSEN et al., 2003; BRDICKA et al., 2000; KAWABUCHI et al., 2000; 
BRDICKOVA et al., 2003; HUR et al., 2003). These four members are monomeric type III 
transmembrane proteins that share a common structure including a short extracellular 
domain, a single transmembrane domain, and a cytoplasmic tail possessing a palmitoylation 
motif (CxxC) juxtaposed to the transmembrane region, as well as multiple tyrosine-based 
signalling motifs (LINDQUIST et al., 2003; SIMEONI et al., 2005). The CxxC motif is 
responsible for lipid-raft targeting (ZHANG et al., 1998a; LIN et al., 1999). In contrast, the 
non-lipid raft transmembrane proteins T-cell receptor interacting molecule (TRIM), SHP-2 
interacting transmembrane adaptor protein (SIT), and linker for activation of X cells (LAX) 
all lack the CxxC motif.  
LAT is probably the best-studied transmembrane adaptor molecule and was first cloned in 
1998 (ZHANG et al., 1998b). It plays an important role in both TCR signalling and T cell 
development (ZHANG et al., 1999a). However, LAT is not only expressed in T lymphocytes 
but also in NK cells, mast cells, megakaryocytes, platelets, and in pre-B cells (GIBBINS et 
al., 1998; SARKAR, 1998; FACCHETTI et al., 1999; SU and JUMAA, 2003). The four 
membrane distal tyrosines (Y132, Y171, Y191 and Y226 in human) are preferentially 
phosphorylated upon TCR engagement, and serve as binding sites for the SH2 domains of 
Grb2 (Y171, Y191, and Y226), Grb2-related adaptor downstream of Shc (Gads) (Y171 and 
Y191), and PLC-γ1 (Y132) (FINCO et al., 1998; ZHANG et al., 1998b, 2000; LIN and WEISS, 
2001; ZHU et al., 2003). Since the SH2 domains of Gads and Grb2 are flanked by two 
additional SH3 domains, these two adaptors are capable of recruiting further signalling 
molecules to LAT. For example, the C-terminal SH3 domain of Gads binds to SLP-76 with 
high affinity (BERRY et al., 2002; LIU et al., 2003). SLP-76 itself also recruits further 
effector molecules to this complex such as the Tec family kinase Itk. To summarize, LAT 
acts as scaffold for several signalling complexes in T cells and couples the immediate 
signalling events upon TCR engagement to processes leading to T cell activation.  
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Identification of NTAL led researchers to believe that the B-cell paralog of LAT. This view 
was mainly supported by the fact that NTAL is closely related to LAT both structurally and 
evolutionarily (BRDICKA et al., 2002; JANSSEN et al., 2003). NTAL contains five potential 
Grb2 binding sites of the YxN type. SLP-65 translocates to lipid rafts upon BCR stimulation 
(FU et al., 1998). Gads and LAT paralogs have been speculated to mediate this 
translocation. However, NTAL has not been shown to associate with SLP-65 or PLC-γ2 
(BRDICKA et al., 2002; JANSSEN et al., 2003). Furthermore, ntal-/- mast cells show increased 
PLC-γ activity, increased inositol 1,4,5-trisphosphate (IP3) production, and increased Ca2+ 
mobilization (VOLNA et al., 2004; ZHU et al., 2004). Additionally, ntal-/- mice have normal 
B cell development and slightly increased BCR-induced Ca2+ mobilization and proliferation 
(ZHU et al., 2004; WANG et al., 2005). Thus, it was postulated that NTAL does not play a 
role in BCR signalling paralleling the role played by LAT in TCR signalling (WANG et al., 
2005).  
Mast cells or NK cells are positive for the endogenous expression of both transmembrane 
adaptors, whereas in B cells only NTAL is present (BRDICKA et al., 2002; JANSSEN et al., 
2003). It was shown that LAT and NTAL exist in distinct and heterogenous lipid raft 
compartments in mast cells (VOLNA et al., 2004) which could add to the complexity of 
transmembrane adaptor function. This was emphasized by the observation that LAX, which 
is excluded from lipid rafts, seems to negatively regulate mast cell signalling through 
NTAL. In sensitized lax-/- mast cells, NTAL expression is down-regulated, whereas LAT 
expression is not affected (ZHU et al., 2006).  
Collectively, the combinatorial expression of different transmembrane adaptor molecules 
may influence the signalling properties of a single adaptor in a positive or negative way. A 
final assessment of the redundancy of the transmembrane adaptors remains to be 
determined. 
 
2.4.  Ca2+: a universal second messenger 
Ca2+ ions are the most widely used second messengers in biology. Ca2+ is essential for the 
early development of organisms, for the diversity and plasticity of immune responses, and 
even for remembering what you are about to read on the following pages. In B lymphocytes, 
the intracellular Ca2+ concentration [Ca2+]i is a critical factor involved in the regulation of   
B cell fates including apoptosis, proliferation, and differentiation. Ca2+ ions exert their 
regulatory function principally via two mechanisms. Several proteins have a specific 
binding site for Ca2+ and their activity directly depends on Ca2+ binding, e.g. phospholipase 
A2 (PLA2) (WHITE et al., 1990) or PKC (reviewed in DEKKER and PARKER, 1994; 
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NEWTON, 1997; OANCEA and MEYER, 1998). Alternatively, Ca2+-mediated signal 
transduction is accomplished by its binding to proteins known as Ca2+ sensors which 
function as regulatory subunits of target proteins. Calmodulin is the most extensively 
studied example of this group of proteins (reviewed in WEINSTEIN and MEHLER, 1994; 
IKURA, 1996). For example, Ca2+-bound calmodulin regulates the calcineurin phosphatase 
complex (CRABTREE and OLSON, 2002; PARSONS et al., 2004) or Ca2+/calmodulin-
dependent protein kinase (CaMK) family members (MCKINSEY et al., 2000; MEANS, 2000).  
Basically, eukaryotic cells can elevate their cytoplasmic Ca2+ concentration by two 
methods: release from intracellular stores (see section 2.4.1) and Ca2+ influx through 
channels in the plasma membrane (see section 2.4.2) (PAREKH and PENNER, 1997; 
BERRIDGE et al., 2000; PAREKH and PUTNEY, 2005). However, [Ca2+]i will ultimately be 
determined by the balance between Ca2+ influx, cytoplasmic Ca2+ buffering, and Ca2+ 
removal, i.e. changes in the activity of sarcoplasmic/endoplasmic reticulum Ca2+-ATPases 
(SERCAs), mitochondrial Ca2+ uptake, plasmalemmal Na+-Ca2+-exchanger, or Ca2+-
ATPases in the plasma membrane will all affect [Ca2+]i (PAREKH and PUTNEY, 2005). By 
modulating the spatial or temporal amplitude, a single BCR can use the same second 
messenger Ca2+ to control a plethora of cellular processes. Additionally, Ca2+ signals often 
appear as regular oscillations whose frequency varies with the strength of the incoming 
signal (BERRIDGE, 1997a). These oscillations also influence the efficiency and specificity of 
gene expression (see section 2.6) (DOLMETSCH et al., 1998).  
 
2.4.1.  PLC-γ activation and Ca2+ release from intracellular stores 
In 1975 the year of my birth, Michell proposed that PLC is essential for the generation of 
cellular Ca2+ signals in response to hormones or neurotransmitters (MICHELL, 1975). During 
the interim the molecular basis for this role has been deciphered. PLC isozymes catalyze the 
hydrolysis of PI(4,5)P2 to the soluble Ca2+-mobilizing second messenger IP3 and the 
membrane-bound diacylglycerol (DAG), an activator of PKC.  
The mammalian PLCs can be divided into six subfamilies, designated β, γ, δ, ε, ζ, and η 
(HARDEN and SONDEK, 2006). The two members of the PLC-γ subfamily, PLC-γ1 and -γ2, 
are mainly regulated by receptor and non-receptor PTKs, and therefore mediate the 
responses downstream of the antigen receptors on lymphocytes (reviewed in RHEE and 
CHOI, 1992a, 1992b; REBECCHI and PENTYALA, 2000; KATAN et al., 2003). T lymphocytes 
mainly express the PLC-γ1 isoform, whereas PLC-γ2 is predominantly expressed in            
B lymphocytes (PARK et al., 1991; SECRIST et al., 1991; RHEE and BAE, 1997; HASHIMOTO 
et al., 2000; IRVIN et al., 2000; WANG et al., 2000; HIKIDA and KUROSAKI, 2005). 
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Both PLC-γ1 and -γ2 possess an N-terminal PH domain, followed by EF-hand motifs, the 
catalytic domain formed from the separated X and Y regions, and a C-terminal C2 domain. 
The catalytic regions X and Y are separated by an X/Y-spanning sequence, also known as   
Z region. The Z region contains an additional PH domain, split by two SH2 and a single 
SH3 domain (see figure 2.1). The domains of the Z region are critical to extrinsic regulation 
of the PLC-γ isoforms, but they also exert an intrinsic control on catalytic activity (see 
below) (reviewed in REBECCHI and PENTYALA, 2000). The precise mechanism of transition 
from an inactive to active form of PLC-γ remains a mystery, but certain requirements are 
well established. One such requirement is the translocation of the PLC-γ isoforms to the 
plasma membrane. The PH domain binds to the non-substrate lipid phosphatidyl-3,4,5-
trisphosphate [PI(3,4,5)P3], which is a product of PI3K (FALASCA et al., 1998). It is also 
possible, that other PLC-γ domains participate in direct interactions with membrane lipids, 
e.g. the C2 domain. A further requirement for PLC-γ stimulation is the phosphorylation of 
specific tyrosine residues (reviewed in REBECCHI and PENTYALA, 2000). In vitro, all three 
types of PTKs (Src, Syk, and Tec) are able to phosphorylate PLC-γ2. However, the 
kinase(s) involved in BCR-induced PLC-γ2 tyrosine phosphorylation are currently under 
investigation. By using antibodies specific for each of the putative phosphorylation sites, 
Kim et al. demonstrated that PLC-γ2 is phosphorylated on Y753, Y759, and Y1217 in response 
to BCR engagement of human Ramos B cells and murine splenic B cells (KIM et al., 2004). 
It has been proposed that phosphorylation of essential residues in the Z region such as Y783 
in PLC-γ1, or Y753 and Y759 in PLC-γ2, and/or other interactions with the SH2 or SH3 
domains could result in conformational changes which abolish an intramolecular inhibition 
imposed by the Z region (HOMMA and TAKENAWA, 1992; REBECCHI and PENTYALA, 2000). 
The phosphorylation-dependent assembly of the Ca2+ initiation complex in B lymphocytes, 
which is composed of SLP-65, Btk, and PLC-γ2, will be discussed in detail below.  
Other ways of PLC-γ activation, which are independent of tyrosine phosphorylation, have 
also been suggested (SEKIYA et al., 1999). For example, PLC-γ2 is activated in vitro by 
SH2-mediated binding of PI(3,4,5)P3 (BAE et al., 1998). Recently, Piechulek et al. suggested 
a novel mechanism of PLC-γ2 activation by Rac GTPases (PIECHULEK et al., 2005). 
However, a final model of PLC-γ2 activation upon BCR engagement has yet to be 
established, and will likely include membrane interaction, tyrosine phosphorylation, and 
association with adaptor molecules.  
IP3-generation by the PLC superfamily is a central process of Ca2+ mobilization from 
intracellular stores. These stores are held within the membrane systems of the endoplasmic 
reticulum (ER) or the sarcoplasmic reticulum (SR) of muscle cells. Ca2+ release from the 
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stores is controlled by various channels, of which the IP3 receptor (IP3R) and ryanodine 
receptor (RYR) families have been studied in the most detail. Principally, these channels are 
activated by Ca2+ itself, a process known as Ca2+-induced Ca2+ release (CICR) (BERRIDGE, 
1997b; BERRIDGE et al., 2000). Ca2+ mobilizing second messengers such as IP3 determine 
whether Ca2+ can activate these channels, i.e. the second messengers increase the Ca2+ 
sensitivity (BERRIDGE, 1997b; BERRIDGE et al., 2000). Ca2+ can regulate Ca2+ release by 
acting from either the lumenal or the cytoplasmic sides of the channels (BERRIDGE et al., 
2000). Cytosolic Ca2+ can either be stimulatory or inhibitory, largely depending on its 
concentration and the IP3R isoform. Three distinct ip3r genes have been identified so far 
(HIKIDA and KUROSAKI, 2005), and targeted disruption of these three genes in DT40 B cells 
abolishes BCR-induced Ca2+ mobilization from intra- and extracellular sources (see also 
section 2.4.2) (SUGAWARA et al., 1997). It seems that IP3 makes IP3Rs more sensitive to the 
stimulatory action of Ca2+ (BOOTMAN and LIPP, 1999). Another intracellular IP3R agonist is 
ATP (IINO, 1991; BEZPROZVANNY and EHRLICH, 1993), and the channel activity of IP3Rs is 
further modulated by serine and tyrosine phosphorylation (NAKADE et al., 1994; 
JAYARAMAN et al., 1996). The Ca2+ signalling properties differ significantly among these 
three IP3R isoforms, as shown in DT40 cells expressing only a single isoform (MIYAKAWA 
et al., 1999). These differences in spatiotemporal Ca2+ signals might be partially caused by 
differential Ca2+ sensitivity of the IP3Rs (MIYAKAWA et al., 2001). Therefore, the 
differential expression and post-translational modifications of the three IP3Rs contribute to 
the generation of transient, sustained, or oscillatory Ca2+ signals.  
 
2.4.2.  Ca2+ entry across the plasma membrane 
Various Ca2+ channels mediate the influx of Ca2+ ions across the plasma membrane. They 
are defined by the method of activation. One can distinguish three major pathways by which 
extracellular Ca2+ can enter cells: voltage-operated Ca2+ channels (VOCCs), ligand-gated 
non-specific cation channels (LGCCs), and receptor-activated Ca2+ channels (RACCs) 
(BARRITT, 1999). VOCCs are found in excitable cells like nerve and muscle cells, but are 
largely excluded from non-excitable cells and are activated by membrane-depolarization. 
Since membrane-depolarization does not initiate lymphocyte activation, the role of VOCCs 
in lymphocytes has been unclear (GALLO et al., 2006). However, emerging evidence 
suggests that channels with L-type (subtype of VOCCs) Ca2+ channel characteristics exist in 
lymphocytes (SADIGHI AKHA et al., 1996; GRAFTON et al., 2003; GOMES et al., 2004; GALLO 
et al., 2006). LGCCs channels open in response to binding of an extracellular ligand, 
typically transmitters such as glutamate, ATP, or acetylcholine (BERRIDGE et al., 2000). 
RACCs are channels which are sensitive to various signals generated following receptor 
Introduction 
 
16
activation. They are defined as any Ca2+ plasma membrane channel that opens as a result of 
the binding of an agonist to its receptor, where the receptor protein is distinct from the 
channel protein, and the activation mechanism does not involve membrane depolarization 
(BARRITT, 1999). Since receptor activation generates multiple signals, RACCs can be 
subdivided into receptor-operated channels (ROCs) and store-operated channels (SOCs). 
The term ROC refers to Ca2+ channels whose opening does not depend on store-emptying. 
Frequently ROCs are activated by intracellular second messengers, e.g. DAG (HOFMANN et 
al., 1999), arachidonic acid (BROAD et al., 1999; MIGNEN and SHUTTLEWORTH, 2000), 
cyclic nucleotides (FINN et al., 1996; APPLEGATE et al., 1997; LENZ and KLEINEKE, 1997), 
or inositol phosphates (BARRITT, 1999; PAREKH and PUTNEY, 2005). Therefore, they are 
also designated as second messenger-operated channels (SMOCs) (PAREKH and PUTNEY, 
2005). Additionally, trimeric G proteins were reported to link receptor proteins to ROCs 
(FASOLATO et al., 1993; BARRITT, 1999). The SOC-mediated Ca2+ entry, also known as 
capacitative Ca2+ entry CCE), is thought to be the major pathway in electrically non-
excitable cells, and is activated by the emptying of intracellular stores (PAREKH and 
PENNER, 1997; PAREKH and PUTNEY, 2005). The best characterized store-operated current is 
the Ca2+ release activated Ca2+ current (ICRAC) (HOTH and PENNER, 1992; reviewed in 
PAREKH and PENNER, 1997; PAREKH and PUTNEY, 2005), which is defined by certain 
electrophysiological properties. In spite of extensive research, the following aspects of 
SOC-mediated Ca2+ influx remain unclear: 1) the signal that relays the Ca2+ store content to 
the SOCs in the plasma membrane, 2) the molecular indentity of the Ca2+ sensor in the 
stores, and 3) the molecular identity of CRAC? 
To address the first question, four different models have been proposed (PUTNEY et al., 
2001). In the first model, a diffusible messenger is released from the depleted stores into 
the cytosol where it then diffuses to the plasma membrane and opens SOCs. Various 
diffusible messengers have been reported, e.g. the Ca2+ influx factor (CIF), PKC, 
lysophospholipid, or calmodulin (reviewed in PAREKH and PUTNEY, 2005). In the second 
model, plasmalemmal SOCs are activated by the direct binding of IP3Rs, which sense the 
fall in Ca2+ levels through Ca2+ binding sites on their lumenal domains. The physical 
interaction might occur in a preformed complex (conformational coupling), or upon 
movement of the peripheral ER (secretion-like coupling) (IRVINE, 1990; KISELYOV et al., 
1999; PATTERSON et al., 1999; PAREKH and PUTNEY, 2005). Basically three lines of 
evidence have led to the suggestion that IP3Rs can activate store-operated channels. First, 
co-immunoprecipitation experiments indicated that IP3Rs can associate with certain 
members of the canonical transient receptor potential (TRPC) family (BOULAY et al., 1999; 
KISELYOV et al., 1999; ROSADO et al., 2002), which are candidates for store-operated 
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channels (see below). Second, IP3Rs seem to activate endogenously expressed store-
operated channels in excised patches (ZUBOV et al., 1999; KAZNACHEYEVA et al., 2000). 
Third, the IP3R antagonist 2-aminoethoxydiphenylborane (2-APB) inhibits store-operated 
Ca2+ influx even when applied following thapsigargin activated Ca2+ influx (MA et al., 
2000). Thapsigargin is an inhibitor of SERCAs and thapsigargin-induced Ca2+ release relies 
on the passive leak of Ca2+ through unidentified channels. However, the 
conformational/secretion-like coupling model has been challenged by several observations. 
For example, Ca2+ influx induced by thapsigargin-evoked store depletion was not affected in 
ip3r-/- DT40 cells (SUGAWARA et al., 1997). Furthermore, neither CCE in lacrimal cells nor 
ICRAC in RBL mast cells is blocked by the intracellular application of the competitive IP3R 
antagonist heparin (BIRD et al., 1991; BROAD et al., 2001). In the third model for SOC 
activation, SOCs do not reside in the plasma membrane in the resting state, but are inserted 
into the membrane upon store depletion via an exocytotic mechanism (vesicular fusion 
model). Finally, it has been postulated that SOCs are maintained in an inactive state due to 
an elevated Ca2+ concentration in their immediate vicinity. Store depletion removes this 
inhibition by enhancing Ca2+ removal from those sites, presumably by the activity of 
SERCAs (removal of Ca2+ inhibition) (BARRITT, 1998). However, it is likely that different 
cell types employ different mechanisms, and that SOCs are regulated by multiple pathways 
(reviewed in PUTNEY et al., 2001).   
Progress has been made in the identification of the molecular Ca2+ sensor in the stores. It 
has been recently postulated that the stromal interaction molecule 1 (STIM1) plays an 
essential role in SOC activation, possibly by sensing the Ca2+ content of the ER (LIOU et al., 
2005; ROOS et al., 2005). STIM1 contains a single membrane-spanning domain and is 
located both in the plasma membrane and intracellular membranes, presumably the ER 
(MANJI et al., 2000). The N-terminus contains an EF-hand domain and is orientated toward 
the extracellular space or the ER lumen. Thus, STIM1 may serve as Ca2+ sensor (LIOU et al., 
2005; ROOS et al., 2005). Since STIM1 was also reported to homo-oligomerize (WILLIAMS 
et al., 2002), it has been speculated that a STIM1-STIM1 interaction links the ER with the 
plasma membrane (ROOS et al., 2005), similar to the coupling models of SOC activation 
described above. In accordance, Liou et al. reported that STIM1 rapidly redistributes into 
puncta near the plasma membrane after store depletion (LIOU et al., 2005). Subsequently 
two alternative methods of STIM1 function were proposed. First, STIM1 located in the ER 
unbinds Ca2+ upon store depletion, and translocates to the plasma membrane for SOC 
activation, similar to the vesicular fusion model of SOC activation described above. Second, 
STIM1 forms a functional SOC with other STIM1 molecules and perhaps additional 
components (ZHANG et al., 2005). Taken together, it is possible that STIM1 is the long 
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sought sensor of Ca2+ store content. However, STIM1 communication with SOCs remains at 
best uncertain.  
Members of the transient receptor potential (TRP) family of ion channels have been 
implicated in store-operated Ca2+ entry. The TRP family can be subdivided into six families, 
i.e. canonical (TRPC), vanilloid (TRPV), melastatin (TRPM), polycystin (TRPP), mucolipin 
(TRPML), and ankyrinTM1 (TRPA) (CLAPHAM, 2003). Although experimental evidence 
has suggested that TRPs may be part of SOCs this remains a controversial issue. For 
example, two different groups expressed TRPC3 in DT40 B lymphocytes. The first group 
demonstrated that the formed channels were store-operated (VAZQUEZ et al., 2001), whereas 
the second group observed that the channels were not store-operated but activated by DAG 
(VENKATACHALAM et al., 2001). Subsequent studies revealed that the expression level of 
TRPC3 was responsible for these distinct behaviours: at low levels TRPC3 is store-
operated, and at high levels receptor-operated (VAZQUEZ et al., 2003). It seems that the 
exogenous expression of a given TRP protein might not result in the correct stoichiometry 
needed for the formation of functional complexes with other TRPs or additional components 
(PAREKH and PUTNEY, 2005). However, it is accepted that there are alternative ways of TRP 
activation, including lipid metabolites. For example, TRPC3, TRPC6 and TRPC7 are 
directly activated by DAG (HOFMANN et al., 1999; OKADA et al., 1999; VENKATACHALAM 
et al., 2001). Conversely, TRPM7 is positively regulated by PI(4,5)P2 and inactivated by 
PI(4,5)P2 hydrolysis (RUNNELS et al., 2002). Furthermore, it was observed that PLC-γ 
directly binds to TRPC1 (TU et al., 2005), TRPC2 (TONG et al., 2004), TRPC3 (PATTERSON 
et al., 2002; CLAPHAM, 2003; VAN ROSSUM et al., 2005) and TRPM7 (RUNNELS et al., 
2002), indicating lipase-independent functions of   PLC-γ. 
Collectively, many questions concerning SOC activation remain unanswered. Hence, future 
investigations should focus on the expression levels and the native environment of channel 
components. Furthermore, the regulation of plasma membrane resident Ca2+ channels by 
lipid mediators or lipase-independent functions of PLC-γ merits attention.  
 
2.4.3.  Principles of receptor-induced Ca2+ mobilization 
The three main pathways of receptor-induced Ca2+ mobilization are summarized in figure 
2.2 (modified from PATTERSON et al., 2005). (1) Agonist binding by plasmalemmal 
receptors leads to IP3 production by PLC isozymes. The soluble IP3 sensitizes IP3Rs in the 
ER, resulting in the Ca2+ release from the stores. (2) The ER transmits information back to 
Ca2+ channels in the plasma membrane. This might occur via the models described above, 
or a combination of these. (3) Alternatively, the plasma membrane receptors transduce the 
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signal directly to the Ca2+ channels in the same membrane. This might occur either via 
conformational changes upon agonist binding or via signalling molecules, i.e. proteins (e.g. 
PLC itself) or lipid mediators (e.g. DAG, arachidonic acid).   
     
 
 
2.5.  Antigen receptor-induced Ca2+ mobilization in B lymphocytes 
The central process of BCR-induced Ca2+ mobilization is the phosphorylation-dependent 
assembly of the Ca2+ initiation complex, containing SLP-65, Btk, and PLC-γ2. Upon BCR 
engagement, SLP-65 becomes tyrosine phosphorylated by activated Syk, and serves as 
scaffold for the SH2-dependent binding of both Btk and PLC-γ2. Thus Btk and PLC-γ2 are 
brought into close proximity with each other, resulting in the Btk-dependent PLC-γ2 
phosphorylation (KUROSAKI et al., 2000; WIENANDS, 2000b). 
It has been previously demonstrated that the PLC-γ2 SH2 domains are essential for coupling 
BCR to PLC-γ2 activation (TAKATA et al., 1995). In subsequent studies using slp-65-/- DT40 
B cells, it was shown that SLP-65 is required for the translocation of PLC-γ2 to the 
membrane and for its subsequent phosphorylation/activation (FU et al., 1998; JUMAA et al., 
1999; SU et al., 1999; WOLLSCHEID et al., 1999; ISHIAI et al., 1999a, 1999b; KUROSAKI and 
TSUKADA, 2000). Furthermore, tyrosine-phosphorylated SLP-65 is also recognized by the 
SH2 domain of Btk (HASHIMOTO et al., 1999; SU et al., 1999). Association of Btk and   
PLC-γ2 with the same SLP-65 molecule was demonstrated to elicit functional Ca2+ 
signalling (CHIU et al., 2002). 
Figure 2.2: Receptor-induced Ca2+ 
mobilization 
Principle steps of the receptor-induced Ca2+ 
mobilization from intra- and extracellular 
sources. (1) Agonist-binding by plasmalemmal 
receptors leads to PLC-mediated IP3 
production, resulting in Ca2+ release from the 
stores. (2) The ER transmits information back 
to Ca2+ channels in the plasma membrane. 
Several mechanisms have been proposed for 
this step, including a diffusible messenger, 
coupling processes, vesicular trafficking, 
removal of Ca2+ inhibition. (3) The receptors in 
the plasma membrane might directly activate 
the Ca2+ channels within the same membrane, 
e.g. via conformational changes or signalling 
molecules (modified from PATTERSON et al., 
2005). 
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As described above, the exact mechanism of BCR-induced PLC-γ2 tyrosine 
phosphorylation remains to be established. Since both SLP-65 phosphorylation, and Btk 
activation occur downstream of Lyn/Syk activation it is difficult to prove whether PLC-γ2 is 
a direct substrate for these two kinases. Based on the following two observations it was 
proposed that PLC-γ2 is a substrate of Btk. First, co-expression of Btk and PLC-γ2 resulted 
in PLC-γ2 tyrosine phosphorylation (FLUCKIGER et al., 1998), and second, PLC-γ2 tyrosine 
phosphorylation was substantially (but not completely) decreased in btk-/- DT40 cells 
(TAKATA and KUROSAKI, 1996). As stated above, PLC-γ2 is phosphorylated on Y753, Y759, 
and Y1217 in response to BCR engagement (KIM et al., 2004). It appears that Btk is mainly, 
but not completely responsible for the phosphorylation of Y753 and Y759 (KIM et al., 2004). 
In contrast, Y1217 seems to be phosphorylated by a Btk-independent pathway. Collectively, 
more experiments must be performed to establish a comprehensive model of PLC-γ2 
activation within the cellular environment. Greater complexity is further generated by recent 
observations that PLC-γ isozymes exhibit several lipase-independent activities affecting 
BCR-induced Ca2+ mobilization (PATTERSON et al., 2002; VAN ROSSUM et al., 2005; YU et 
al., 2005). 
To rescue SLP-65 deficiency, SLP-76 has to be co-expressed with LAT and Gads (ISHIAI et 
al., 2000). This implies that SLP-65 is recruited to the plasma membrane by molecules that 
cannot interact with SLP-76 or that SLP-65 can mediate its own membrane translocation. A 
LAT/Gads paralogous pair that is capable of mediating SLP-65 membrane recruitment 
remains to be described in B lymphocytes. Thus, it was investigated whether SLP-65 is able 
to mediate its own membrane translocation. In support of this model, two alternative and 
mutually non-exclusive paths have been reported to date. First, it was shown that the     
SLP-65 SH2 domain binds to a phosphorylated non-ITAM tyrosine in the cytoplasmic tail 
of Ig-α (ENGELS et al., 2001; KABAK et al., 2002). Second, recent work indicates that a 
leucine-zipper motif at the N-terminus of SLP-65 is necessary and sufficient for membrane 
localization (KOHLER et al., 2005). Since this association of SLP-65 does not require BCR 
signalling, it might be that there are alternative ‘pools’ of SLP-65.  
Both Btk and PLC-γ2 possess PH domains that bind selectively to the PI3K product 
PI(3,4,5)P3 (FALASCA et al., 1998; SATTERTHWAITE et al., 1998; MARSHALL et al., 2000). 
These associations may stabilize the recruitment of the Ca2+ initiation complex to the 
plasma membrane. A PI3K-induced translocation to the membrane and activation of PLC-γ2 
has been reported in fibroblasts (RHEE and BAE, 1997; BAE et al., 1998; FALASCA et al., 
1998), and PI3K-dependent membrane recruitment of both PLC-γ2 and Btk has been 
demonstrated in mouse megakaryocytes (BOBE et al., 2001). It was also demonstrated that 
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PI(3,4,5)P3 acts both at the level of Btk-mediated PLC-γ2 tyrosine phosphorylation, and as 
an activator of the lipase activity of the phosphorylated PLC-γ2 (KIM et al., 2004). Thus, 
PI3K activation is generally considered to contribute to PLC-γ2 activation. Heterodimer-
type (class Ia) PI3Ks are composed of a catalytic subunit (p110; isoforms α, β, γ and δ) and 
a regulatory subunit encoded by at least three distinct genes (p85α, p85β, p55γ) (figure 2.1; 
VANHAESEBROECK et al., 1997; FRUMAN et al., 1998; RAMEH and CANTLEY, 1999; 
CANTRELL, 2001). Activated Syk phosphorylates the B cell co-receptor CD19, and B-cell 
adaptor for PI3K (BCAP) which provide binding sites for PI3Ks (TUVESON et al., 1993; 
OKADA et al., 2000; OKKENHAUG and VANHAESEBROECK, 2003). Thus, Syk has a positive 
regulatory role in BCR-induced Ca2+ mobilization not only through SLP-65 
phosphorylation, but also through PI3K activation. The importance of PI(3,4,5)P3 is further 
evidenced by the deletion of SHIP. This enzyme antagonizes the catalytic activity of PI3K 
by generating phosphatidyl-3,4-bisphosphate [PI(3,4)P2] from PI(3,4,5)P3. SHIP deficiency 
leads to increased PI(3,4,5)P3 levels, and thus to enhanced PLC-γ2 activation (BRAUWEILER 
et al., 2000). Several positive and negative feedback loops in BCR-induced Ca2+ 
mobilization that contribute to fine-tuning Ca2+ responses in B lymphocytes have been 
described, and target the catalytic activities of Syk, Btk, or PLC-γ2, respectively (reviewed 
in HIKIDA and KUROSAKI, 2005).  
Although many details regarding the assembly of the Ca2+ initiation complex in                   
B lymphocytes have been clarified during the last years, central aspects remain unclear. 
What is the exact activation mechanism of PLC-γ2? How is the Ca2+ initiation complex 
translocated to the plasma membrane? What is the role of universal and B cell-specific 
adaptor proteins in the modulation of BCR-induced Ca2+ mobilization? 
 
2.6.  Effects of Ca2+ on B cell responses  
It has been shown that B cells mobilize Ca2+ to different extents from intracellular stores 
and across the plasma membrane depending on their developmental stage. Ca2+ entry 
through channels in the plasma membrane increases with maturation (KONCZ et al., 2002; 
KOVESDI et al., 2002). The Ca2+ signal patterns within a given cell can occur as single 
transients, as sustained plateau, or as oscillations (BERRIDGE, 1993; CLAPHAM, 1995). It was 
demonstrated that the different patterns influence the specificity of cellular responses. A 
major consequence of Ca2+ mobilization is activation of Ca2+-sensitive transcription factors, 
including NFAT and NF-κB (BAEUERLE and HENKEL, 1994; CRABTREE and CLIPSTONE, 
1994; FRANTZ et al., 1994; NEGULESCU et al., 1994; RAO, 1994; FANGER et al., 1995; 
SHIBASAKI et al., 1996; TIMMERMAN et al., 1996). It was reported that the amplitude and 
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duration of Ca2+ signals in B lymphocytes control the differential activation of NFAT and 
NF-κB (DOLMETSCH et al., 1997). NF-κB is selectively activated by a large transient rise in 
[Ca2+]i, whereas NFAT activation requires a low sustained Ca2+ plateau (DOLMETSCH et al., 
1997). Additionally, oscillations reduce the effective Ca2+ threshold for the activation of 
transcription factors (DOLMETSCH et al., 1998). Furthermore, oscillation frequency was 
shown to control specificity, i.e. rapid oscillations stimulate both NFAT and NF-κB, while 
infrequent oscillations activate only NF-κB (DOLMETSCH et al., 1998). The importance of 
differential Ca2+ signalling for immune responses could also be demonstrated in different 
anergy mouse models. In the hen egg lysozyme (HEL) mouse model, mice with B cells 
specific for HEL are crossed with mice expressing HEL as a soluble ‘neo-self antigen’.       
B cells from those double-transgenic mice are rendered anergic by chronic exposure to HEL 
in vivo (MASON et al., 1992; HEALY and GOODNOW, 1998). These self-tolerant B cells 
reveal an increased basal level in [Ca2+]i and a concomitant increase in resting nuclear levels 
of NFAT (HEALY et al., 1997). Furthermore, the self-tolerant B cells fail to evoke a BCR-
induced large Ca2+ transient observed in naïve non-tolerant control B cells (COOKE et al., 
1994; HEALY et al., 1997). These results were recently extended by using the B cell anergy 
model of ‘Ars/A1’ transgenic mice (BENSCHOP et al., 2001). It was shown that maintenance 
of B cell anergy requires constant BCR occupancy and signalling. Removal of self-antigen 
reduced basal [Ca2+]i to normal levels and recovered BCR-induced Ca2+ mobilization 
(GAULD et al., 2005). 
The importance of a certain level of PLC-γ activity for B cell development was described. 
PLC-γ2-deficient mice exhibit a partial block at the developmental transition following pre-
BCR signalling and a more complete block at the transition from immature to mature          
B lymphocytes (HASHIMOTO et al., 2000; WANG et al., 2000; HIKIDA et al., 2003; BELL et 
al., 2004; HIKIDA and KUROSAKI, 2005). In plc-γ2-/- plc-γ1+/- mice, the block from pro- to 
pre-B-cell transition was more complete, and allelic exclusion of the IgH chain locus was 
perturbated (WEN et al., 2004). 
The studies described above support the importance of Ca2+ signalling in B cell biology, e.g. 
in transcriptional regulation, tolerance induction, or allelic exclusion. Thus, a principle focus 
of this thesis is the regulation and fine-tuning of BCR-induced Ca2+ mobilization. In the 
experiments presented herein, DT40 B lymphocytes and derivatives that were rendered 
deficient for central components of B cell signalling pathways were applied to gain a greater 
understanding of the involvement of adaptor proteins in central BCR-triggered processes, 
i.e. tyrosine phosphorylation and Ca2+ mobilization.  
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3.  Aims of work 
This thesis addressed the question whether Ca2+ mobilization in B cells is controlled by 
mechanisms that are analogous to TCR-mediated signalling. This working hypothesis was 
investigated using the DT40 B cell model system, which is prone to a high frequency of 
homologous recombination, and therefore a suitable tool for gene disruption and subsequent 
reconstitution experiments. 
 
The hypothesis was investigated by the following two approaches: 
 
1) Defining the role of Grb2 in BCR signal transduction. 
Gads is an essential component of TCR-induced Ca2+ mobilization but plays only a minor 
role in BCR signal transduction. Thus, this thesis analyses whether the adaptor Grb2 plays a 
functionally similar role in BCR-induced Ca2+ mobilization using grb2-/- DT40 cells. The 
function of Grb2 after BCR engagement is investigated by reconstitution experiments with 
different Grb2 mutants. This approach should lead to the elucidation of effector proteins 
downstream of Grb2. Following the identification of these mediators, their role in BCR 
signal transduction can be further analysed by gene targeting in DT40 cells. 
 
2) Defining the role of NTAL in BCR-induced Ca2+ mobilization. 
The recently identified transmembrane adaptor NTAL is closely related to LAT which is 
instrumental in localizing the TCR-controlled Ca2+ initiation complex to the plasma 
membrane. Thus, the impact of NTAL on BCR-initiated Ca2+ signalling was investigated by 
generating ntal-/- DT40 cells, and reconstitution experiments with wild-type chicken NTAL, 
and derivatives in which lipid raft targeting, and tyrosine-based signalling motifs were 
inactivated.  
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4.  Material and Methods 
 
4.1.  Materials 
All chemicals and biologically reactive reagents were purchased from Roth, Sigma/Aldrich 
(Fluka), Merck, Invitrogen (Gibco; Molecular Probes), Uptima, Becton Dickinson, or 
Amersham Biosciences. All chemicals were purchased in pA quality unless otherwise 
indicated.  
 
4.1.1.  Antibodies 
 
Table 4.1: Primary antibodies (IB, immunoblot; IP, immunopurification) 
antibody supplier/reference application 
rabbit-anti-Grb2 (C-23)  Santa Cruz Biotechnolgoy IB, IP 
mouse-anti-Grb2 (3F2) upstate IB 
rabbit-anti-actin Sigma IB 
rabbit-anti-chicken SLP-65 ISHIAI et al., 1999b IB, IP 
rabbit-anti-PLC-γ2 (Q-20) Santa Cruz Biotechnolgoy IB, IP 
rabbit-anti-mouse NTAL this thesis IB 
rabbit-anti-chicken NTAL this thesis IB, IP 
rabbit-anti-chicken Lyn TAKATA et al., 1994 IB, IP 
rabbit-anti Lyn (44) Santa Cruz Biotechnolgoy IB 
mouse-anti-phosphotyrosine 
(pTyr) (4G10) 
upstate IB, IP 
mouse-anti-HA* (F-7) Santa Cruz Biotechnolgoy IB, IP 
rat-anti-HA* (3F10) Roche IB, IP 
rabbit-anti-LAT (FL-233) Santa Cruz Biotechnolgoy IB, IP 
rabbit-anti-mouse Dok-3 LEMAY et al., 2000 IB, IP 
mouse-anti-chicken IgM (M4) SouthernBiotech DT40 stimulation 
mouse-anti-chicken IgM (M4) hybridoma (CHEN et al., 1982) 
(Riken Cell Bank 1611)  
DT40 stimulation 
goat-anti-chicken IgM FITC Bethyl Laboratories FACS analysis 
*HA = eleven amino acid peptide derived from influenza hemagglutinin (YPYDVPDYA) 
 
 
(continued on next page) 
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antibody supplier/reference application 
F(ab')2 fragment goat anti-
mouse IgG, F(ab')2 fragment 
specific 
Jackson ImmunoResearch K46/ IIA1.6 
stimulation 
F(ab')2 fragment goat anti-
mouse IgG + IgM (H+L) 
Jackson ImmunoResearch WEHI231 stimulation 
F(ab')2 fragment goat anti-
human IgM, Fc5μ fragment 
specific 
Jackson ImmunoResearch Ramos stimulation 
 
Table 4.2: Secondary antibodies 
antibody supplier application 
goat-anti-rabbit IgG/HRPO Pierce immunoblot 
goat-anti-rat IgG/HRPO Pierce immunoblot 
goat-anti-mouse IgG/HRPO Pierce immunoblot 
 
 
4.1.2.  Enzymes 
Restriction endonucleases  New England Biolabs, MBI Fermentas, 
GibcoBRL (Invitrogen) 
Calf Intestine Phosphatase (CIP)   New England Biolabs 
T4 DNA Ligase     Promega, New England Biolabs 
Taq DNA polymerase    New England Biolabs 
Taq PCR Master Mix Kit    Qiagen 
DNA polymerase I, Large (Klenow) fragment New England Biolabs 
LA-Taq DNA Polymerase    Takara (Cambrex) 
PrimeStar DNA Polymerase    Takara (Cambrex) 
Pfu DNA Polymerase     Promega 
Elongase Polymerase Mix    Invitrogen 
Moloney murine leukemia virus  
reverse transcriptase (MMLV-RT)   MBI Fermentas 
LR Clonase Mix     Invitrogen 
Topoisomerase     Invitrogen 
PNGase F      New England Biolabs 
 
 
Material and Methods 
 
 
26
4.1.3. Vectors and cDNAs 
Table 4.3: Vectors 
vector source/supplier application 
cloning vectors 
pCR2.1-Topo Invitrogen T/A cloning (4.2.1.17.) 
pCRII-Topo Invitrogen T/A cloning (4.2.1.17.) 
pENTR/SD/D-Topo Invitrogen entry vector (4.2.1.18.)  
pBluescript SK II (–) Stratagene targeting constructs 
p-neo T. Kurosaki neomycin resistance cassette for targeting 
constructs (with β-actin promotor) 
p-hisD T. Kurosaki histidinol resistance cassette for targeting 
constructs (with β-actin promotor) 
pJG4-5 DT40 cDNA 
library 
T. Kurosaki amplification of complete chicken dok-3 
cDNA ends (see below) 
pEGFP-N1   BD Biosciences Clontech cloning of mLyn/EGFP construct 
pcDNA6/TR Invitrogen amplification of blasticidin resistance cDNA 
for generation of pMSCVblast 
bacterial expression vectors 
pGEX-3X Amersham Biosciences expression of GST/chNTAL(aa150-198) 
and GST/mNTAL(aa155-203) (4.2.3.1.) 
pGEX-4T-1 Amersham Biosciences/ 
A. Grabbe 
 
expression of GST/mGrb2[SH2] and 
GST/mGrb2[cSH3] (4.2.3.1.) 
mammalian expression vectors 
pApuroII T. Kurosaki expression of chicken Dok-3 
pApuroII/DEST A T. Kurosaki expression of mouse NTAL, chicken NTAL, 
and chicken NTAL HA 
pMSCVpuro BD Biosciences Clontech expression of mouse Grb2, chicken Grb2, 
human LAT, and variants 
pMSCVpuro/DEST A B. Stork expression of chicken NTAL HA and variants 
pMSCVblast B. Stork expression of mLyn/EGFP  
p5N-M-IRES-hph M. Jücker expression of Grb2[R86K] (figure 5.13) 
MI165 T. Kurosaki expression TM-PLC-γ2  
pHCMV-VSV-G M. Jücker expression of VSV-G/ pseudo-typing of 
retroviruses(4.2.2.6. and 4.2.2.7.) 
DEST = destination vector for Gateway® technology (see 4.2.1.18.) 
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Table 4.4: cDNAs 
cDNA source/supplied by expression vector 
chicken grb2 DT40 wt cells pMSCVpuro 
p5N-M-IRES-hph 
mouse grb2 A. Grabbe pMSCVpuro 
chicken ntal DT40 wt cells pApuroII/DEST A 
pMSCVpuro/DEST A 
mouse ntal V. Horejsi pApuroII/DEST A 
human lat J. Wienands pMSCVpuro 
mouse lyn M. Reth pMSCVblast 
chicken dok-3 DT40 wt cells pApuroII 
 
Chicken grb2, ntal, and dok-3 cDNAs were amplified from wild-type DT40 cDNAs (see 
4.2.1.15. and 4.2.1.16.). Complete chicken dok-3 cDNA ends were amplified from the 
pJG4-5-based DT40 cDNA library. Coding sequences for variants of chicken Grb2, chicken 
NTAL, and human LAT, respectively were generated by site-directed mutagenesis 
(4.2.1.16.). Expression cassettes encoding either C-terminally HA-tagged chicken NTAL or 
TM-Grb2 were generated by PCR. The tm-grb2 cDNA encompasses ntal base pairs 1-282 
and full length grb2 cDNA at the 3’ end (4.2.1.16.).  
 
4.1.4.  Oligonucleotides 
All oligonucleotides were synthesized by MWG-Biotech (Ebersberg, Germany), Invitrogen 
(Japan), or Proligo (Japan). 
Table 4.5 : Oligonucleotides 
Primer Sequence (5`→3`) Application 
chGrb2for atg gaa gcc atc gcc aaa tac g cDNA amplification 
chGrb2rev cta gat gtt ccg gtt cac tg cDNA amplification 
chGrb2_W36Kfor gaa tgt gat cag aat aag tac aag gca gaa ctc mutagenesis 
chGrb2_W36Kfor gag ttc tgc ctt gta ctt att ctg atc aca ttc mutagenesis 
chGrb2_R86Kfor tgc ctt cct tat caa gga gag tga gag tgc mutagenesis 
chGrb2_R86Kfor gca ctc tca ctc tcc ttg ata agg aag gc mutagenesis 
chGrb2_W193Kfor aat tct gac ccc aac aag tgg aag gga gcc tg mutagenesis 
chGrb2_W193Kfor cag gct ccc ttc cac ttg ttg ggg tca gaa ttg mutagenesis 
chNTALfor5 atg tgg ctg ggc cat ggc gca g cDNA amplification 
chNTALrev2 ctt cac ttt gac agc acg acg cDNA amplification 
(continued on next page) 
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Primer Sequence (5`→3`) Application 
chNTALentry_for cac cat ggc gca gcc gga gct gct g cloning 
chNTALentry_rev tca ctt tga cag cac gac ggc cloning 
chNTALentry_revHA tca ggc gta gtc tgg cac atc gta ggg gta ctt tga 
cag cac gac ggc atc 
cloning 
chNTAL_Y95Ffor tgc tga gcc ccg ctt cca gaa ctt cct gac mutagenesis 
chNTAL_Y95Frev gtc agg aag ttc tgg aag cgg ggc tca gca mutagenesis 
chNTAL_Y136Ffor gga ctc gca ttc ctt cca aaa cgt cat cat tg mutagenesis 
chNTAL_Y136Frev caa tga tga cgt ttt gga agg aat gcg agt cc mutagenesis 
chNTAL_Y155Ffor tga tgc aga aga ctt cga gaa cag  cac agc mutagenesis 
chNTAL_Y155Frev gct gtg ctg ttc tcg aag tct tct gca tca mutagenesis 
chNTAL_Y184Ffor tga gga gcc aga ctt cgt gaa cac gga ccc mutagenesis 
chNTAL_Y184Frev ggg tcc gtg ttc acg aag tct ggc tcc tca  mutagenesis 
chNTAL_C23,26Afor tgg ctg tca gtg ccg ccg tca ggg ccc agc mutagenesis 
chNTAL_C23,26Arev gct ggg ccc tga cgg cgg cac tga cag cca mutagenesis 
NTALgenfor1 gct ctc cat gcc tgg att tct cct gg genomic PCR 
NTALgenrev2 cac aca tca ccc tgg gtc act tct ac genomic PCR 
probegenfor2 cgc tgc tta cct gta agt tca cgc ac probe for Southern 
probegenfor2 tca aca ctg tga ggg atc agc gtg g probe for Southern 
chNTALpep3for gag gaa ttc aga tga tgc aga aga cta c GST fusion protein 
chNTALpep3rev gag gaa ttc tca ctt tga cag cac gac  GST fusion protein 
mNTALpep3for cag gaa ttc aga gga ctt tga gga tta c GST fusion protein 
mNTALpep3rev cca gaa ttc cta gat gtt ctc tgc tgc GST fusion protein 
hNTALfor1 tgg agg atc cag cat ctt cca ggt ac  cDNA amplification 
hNTALrev1 ggg tga cag ctt atc cta aat cct gc cDNA amplification 
hLATforBgl aaa aga tct atg gag gag gcc atc ctg  cloning 
hLATrevEco aaa gaa ttc tca gtt cag ctc ctg cag  cloning 
hLAT_Y132Ffor atc aca acc cag gct tcc tgg tgg tgc ttc c mutagenesis 
hLAT_Y132Frev gaa gca cca cca gga agc ctg ggt tgt gat ag mutagenesis 
NTALfor atg gcg cag ccg gag ctg ctg  TM-Grb2 construct 
bridge2for gag agc agt gct gag ccc cgc atg gaa gcc atc 
gcc aaa tac 
TM-Grb2 construct 
bridge2rev cgt att tgg cga tgg ctt cca tgc ggg gct cag cac 
tgc tct c 
TM-Grb2 construct 
Grb2rev cta gat gtt ccg gtt cac tg TM-Grb2 construct 
mNTAL_ENTRfor cac cat gag tgc cga gct gga gct g cloning 
(continued on next page) 
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Primer Sequence (5`→3`) Application 
mNTAL_ENTRrev_ut cta gat gtt ctc tgc tgc ggc cloning 
blast_HindIIIfor tcc aag ctt acc atg gcc aag cct ttg tc cloning 
blast_ClaIrev ctg atc gat cag aca tga taa gat aca ttg cloning 
mLynforBglII tgg aga tct gcc gcc acc atg gga tgt att aaa tca cloning 
mLynrevBamHI ttt gga tcc ggt tgc tgc tga tac tgc cct tc cloning 
pJG/4-5DT40for ttg ctg agt gga gat gcc tcc tac c Dok-3 library screen 
pJG/4-5DT40rev caa gcc gac aac ctt gat tgg aga c Dok-3 library screen 
chDok-3cDNAforSTART gct ggg ccc atg gag aga cca gtg  cDNA amplification 
chDok-3cDNAfor3 cct atg gag gag aac tgc ctc tac cDNA amplification 
chDok-3cDNArev1 ctg atc ttg gcc gaa ttt gcg  cDNA amplification 
chDok-3cDNAfor5’UTR cag ttg ctt tgg ctg aat cag tca c cDNA amplification 
chDok-3cDNArev3’UTR ttt tgt tac ggc gcc ccc tgg cgg  cDNA amplification 
Dok-3_LA_for tag cac agc tgt aga gat ggc agt g genomic PCR 
Dok-3_LA_rev agc aca tga agt cat cgc ttc tcc genomic PCR 
Dok-3_RA_for(INS) gca cgt tat ggg tga cat cat ggc ag genomic PCR 
Dok-3_RA_for(REP) gag aag ttt gat gca cgg gat cac g genomic PCR 
Dok-3_RA_rev gaa gat gtt ctc ata gag atg ctc gg genomic PCR 
Dok-3_ATGmut_for gct gtg ctg ggc cct tgg aga gac cag tg mutagenesis (left arm) 
Dok-3_ATGmut_rev cac tgg tct ctc caa ggg ccc agc aca gc  mutagenesis (left arm) 
Dok-3_Stopexon3_for cag ccc atc cct atg tag gag aac tgc ctc  mutagenesis (right arm)
Dok-3_Stopexon3_for gag gca gtt ctc cta cat agg gat ggg ctg mutagenesis (right arm)
screenLAfor2 gag gaa gcc aag atg gtg tat ctc c genomic PCR (screen) 
screenLAfor3 ccc ttc tct tca gtg caa caa tgc c genomic PCR (screen) 
chDok-3rev2 tgc cat gat gtc acc cat aat gtg c genomic PCR (screen) 
Neo_rev cgg acc gct atc agg aca tag cgt tg genomic PCR (screen) 
HisD_rev tgc ccc ttc ttc gct ggt acg agg ag genomic PCR (screen) 
hGAPDHfor tga agg tcggag tca acg gat ttg cDNA amplification 
hGAPDHrev cat gtg ggc cat gag gtc cac cac cDNA amplification 
chGAPDHfor aat gca tcg tgc acc acc aac cDNA amplification 
chGAPDHrev tca ctc ctt gga tgc cat gtg  cDNA amplification 
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4.1.5.  Solutions, buffers, and media 
The compositions of all solutions and buffers used are listed in the sections in which the 
corresponding experimental procedures are described. All solutions and buffers are aqueous 
solutions and stored at room temperature unless otherwise indicated. If solutions, buffers, or 
media had to be autoclaved it is indicated. Autoclaving of liquids was carried out at 125 °C 
for 30 min. RPMI medium was already endotoxin tested and filter sterilized.  
 
The following common buffers were used: 
PBS............................ 137 mM NaCl; 27 mM KCl; 43 mM Na2HPO4 ⋅ 7 H2O; 14 mM 
KH2PO4; pH ~ 7.3    
Tris/HCl..................... 0.5-1.5 M Tris; adjust pH to 6.8-8.8 with HCl 
TE buffer................... 10 mM Tris/HCl, pH 8.0; 1 mM EDTA, pH 8.0   
 
4.1.6.  Bacteria strains 
The following E. coli strains were used for the production of expression vectors, production 
of pCR-Topo or pENTR-Topo plasmids, or expression of recombinant proteins (BL21), 
respectively. The generation of competent bacteria and their transformation is described in 
4.2.1.9.  
Table 4.6: Bacteria strains 
Strain Genotype application 
DH5α F
- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ– 
plasmid amplification
Top10F’ 
F'[lacIq Tn10(tetR)] mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 deoR nupG recA1 araD139 Δ(ara-
leu)7697 galU galK rpsL(StrR) endA1 λ- 
plasmid amplification
XL1 blue 
endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 
F'[ ::Tn10 proAB+ lacIq Δ(lacZ)M15] hsdR17(rK- mK+) 
plasmid amplification
BL21(DE3) F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3) 
Expression of GST 
fusion proteins 
DB3.1 
F- gyrA462 endA1 glnV44 Δ(sr1-recA) mcrB mrr 
hsdS20(rB-, mB-) ara14 galK2 lacY1 proA2 rpsL20(Smr) xyl5 
Δleu mtl1 
amplification of 
destination vectors 
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4.1.7.  Additional materials 
GeneRulerTM 1 kb DNA ladder    MBI Fermentas 
λ-DNA/Hind III marker     MBI Fermentas 
RainbowTM coloured protein molecular weight markers  
(2.5-45 kDa and 14.3-220 kDa)    Amersham Biosciences 
Prestained Protein Marker, Broad Range (6.5-175 kDa) New England Biolabs 
Protease Inhibitor Cocktail (P 2714)    Sigma-Aldrich 
Tissue culture equipment (dishes, pipettes, tubes etc.) Greiner, Nunc, Falcon 
Electroporation cuvettes (4 mm gap)    Peqlab 
Nitrocellulose filter Hybond ECLTM    Amersham Biosciences 
Nylon Membrane Hybond N+    Amersham Biosciences 
ECLTM Western blotting detection reagents   Amersham Biosciences 
Human Immune System MTCTM cDNA Panel  Becton Dickinson 
ABI PRISMTM BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit 
 
4.1.8.  Instruments 
Eppendorf Thermomixer comfort 
Eppendorf centrifuge 5417R 
pH meter inoLab® pH Level 1 
Eppendorf BioPhotometer 
Eppendorf Mastercycler personal and Eppendorf Mastercycler epgradient 
Gel Imager (Intas, Göttingen) 
ABI PRISM® 3100 Genetic Analyser  
Heraeus HERAcell 150 (cell culture incubators) 
INFORS Unitron (37 °C shaker) 
Heraeus Kelvitron®t (bacteria incubator) 
Centrifuges SORVALL® RC 3B Plus and SORVALL® RC 26 Plus 
Trans-Blot SD Semi-Dry Transfer Unit (Bio-Rad)  
and T70/T77 semi-dry transfer unit (Amersham Biosciences) 
film developer Optimax Typ TR 
Chemi Lux Imager (Intas, Göttingen) 
HERAsafe (cell culture bench) 
Heraeus Multifuge 3 S-R 
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BIO-RAD Gene Pulser & BIO-RAD Capacitance Extender 
Automatic DNA isolation system PI-50alpha (Kurabo Industries, Japan)  
FACSCalibur (Becton Dickinson) 
LSR II (Becton Dickinson) 
Leica Laser Scanning Spectral Confocal Microscope TCS SP2 
 
4.1.9.  Software  
CellQuest; FlowJo (Ca2+ mobilization analysis) 
CSX-1400M Camera Controller (Chemi Lux Imager) 
Gel documentation software GDS (Gel Imager) 
ABI PRISM® GeneScan® Analysis Software (sequencing analysis) 
Adobe® Photoshop® CS2 (image editing) 
pDRAW 3.1; Clone Manager 7 (in silico cloning) 
CorelDraw; MS Office  
 
4.1.10. Web-sites and databases 
The following databases were used for the identification of avian cDNA orthologs and 
genomic sequences by blast searches: 
http://www.ncbi.nlm.nih.gov 
http://www.chick.umist.ac.uk 
http://www.ensembl.org 
http://www.expasy.org 
http://www.tigr.org 
http://pheasant.gsf.de/DEPARTMENT/dt40.html  
http://www.matrixscience.com 
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 4.2.   Experimental Procedures 
 
4.2.1.   Methods in Molecular Biology 
 
4.2.1.1. Digestion of DNA with restriction endonucleases 
For the sequence-specific cleavage of DNA molecules the samples were incubated with 
restriction endonucleases following the manufacturer’s instructions. 
   
4.2.1.2. Agarose gel electrophoresis of nucleic acids 
After restriction endonucleases digestion of DNA the resulting discrete fragments were 
resolved by agarose gel electrophoresis. Gels were prepared by dissolving 0.8-2 % agarose 
(w/v) in TAE or TBE buffer, respectively. The agarose was melted in a microvave, ethidium 
bromide was added to a final concentration of 0.5 µg/mL, and the solution was poured into a 
sealed gel casting platform. The DNA samples to be resolved were mixed with an 
appropiate volume of 6x DNA loading buffer. Additionally a DNA molecular weight 
standard was loaded (GeneRulerTM 1 kb DNA ladder, MBI Fermentas). The electrophoresis 
was performed in a gel chamber filled with TAE or TBE buffer at a voltage of 5 V/cm 
electrodal distance.  
 
TAE buffer (50x).............................. 2 M Tris/acetic acid, pH 7.8; 0.5 M NaOAc; 50 mM 
EDTA, pH 8.0 
TBE buffer (10x)............................... 0.9 M Tris; 0.9 M boric acid; 10 mM EDTA, pH 8.0 
6x DNA loading buffer..................... 10 mM Tris/HCl, pH 8.0; 1 mM EDTA, pH 8.0;      
0.25 % (w/v) bromophenolblue; 15 % (w/v) Ficoll 
 
4.2.1.3. Extraction of DNA from agarose 
Isolation of DNA fragments from agarose gels was achieved with QIAEX II gel extraction 
kit (Qiagen) or Wizard® SV Gel and PCR Clean-Up System (Promega) as per 
manufacturer’s instructions. DNA was eluted with an appropriate volume of dH2O or        
10 mM Tris/HCl, pH 8.0.  
 
4.2.1.4. Phenol/chloroform extraction and ethanol precipitation of DNA 
The aequous DNA solution was extracted with ½ volume phenol and ½ volume chloroform. 
The mixture was centrifuged at 16,000 g for 5 min at room temperature. The aqueous phase 
was re-extracted with ½ volume chloroform and centrifuged at 16,000 g for 1 min at room 
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temperature. Subsequently the DNA was concentrated by ethanol precipitation by adding 
1/10 volume 3 M NaOAc followed by 2.5 volumes of ice-cold 100 % ethanol, and the 
samples were then placed at -80 °C for 15-20 min. The samples were centrifuged at    
16,000 g and 4 °C for 10 min. The supernatant was discarded and the DNA pellet was air-
dried for 10 min. The dry pellet was dissolved in an appropriate volume of dH2O or TE 
buffer, pH 8.0. 
 
4.2.1.5. Photometric determination of DNA and RNA concentrations 
DNA and RNA concentrations were determined with the BioPhotometer (Eppendorf) as per 
manufacturer’s protocol. The DNA and RNA concentrations are calculated by the following 
formulas: 
    1 A260 Unit of dsDNA ≈ 50 µg/mL H2O 
    1 A260 Unit of ssRNA ≈ 40 µg/mL H2O 
The purity of DNA or RNA can be estimated by the following values: 
    pure DNA: A260/A280 ≥ 1.8 
    pure RNA: A260/A280 ≥ 2.0 
 
4.2.1.6. Fill-in of 3’-recessed DNA ends 
2 µL dNTPs (2.5 mM each) and 2 U Klenow fragment were added to the restriction 
endonuclease digested samples and incubated at 25 °C for 30 min. The DNA was purified 
by agarose gel electrophoresis and subsequent extraction (see 4.2.1.3.). 
 
4.2.1.7. Dephosphorylation of vector DNA 
Prior to ligation the vector DNA was dephosphorylated at the 5`-end with calf intestine 
phosphatase (CIP) (NEB). 1 µL CIP (1U/µL) was directly added to each 40 µL of restriction 
digest and incubated at 37 °C for up to 1 h. After gel electrophoresis the dephosphorylated 
vector DNA was extracted from agarose (see 4.2.1.3.). 
 
4.2.1.8 Ligation of DNA fragments 
For the ligation of linearized vectors and DNA fragments encoding proteins (inserts) the T4 
DNA ligase was used (NEB). This enzyme catalyzes the formation of phosphodiester bonds 
between adjacent 3`-OH and 5`-P ends in dsDNA. For ligations of cohesive ends a molar 
ratio of 1:3 (vector : insert DNA) was chosen, for ligations of blunt ends a molar ratio of 
1:5. In addition to vector and insert DNA the ligation reaction contained 0.5 µL T4 DNA 
ligase (NEB) and an appropriate volume of 10x ligase buffer (NEB). If necessary the 
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reaction volume was brought up to 10 µL with dH2O. In order to check the ability of vector 
DNA to religate, one sample was set up without the addition of insert DNA. Ligation 
reactions were incubated at room temperature for 1h or at 16 °C overnight, and used directly 
for the transformation of competent bacteria. 
 
4.2.1.9. Generation of transformation competent E. coli bacteria and transformation 
5 mL LB medium were inoculated with the E. coli strain and incubated at 37 °C overnight 
with shaking (200 rpm). The next day 150 mL LB medium were inoculated with 900 µL 
overnight culture. The culture was grown until an OD600 value of 0.45-0.55 was reached. 
The bacteria suspension was put on ice for 10 min and then harvested at 2,000 rpm at 4 °C 
for 10 min. The supernatant was removed and the bacteria were resuspended with 30 mL 
TFB I. After 10 min incubation on ice, the bacteria were centrifuged and resuspended in      
6 mL ice-cold TFB II. 50 µL portions of this cell suspension were transferred to a 1.5 mL 
Eppendorf tube and were flash frozen with liquid nitrogen. The competent bacteria were 
stored at -80 °C until usage. 
 
LB medium…………………10 g tryptone; 5 g Yeast Extract; 10 g NaCl ad 1000 mL 
dH2O; autoclaved; 4 °C storage 
TFB I………………………. 50 mM MnCl2 ⋅ 4 H2O; 100 mM KCl; 10 mM CaCl2 ⋅ 2 H2O; 
30 mM KOAc, pH 6.0; 15 % (v/v) glycerol; adjust to pH 6.1 
with HOAc; autoclaved; 4 °C storage 
TFB II……………………… 75 mM CaCl2 ⋅ 2 H2O; 10 mM KCl; 10 mM MOPS; 15 % 
(v/v) glycerol; adjust to pH 7.0 with KOH; autoclaved; 4 °C 
storage 
 
Competent bacteria were thawed on ice. An appropriate amount of plasmid DNA or 5 µL of 
a ligation reaction, respectively were added to the bacteria and the suspension was mixed by 
stirring with a pipet tip. The transformation sample was incubated on ice for 15 min and 
then heat-shocked at 42 °C for 45-60 s. The bacteria was returned to ice for 2 min and then 
300 µL LB medium were added, and incubated at 37 °C for 30 min. Subsequently the 
bacteria was spread onto LB plates containing an appropriate antibiotic and incubated at    
37 °C overnight. Bacteria transformed with pCRII-Topo or pCR2.1-Topo constructs were 
spread on LB/ampicillin/IPTG/X-Gal plates for blue/white colour selection. The next day 
transformants were analyzed by PCR or plasmid miniprep cultures were inoculated (see 
4.2.1.10.). 
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LB/agar…………………….. 20 g agar per 1000 mL LB; autoclaved and cooled to 60 °C; 
addition of antibiotic (see below); 4 °C storage 
X-Gal/IPTG plates................ LB/ampicillin/agar, supplemented with 80 µg/mL X-Gal and 
20 mM IPTG; 4 °C storage 
 
Table 4.7: Selection of bacteria 
antibiotic final concentration
Ampicillin (Amp) 50-100 µg/mL 
Kanamycin (Kan) 30-50 µg/mL 
Chloramphenicol (Cmp) 100 µg/mL 
 
 
4.2.1.10. Isolation of Plasmid-DNA 
For the analytical plasmid isolation 5 mL LB/Amp or LB/Kan medium were inoculated with 
a single bacterial colony at 37 °C in a shaker (200 rpm) overnight. The next day the plasmid 
DNA was isolated using the Nucleospin® Plasmid Kit (Macherey-Nagel) or Wizard® Plus 
SV Minipreps Kit (Promega) as per manufacturer`s instructions. For the production of larger 
amounts of plasmid DNA, 50-250 mL LB medium supplemented with an appropriate 
antibiotic were inoculated and the culture was grown at 37 °C in a shaker (200 rpm) 
overnight. The preparation of plasmid DNA was carried out with the NucleoBond® PC 100 
or the NucleoBond® PC 500 Kit (Macherey-Nagel), respectively, as per manufacturer`s 
protocol. 
 
4.2.1.11. Bacterial strain storage 
For the long term strain storage, 1-2 mL of a freshly saturated bacterial culture were 
harvested at 3,000 rpm for 5 min. The supernatant was removed and the bacteria were 
resuspended in ¼ volume LB/antibiotic and ¼ volume glycerol (87 %). The bacterial stocks 
were stored at -80 °C. 
 
4.2.1.12. Isolation of genomic DNA from tissue culture cells 
For PCR applications (see section 4.2.1.16.), DT40 cells were washed once with PBS and 
resuspended in buffer K at a density of 5 ⋅ 106 cells/mL. The cell suspension was incubated 
at 56 °C for 1 h, and then the Proteinase K was heat-inactivated at 95 °C for 15 min. The 
genomic DNA within the cell lysate was directly used as template for PCR. Alternatively, 
Material and Methods 
 
 
37
genomic DNA isolated with the Automatic DNA Isolation System PI-50alpha (Kurabo 
Industries, Japan) was used as template for PCRs. 
 
buffer K.............................................10 mM Tris/HCl, pH 8.0; 50 mM KCl; 0.45 % NP-40; 
0.45 % Tween-20; 100µg/mL Proteinase K  
 
For Southern blot analysis, DT40 genomic DNA was isolated using the Automatic DNA 
Isolation System PI-50alpha as per manufacturer`s protocol.  
 
4.2.1.13. Southern blotting 
Southern blotting was performed for the identification of ntal-/- DT40 clones by digesting  
20 µg of genomic DNA with 50 U restriction endonuclease overnight (300 µL total 
volume). The next day 50 U restriction endonuclease were added, and digestion was 
continued for 4 h at 37 °C. Then 1/25 volume 5 M NaCl were added and the sample was 
mixed by tapping. After addition of 2 volumes ice-cold 100 % EtOH, the samples were 
placed at -80 °C for 10 min. The samples were centrifuged at maximum speed and 4 °C for 
15 min. The supernatant was discarded and the samples were re-centrifuged at maximum 
speed and 4 °C for 5 min. After removal of remaining liquid, the samples were dried with a 
speed vac for 3 min. The digested DNA was resuspended in 30 µL TE buffer and left at 
room temperature for at least 1 h. DNA fragments were resolved by agarose gel 
electrophoresis overnight (0.7 % agarose in 0.5 x TBE; running buffer: 0.5 x TBE).       
Hind III-digested λ-DNA was used as marker (MBI Fermentas). The gel was incubated with 
ethidium bromide and complete digestion was confirmed. Then the gel was incubated for    
2 x 30 min with denaturing buffer under gentle agitation. After two brief washes with dH2O, 
the gel was incubated for 2 x 30 min with neutralization buffer under gentle agitation. After 
two washes with dH2O, the gel was blotted onto a nylon membrane by an upward capillary 
transfer. A spongy stone was placed in a reservoir tank filled with 20x SSC buffer. On the 
top of the stone, a transfer stack was assembled consisting of Whatmann 3MM paper, the 
gel, a Hybond-N+ nylon membrane (Amersham Biosciences), and two pieces of Whatmann 
3MM paper. As each layer was applied, it was wet with 20x SSC buffer and air-bubbles 
were removed. Finally a ~10 cm stack of paper towels, a glass plate and 0.2-0.4 kg weight 
were laid on the top of the stack. After over-night-transfer, the membrane was recovered 
and the position of the wells was marked. To confirm complete DNA transfer, the gel was 
re-stained with ethidium bromide. The nylon membrane was air-dried, baked for 1 h at      
80 °C, UV-crosslinked and stored until hybridization.  
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denaturing buffer............................... 0.5 M NaOH; 1 M NaCl 
neutralization buffer.......................... 1 M Tris/HCl, pH 8.0; 1.5 M NaCl 
20x SSC............................................ 3 M NaCl; 0.3 M sodium citrate dihydrate; adjust pH to 
7.2 with 1 M HCl 
 
Radioactive labelling of probes 
DNA fragments generated by PCR or by restriction endonuclease digest served as probes. 
30-50 ng of DNA (200-1000 bp length) were labelled with [α-32P]dCTP (RedivueTM;        
370 MBq/mL; 10 mCi/mL; Amersham Biosciences) using the RediprimeTM DNA Labelling 
System (Amersham Biosciences) and following the instructions of the manual. 
Unincorporated nucleotides were removed using ProbeQuantTM G-50 Micro Columns 
(Amersham Biosciences). Successful [α-32P]dCTP incorporation was confirmed using a 
TriCarb scintillation counter (Packard Instruments).  
 
Hybridization & autoradiographie 
Nylon membranes were soaked in 2x SSC and placed into a heat-sealable plastic bag. To 
block non-specific binding, pre-warmed pre-hybridization buffer with 0.1 mg/mL salmon 
sperm DNA (10 mg/mL stock; denatured by heating to 95 °C for 5 min) was added to the 
bag. After sealing the bag, the membrane was incubated in a water bath at 42 °C for 4 h or 
overnight. Subsequently salmon sperm DNA and the [α-32P]dCTP-labelled probe were 
mixed, denatured by heating to 95 °C for 5 min, and added to pre-warmed hybridization 
buffer. The nylon membrane was incubated with this hybridization solution at 42 °C 
overnight. Different pre-hybridization and hybridization buffers were used according to the 
desired stringency conditions (see table 4.8). The next day the membrane was washed three 
times according to table 4.8. Subsequently the membrane was exposed for 1-3 h or 
overnight to an imaging plate, which was then analyzed using a phosphor-imager. 
Alternatively, the membrane was exposed to an X-ray film overnight at -80 °C. If the 
membrane was to be hybridized with an alternative probe, the membrane was stripped with 
a high stringency washing buffer (see table 4.8) two times for 15 min in the microwave. 
Probe removal was confirmed by exposing the membrane to an imaging plate for 1 h at RT.    
 
pre-hybridization buffer…………………… 35-50 % Formamide (see table 4.8);                
5x Denhardt’s solution; 5x SSPE; 0.5 % SDS 
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50x Denhardt’s solution…………………… 10 mg/mL Ficoll® 400; 10 mg/mL 
polyvinylpyrrolidone; 10 mg/mL BSA (fraction 
V); sterile filtered and stored at -20 °C 
20x SSPE…………………………………..3 M NaCl; 0.2 M NaH2PO4; 20 mM EDTA; 
adjust to pH 7.0 with NaOH 
hybridization buffer………………………..  pre-hybridization buffer containing 10 % (w/v) 
dextran sulphate  
washing buffer……………………………..  0.1-2x SSC (see table 4.8); 0.1 % SDS 
 
Table 4.8: Stringency conditions for hybridization and washing 
step component high 
stringency 
medium 
stringency 
low 
stringency 
pre-hybridization/ 
hybridzation 
formamide 50 % 40 % 35 % 
first wash 
(1x 10 min at RT) 
SSC 2x 
second and third wash 
(2x 10 min at 50 °C) 
SSC 0.1x 0.25x 0.4 
 
 
4.2.1.14. Isolation of total RNA from eukaryotic cells 
Total RNA was isolated by using the RNeasy® Mini Kit (Qiagen) according to the 
manufacturer’s instructions. Disruption and homogenization of cell lysates was carried out 
using QIAshredderTM columns (Qiagen) as per manufacturer`s protocol. 
Alternatively, total RNA was isolated by using RNAzol B (IsoTex Diagnostics) according 
to manufacturer’s protocol. In brief, 7.5 ⋅ 106 cells were harvested and washed once with 
PBS. The cell pellet was briefly vortexed, 300 µL RNAzol B were added, and the cells were 
lysed by repeated pipetting. 1/10 volume CHCl3 was added, and the sample was vortexed 
for 15 s and put on ice for 15 min. Phases were separated by centrifugation at 12,000 g for 
15 min at 4 °C. The upper colorless aqueous phase was transferred to a new Eppendorf tube 
(~130 µL), and then 1 volume isopropanol was added. The sample was vortexed and placed 
on ice for 15 min. After centrifugation at 12,000 g and 4 °C for 15 min, the supernatant was 
discarded and the RNA precipitate was washed with 1 mL ice-cold 70 % EtOH. The sample 
was centrifuged at 12,000 g and 4 °C for 5 min and the supernatant discarded. The RNA 
pellet was air-dried 1-2 min and resuspended with 12 µL RNase-free dH2O. 
The isolated RNA was used directly for reverse transcription or stored at -80 °C. 
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4.2.1.15. Reverse transcription 
First strand cDNAs were synthesized from RNA templates using the RevertAidTM H Minus 
First Strand cDNA Synthesis Kit (MBI Fermentas). The kit contains a genetically 
engineered version of the Moloney Murine Leukemia Virus Reverse Transcriptase which 
lacks ribonuclease H activity specific to RNA in RNA-DNA hybrids. For the reverse 
transcription, 10 ng - 5 µg of total RNA were brought up to a volume of 11 µL with RNase-
free dH2O. Then 1 µL oligo(dT)18 primer (0.5 µg/µL stock) or 1 µL random hexamer primer 
(0.2 µg/µL stock) were added and gently mixed. The mixture was incubated at 70 °C for     
5 min and subsequently chilled in an ice bath. The following components were added in the 
indicated order:  4 µL 5x reaction buffer 
1 µL ribonuclease inhibitor (20 U/µL stock) 
2 µL dNTP mix (10 mM stock) 
The mixture was incubated at 37 °C for 5 min if oligo(dT)18 primers were used, and at 25 °C 
for 5 min if random hexamer primers were used. Then 1 µL of RevertAidTM H Minus         
M-MuLV reverse transcriptase (200 U/µL stock) was added, and reverse transcription was 
carried out at 42 °C for 1 h. If random hexamer primers were used, the samples were 
incubated at 25 °C for 10 min and finally at 42 °C for 1 h. The reaction was stopped by 
heating at 70 °C for 10 min. The first strand cDNA was used directly for amplification by 
PCR (see section 4.2.1.16.) 
 
4.2.1.16. Polymerase chain reaction (PCR) 
General aspects 
The Polymerase chain reaction is a technique for the selective in vitro amplification of 
specific DNA fragments (SAIKI et al., 1985; MULLIS et al., 1986; MULLIS and FALOONA, 
1987). In table 4.9 the DNA polymerases used and their common features are listed. 
 
Table 4.9: DNA polymerases and their application 
DNA 
polymerase 
supplier Processivity 
[bases/min] 
elongation 
T [°C] 
3`-5`-proof-
reading 
overhang 
A’s 
application 
Taq NEB, 
Qiagen 
1000 72 no yes analytical PCRs 
Pfu Promega 500 68 yes no cDNA amplification 
Elongase Invitrogen 1000-1300 68 yes no cDNA amplification 
LA-Taq Takara 1000 68-72 yes yes long range PCRs 
(genomic templates) 
Primestar Takara 1000 72 yes no cDNA amplification 
(GC-rich templates) 
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All PCRs were set up in a volume of 20-50 µL, containing up to 500 ng of genomic DNA or 
10-50 ng plasmid as template. The synthetic oligonucleotides (primers) were designed with 
40-60 % GC content, no internal structure or complementarity at the 3’-ends. The final 
primer concentration varied between 0.1 and 0.5 µM. Annealing temperatures were chosen 
~5-10 °C lower than the melting temperature Tm. The final concentration of each dNTP was 
chosen between 50 and 500 µM (most commonly 200 µM). All DNA polymerases were 
used with supplied buffers. All PCRs were prepared on ice and immediately put into the    
95 °C heating block (pseudo hot start). In table 4.10 the cycling parameters are summarized.   
 
Table 4.10: Summary of cycling parameters 
step reaction T [°C] t go to loops 
1 initial denaturation 94-98 1-3 min  
2 denaturation 94-98 10-30 s  
3 annealing 55-68 0-30 s (*)  
4 elongation 68 or 72 see table 4.9 18-35x to step 2 
5 final elongation 72 5-10 min  
6  12 ∞  
* For 2-step-PCRs, the annealing was omitted. 
 
If the amplicons were to be subcloned into the vectors pCR2.1-Topo or pCRII-Topo (see 
section 4.2.1.17.), single 3’-A overhangs had to be present. If the DNA polymerases were 
not capable of adding this 3’-A (see table 4.9), an A-tailing procedure was performed. For 
that 0.2 µL Taq DNA polymerase (NEB) and 1 µL dNTPs (10 mM) were added to the 
completed PCR reaction (50 µL) and incubated at 72 °C for 10 min.  
 
Long distance PCR 
LA-Taq (Takara) was used for long distance PCRs. The genomic templates were isolated 
and purified as described in section 4.2.1.12. The homologous sequences flanking the 
resistance cassettes of the targeting constructs pNTAL-neo/hisD and pDok-3-neo/hisD, 
respectively were amplified by long distance PCRs. PCR reactions containing LA-Taq were 
set up according to manufacturer’s instructions. 
 
Site-directed mutagenesis 
The basic procedure of site-directed mutagenesis utilizes a supercoiled dsDNA vector with 
an insert of interest and two synthetic oligonucleotides containing the desired mutation. In 
these oligonucleotides, the desired mutation (substitution, deletion or insertion) is in the 
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middle with ~10-15 bases of correct sequence on both sides. The oligonucleotides are 
complementary to opposite strands of the vector and are extended during PCR with Pfu 
DNA polymerase. This generates a mutated plasmid containing staggered nicks. Following 
PCR, the sample is treated with Dpn I endonuclease, which is specific for methylated and 
hemimethylated DNA. Since plasmid DNA isolated from most E. coli strains is dam 
methylated, Dpn I digests the parental DNA template. The nicked, mutated plasmid is then 
transformed into competent bacteria (see 4.2.1.9.). The sample reactions were prepared as 
indicated below: 
 5-50 ng template DNA 
2.5 µL 10 Pfu reaction buffer 
 65 ng forward mutagenesis oligonucleotide 
 65 ng reverse mutagenesis oligonucleotide 
 0.8 mM dNTPs 
 0.5 µL Pfu DNA polymerase (2.5 U/µL) 
 dH2O to a final volume of 25 µL 
 
In table 4.11 the cycling parameters for the site-directed mutagenesis PCR are listed. 
 
Table 4.11: Cycling parameters for mutagenesis PCR 
step reaction T [°C] t go to loops 
1 initial denaturation 95 30 s  
2 denaturation 95 30 s  
3 annealing 55 1 min  
4 elongation 68 1 min/kb 
plasmid 
12-18x to step 2 
5  12 ∞  
 
Following PCR, 1 µL of Dpn I restriction endonuclease is directly added to each 
amplification reaction and incubated at 37 °C for 1 h. 5 µL of this reaction were used for 
transformation. Successful site-directed mutagenesis was confirmed by DNA sequencing. 
 
Bacterial PCR 
Analysis of bacterial transformants was performed by analytical plasmid preparation (see 
4.2.1.10.) or by PCR. Single colonies were picked from an agar plate, saved on a second 
agar plate and resuspended in 18.7 µL dH2O. The suspension was heated to 95 °C for 5 min. 
Subsequently, 6.3 µL PCR mix were added, containing 250 µM dNTPs, 0.2 µM primers 
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(forward and reverse), buffer (for final volume of 25 µL), and 0.3 µL Taq DNA polymerase 
(NEB). 
 
Splicing by overlap extension (SOE)/ Megaprime PCR 
The cDNA encoding the NTAL/Grb2 chimeric protein described in section 5.1.12. was 
generated by SOE-PCR, alternatively called megaprime PCR. This method employs four 
different olignucleotides for the amplification of two different DNA fragments (ntal cDNA 
coding for amino acids 1-94 and grb2 full length cDNA). The 3’-oligonucleotide of the    
5’-fragment (bridge2rev; see table 4.5) and the 5’-oligonucleotide of the 3’-fragment 
(bridge2for) are complementary to each other. First two separate PCRs were performed, 
amplifying the partial ntal cDNA (oligonucleotides NTALfor and bridge2rev) and full 
length grb2 cDNA (oligonucleotides bridge2for and Grb2rev). The fragments were purified 
(see 4.2.1.3.) and used for a second PCR, together with the two distal oligonucleotides 
NTALfor and Grb2rev. This results in the exponential amplification of tm-grb2 cDNA.  
 
4.2.1.17. Cloning of PCR products 
Cloning of PCR products with 3’-A overhangs was carried out using the TOPO TA 
Cloning® Kits from Invitrogen, using either pCR2.1-Topo or pCRII-Topo. The ligation 
reactions were set up according to the manufacturer’s instructions. The PCR product is 
ligated into a multiple cloning site within the α-peptide coding region of β-galactosidase, 
allowing for blue/white screening. Transformations of DH5α or Top10F’ bacteria with the 
Topo ligation reactions are described in section 4.2.1.9. For Top10F’ bacteria, IPTG has to 
be added to the plates, since this strain overexpresses the Lac repressor. 
Alternatively, PCR amplicons were ligated into pENTR/SD/D-Topo to generate an entry 
vector for the Gateway® system (see 4.2.1.18.). This was also performed according to the 
manufacturer’s instructions. 
 
4.2.1.18. Gateway® System (Invitrogen) 
The Gateway® Technology is based on the bacteriophage lambda site-specific 
recombination system which allows for the integration of lambda into the E. coli 
chromosome and the switch between the lytic and lysogenic pathways (PTASHNE et al. 
1992). Lambda integration is an intermolecular DNA recombination mediated by lambda 
and E. coli-encoded recombination proteins. The recombination occurs between site-specific 
attachment (att) sites, i.e. attB on the E. coli chromosome and attP on the lambda 
chromosome. Recombination occurs between attB and attP sites and gives rise to attL and 
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attR sites. The lytic pathway (reaction: attL x attR → attB x attP) is catalyzed by the 
bacteriophage λ Integrase (Int) and Excisionase (Xis) proteins, and the E. coli Integration 
Host factor (IHF) protein. These three proteins are components of the LR ClonaseTM enzyme 
mix (Invitrogen). The Gateway® Technology uses the lambda recombination system for the 
transfer of heterologous DNA sequences flanked by modified att sites between vectors. The 
LR ClonaseTM enzyme mix catalyzes the recombination of an attL substrate (entry clone) 
with an attR substrate (destination vector), thereby generating an attB-containing expression 
clone. In table 4.12 common features of the Gateway® vectors are listed.  
 
Table 4.12: Gateway® vectors 
vector 
att 
sites 
propagated 
in 
selection vectors used in this thesis 
Entry attL DH5α Kan 
pENTR/SD/D/chNTAL wt 
pENTR/SD/D/chNTAL wt HA 
pENTR/SD/D/chNTAL Y95F/Y136F/Y155F/Y184F  HA 
pENTR/SD/D/chNTAL      
                     Y95only/Y136only/Y155only/Y184only HA 
pENTR/SD/D/chNTAL 4Y4F HA 
pENTR/SD/D/chNTAL C23,26A HA 
pENTR/SD/D/mNTAL 
Destination attR DB3.1 Amp/Cmp 
pApuroII/DEST A 
pMSCVpuro/DEST A 
Expression attB DH5α Amp 
pApuroII/chNTAL wt  
pApuroII/chNTAL wt HA   
pMSCVpuro/chNTAL wt HA 
pMSCVpuro /chNTAL Y95F/Y136F/Y155F/Y184F  HA 
pMSCVpuro /chNTAL  
                   Y95only/Y136only/Y155only/Y184only HA  
pMSCVpuro /chNTAL 4Y4F HA 
pMSCVpuro /chNTAL C23,26A HA 
pApuroII/mNTAL wt (for antibody check) 
 
Chicken ntal cDNA and a PCR-generated expression cassette encoding C-terminally HA-
tagged chicken NTAL were cloned into the entry vector pENTR/SD/D-Topo (Invitrogen). 
By site-directed mutagenesis of pENTR/SD/D/chNTAL wt HA the mutant entry constructs 
listed in the table above were obtained. The destination vectors pApuroII/DEST A and 
pMSCVpuro/DEST A were generated by insertion of the Gateway® conversion cassette A 
(Invitrogen) into the Sma I-site of pApuroII and the Hpa I-site of pMSCVpuro, respectively. 
The destination conversion cassettes contain the ccdB gene, encoding a protein which 
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interferes with E. coli DNA gyrase and thereby inhibiting growth of most E. coli strains. 
Destination vectors containing the ccdB gene have to be propagated in the DB3.1 E. coli 
strain, which is resistant to CcdB effects. Upon LR ClonaseTM enzyme mix-catalyzed 
recombination the ccdB gene is replaced by the cDNA of interest. For LR-reaction, the 
following components were mixed: 
5x LR reaction buffer     4 µL 
supercoiled Entry-clone  100 ng 
supercoiled Destination vector 300 ng 
Topoisomerase (10 U/µL)  1.5 µL 
TE-buffer    ad 16 µL 
4 µL LR ClonaseTM enzyme mix were added, and the reaction was incubated at 25 °C for    
45 min. 2 µL Proteinase K (2µg/µL) were added, and the reaction was incubated at 37 °C 
for 10 min. 3 µL of the reaction mixture were used for transformation of competent DH5α 
E. coli.   
 
4.2.1.19. DNA sequence analysis 
Sequence analysis of DNA samples was performed by the dideoxy method (SANGER et al., 
1977). Sequencing reactions were carried out with the ABI PRISM® 3100 Genetic Analyser 
(Applied Biosystems, Perkin-Elmer) and fluorescence-labelled dideoxy nucleotides (ABI 
PRISMTM BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit, Applied Biosystems, 
Perkin-Elmer) as per manufacturer`s instructions. Alternatively, sequencing was performed 
by MWG Biotech (Ebersberg, Germany). 
 
 
 
4.2.2.   Cell culturing 
 
4.2.2.1. General aspects 
Complement factors within fetal calf serum (FCS) and chicken serum (CS) were inactivated 
by heating to 56 °C for 30 min before usage. The cell density of a culture was determined 
with a Neubauer chamber slide. Cells were centrifuged with a refrigerated centrifuge 
(Heraeus Multifuge 3 S-R) for 4 min at 300 g and 4 °C (unless otherwise indicated) 
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4.2.2.2. Cell culturing conditions 
All used cell lines were cultured in a 5 % CO2 humidified atmosphere at 37 °C. Wild-type 
DT40 B lymphocytes and derivatives were cultured in RPMI 1640 containing 10 % FCS,    
1 % CS, 3 mM L-glutamine, 50 µM β-mercaptoethanol, 50 U/mL penicillin, and 50 µg/mL 
streptomycin. Murine B cell lines K46, CH31, WEHI-231, TK µ+, and TKµ-, and the human 
B cell line Ramos were cultured in RPMI 1640 containing 10 % FCS, 2 mM L-glutamine,   
2 mM pyruvate, 50 µM β-mercaptoethanol, 50 U/mL penicillin, and 50 µg/mL 
streptomycin. The murine B cell line IIA1.6 was cultured in RPMI 1640 containing 10 % 
FCS, 6 mM L-glutamine, 8 mM pyruvate, 50 µM β-mercaptoethanol, 50 U/mL penicillin, 
and 50 µg/mL streptomycin. HEK293T cells were cultured in DMEM containing 10 % 
FCS, 2 mM L-glutamine, 50 U/mL penicillin, 50 µg/mL streptomycin, and non-essential 
amino acids. Plat-E cells were cultured in DMEM containing 10 % FCS, 2 mM                  
L-glutamine, 10 µg/mL blasticidin, 2.5 µg/mL puromycin, 50 U/mL penicillin, and            
50 µg/mL streptomycin. The adherent growing HEK293T and Plat-E cells were split using 
Trypsin/EDTA solution. 
 
4.2.2.3. Cell lines 
DT40 (ATCC Number: CRL-2111) 
The chicken DT40 B cell line is derived from an avian leucosis virus (ALV)-induced bursal 
lymphoma (BABA and HUMPHRIES, 1984; BABA et al., 1985). The original lymphoma was 
induced by viral infection of a 1 day old chicken with Rous associated virus 1 (RAV-1). 
DT40 cells express surface IgM and continue to undergo IgL gene conversion during in 
vitro cell culture (BUERSTEDDE et al., 1990; KIM et al., 1990). Stimulation of DT40 cells by 
anti-chicken IgM antibodies ultimately leads to apoptosis, mimicking the elimination of 
self-reactive B cells (TAKATA et al., 1995). The most unique feature of DT40 cells is the 
high ratio of targeted to random integration of exogenous DNA (reviewed in SONODA et al., 
2001; WINDING and BERCHTOLD, 2001). Targeted integration occurs in frequencies similar 
to those of random integration (BUERSTEDDE and TAKEDA, 1991). Although the molecular 
basis for the high targeting efficiencies is unknown, it has been speculated that it may be 
related to the Ig gene conversion activity, since both processes are mediated by homologous 
recombination and presumably share the same enzymatic activities (SONODA et al., 2001). 
In table 4.13 the DT40 knock-out cell lines used in this thesis are listed. 
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Table 4.13: DT40 knock-out cell lines 
DT40 knock-out cell line reference 
btk-/- DT40 TAKATA and KUROSAKI, 1996 
dok-3-/- DT40 this thesis 
grb2-/- DT40  HASHIMOTO et al., 1998 
lyn-/- DT40 TAKATA et al., 1994 
ntal-/- DT40 this thesis  
p110α-/- DT40 INABE et al., 2002 
plc-γ2-/- DT40 TAKATA et al., 1995 
slp-65-/- DT40 ISHIAI et al., 1999b 
syk-/- DT40 TAKATA et al., 1994 
 
 
K46  
The K46 cell line represents a murine B cell lymphoma and was established from BALB/c 
mice (KIM et al., 1979). In contrast to the originally described cell line, K46 cells express 
membrane IgG2a/κ. 
 
IIA1.6 
The IIA1.6 cell line is derived from the murine B cell lymphoma A20, which was 
established from a spontaneous reticulum cell neoplasm found in an old BALB/cAnN 
mouse (KIM et al., 1979). IIA1.6 cells express membrane IgG2a and do not express Fcγ 
receptors (JONES et al., 1986; VAN DEN HERIK-OUDIJK et al., 1994). 
 
CH31 
CH31 B cells belong to a series of 27 B-cell lymphomas (CH series), induced in B10.H-
2aH-4bp/Wts mice by adoptive hyperimmunization with sheep erythrocytes (LANIER et al., 
1982). CH31 cells express membrane IgM/κ (PENNELL et al., 1985). 
 
WEHI-231 (ATCC Number: CRL-2111) 
WEHI-231 B cells derive from a mineral-oil induced tumor in (Balb/c x NZB) F1 mice. 
They express surface IgM. 
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TKµ+ and TKµ- 
TKµ- is an Ig-negative subclone of Abelson leukemia virus (AMuLV)-transformed pre-B 
cell line 18-81 (JACK and WABL, 1988). TKµ+ cells were transfected with a µ-chain 
encoding vector and thus express a pre-BCR (KEYNA et al., 1995). 
 
Ramos (ATCC Number: CRL-1596) 
The Ramos B cell was established from an American Burkitt lymphoma (3 years old male 
patient) (KLEIN et al., 1975). The cells express surface IgM/λ.  
 
HEK293T (ATCC Number: CRL-1573) 
HEK 293 cells were generated by transformation of human embryonic kidney (HEK) cell 
cultures with sheared adenovirus 5 DNA (GRAHAM et al., 1977). HEK293T cells are higly 
transfectable derivatives of HEK293 cells into which the temperature sensitive gene for 
SV40 T-antigen was inserted.  
 
Platinum-E (Plat-E) 
Plat-E cells are a third generation retrovirus packaging cell line based on the HEK293T cell 
line. In Plat-E cells, the viral structural genes gag-pol and env are expressed under the 
control of the EF1α promotor, which is 100-fold more potent than the MuLV-LTR in 293T 
cells. Both gag-pol and env were joined to genes encoding selectable markers via an internal 
ribosome entry site (IRES) (MORITA et al., 2000).  
 
4.2.2.4. Freezing and thawing of eukaryotic cells 
For freezing, cells were harvested and resuspended in freezing medium. The cell density 
was adjusted to 1-1.5 ⋅ 107 cells/mL. 1 mL cell suspension was transferred into a cryo-tube 
and immediately put at -80 °C in a polysterene box, thereby guaranteeing a freezing rate of 
approximately -1 °C/min.  
Cells were thawed rapidly at 37 °C and immediately put into 10 mL culture medium to 
dilute the DMSO. Then the cells were centrifuged, resuspended in fresh culture medium, 
and transferred to a Petri dish. 
 
Freezing medium...............................90 % (v/v) FCS; 10 % (v/v) DMSO 
 
 
 
Material and Methods 
 
 
49
4.2.2.5. Transfection of DT40 lymphocytes by electroporation 
1 ⋅ 107 cells were harvested, washed with PBS, and resupended in 0.5 mL PBS. Then        
10-25 µg of linearized DNA and the cell suspension were transferred to an electroporation 
cuvette (4 mm electrode gap, Peqlab Biotechnologie GmbH, Germany). After 10 min 
incubation on ice the cells were electroporated at 550 V and 25 µF or 250 V and 975 µF, 
respectively. The electroporated cells were incubated on ice for 10 min and resuspended in 
DT40 medium (see section 4.2.2.2.). The cells were incubated at 37 °C and 5 % CO2 for    
24 h and then resuspended in DT40 medium containing an appropriate concentration of 
antibiotic (see table 4.14). The cells were plated in two 96-well-dishes with 0.2 mL/well. 
After 5-7 days stable transfectants were visible and transferred to 24-well-dishes.  
 
Table 4.14: Selection of DT40 cells 
antibiotic final concentration 
G418 2 mg/mL [effective] 
Histidinol 1 mg/mL 
Hygromycin B 1.5-2.0 mg/mL 
Puromycin 0.5 µg/mL 
Blasticidin S 50 µg/mL 
 
 
4.2.2.6. Transfection of Plat-E cells with FuGENE® for the production of recombinant      
 viruses                                                                                                                                                    
Plat-E cells were used as packaging cell line for the production of recombinant, replication-
incompetent retroviruses. These retroviruses were then used for the transduction of             
B lymphocytes (see 4.2.2.7.). Plat-E cells were split to about 50-60 % confluency prior to 
transfection (9 cm dish). The following components were mixed in the given order: 
  400 µL RPMI w/o supplements 
  15 µL FuGENE® (Roche Diagnostics) (directly pipetted into liquid) 
  3.6 µg retroviral expression vector 
1.4 µg pHCMV-VSV-G (if viruses had to be pseudo-typed, i.e. for infection  
of DT40) 
The components were mixed by tapping and left at RT for 15 min. The Plat-E medium was 
aspirated from the dish and fresh DT40 or K46 medium was given onto the cells. The 
transfection mixture was added dropwise to the cells. After 48 h incubation at 5 % CO2 and 
37 °C, the cell supernatant containing the retroviruses was used for transduction.    
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4.2.2.7. Transfection of lymphocytes by retroviral gene transfer 
The retroviral gene transfer technology introduces efficiently stable, heritable genetic 
material into the genome of any dividing cell type (AUSUBEL et al. 1995; COFFIN et al. 
1996). The retroviral gene transfer technology is based on the parallel design of packaging 
cell lines and retroviral expression vectors. Packaging cell lines package recombinant 
retroviral RNAs into infectious, replication-incompetent particles. In a packaging cell line, 
the viral gag, pol, and env genes are stably integrated into the genome. 
The retroviral vectors p5N-M-IRES-hph and pMSCVpuro/blast used in this thesis are 
derived from Moloney murine leukemia virus (MMLV) and from PCC4-cell-passaged 
myeloproliferative sarcoma virus (PCMV, HILBERG et al., 1987; HAWLEY et al., 1994), 
respectively. Retroviral expression vectors provide the packaging signal Ψ+, transcription 
and processing elements (5`- and 3`-long terminal repeats, LTRs), the target gene, and a 
selectable marker. Transfection of the retroviral vector into a packaging cell line produces 
replication-incompetent viruses, with the viral genomic transcript containing the target gene 
and the selectable marker.  
The viral env gene expressed by the packaging cell line encodes the envelope protein. This 
protein determines the range of infectivity (tropism) of the packaged virus. Viral envelopes 
are classified according to the receptors used to enter the host cells. An overview is given in 
table 4.15. 
 
Table 4.15: Retroviral tropism 
tropism viral entry mechanism 
ecotropic recognition of receptor on mouse and rat cells 
amphotropic recognition of receptor found on a broad range of mammalian 
cells 
dualtropic recognition of two different receptors found on a broad range 
of mammalian cells 
pantropic lipid binding and plasma membrane fusion, thereby infecting 
both mammalian and non-mammalian cells 
 
In pantropic packaging cell lines, virions are pseudo-typed with the envelope glycoprotein 
from the vesicular stomatitis virus (VSV-G). Since stable expression of the VSV-G 
envelope protein is toxic, transient virus was produced by cotransfecting a retroviral 
expression vector and pHCMV-VSV-G into Plat-E cells (see section 4.2.2.6. for details). 
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Transfection of DT40 cells with recombinant retroviruses  
DT40 cells were infected with VSV-G pseudo-typed recombinant retroviruses. In a 6 cm 
dish 1.5 mL fresh DT40 medium and 45 µL of a polybrene stock solution (final 
concentration 3 µg/mL) were mixed. The retroviral supernatant was centrifuged at 300 g 
and 4 °C for 4 min. Then 1 ⋅ 106 DT40 cells were resuspended with 3 mL retroviral 
supernatant and transferred to the 6 cm dish. After 24 h the DT40 cells were resuspended in 
fresh medium, and following an additional 24 h the antibiotic for selection was added to the 
cells (see 4.2.2.5.). All manipulations of pseudo-typed retroviruses were performed in 
compliance with the S2 standard and safety intructions.  
 
polybrene stock solution................... 3 mg/mL polybrene in PBS; sterile filtered; freshly 
prepared prior to each infection 
 
Transfection of K46 cells with recombinant retrovirus  
Murine K46 cells were infected with ecotropic recombinant retroviruses, i.e. the virions do 
not harbor VSV-G. The infection procedure was identical to the protocol for DT40 cells (see 
above). K46 cells were selected with 10 µg/mL puromycin. 
 
4.2.2.8. Calcium phosphate transfection of HEK293T cells  
HEK293T cells were transfected with pApuroII-DEST/chNTAL or pApuroII-
DEST/mNTAL by the calcium phosphate method. The cells were split to about 50-60 % 
confluency prior to transfection (6 cm dish). Then 15 µg plasmid DNA and 63 µL                
2 M CaCl2 were brought to a volume of 250 µL with TE buffer and incubated at RT for     
10 min. While gently mixing, 250 µL 2x HBS were added dropwise to the DNA/CaCl2 
solution. After 15 min incubation on ice, the entire 500 µL were gradually and evenly added 
dropwise to the cell medium. After 14-16 h incubation the cells were lysed. The lysates 
were used for testing the specificity of the polyclonal rabbit-anti-chicken NTAL or rabbit-
anti-mouse NTAL antibodies, respectively (see 4.2.3.1. and 4.2.3.2.).    
 
2x HBS.................................. 50 mM HEPES; 280 mM NaCl; 1.5 mM Na2HPO4 ⋅ 2H2O; 
adjust pH to 7.0 with 1 M NaOH; sterile filter 
 
4.2.2.9. Cloning of cell populations 
For the subcloning of heterogenous eukaryotic cell populations the cell density was adjusted 
to 2.5 cells/mL in 20 mL complete medium. The cell suspension was spread on one 96-well-
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dish in aliquots of 0.2 mL. Single clones were visible after 5-10 days and transferred to a 
24-well-dish. 
 
4.2.2.10. Confocal laser scanning microscopy  
Confocal laser scanning microscopy of the Lyn/EGFP-positive transfectants (see section 
5.2.5.) was performed on harvested cells washed twice with Krebs-Ringer solution 
containing Ca2+ (see 4.2.2.11.2.), and resuspended at a density of 1 ⋅ 106 cells/400 µL 
Krebs-Ringer solution with Ca2+. Following cells sedimentation in 4-well chamber slides 
(Lab-TekTM, Nunc) the cells were subjected to confocal laser scanning microscopy using the 
Leica TCS SP2 microscope (kindly performed by I. Goldbeck; Leica objective PL APO 63x 
1.3 Glycerol HCX CS; zoom 1-5). Images were exported to Adobe® Photoshop® CS2. 
 
4.2.2.11.    FACS analysis (flow cytometry) 
4.2.2.11.1. Analysis of surface IgM expression on DT40 cells 
For the analysis of surface IgM expression, 0.5-1 ⋅ 106 DT40 cells were transferred to a 
FACS tube, centrifuged, and washed twice with 2 mL cold PBS. The supernatant was 
removed and the cells were resuspended in ~200 µL PBS. After addition of 2 µL FITC-
conjugated goat-anti-chicken IgM (Bethyl Laboratories), the cell suspension was incubated 
on ice for 15 min in the dark. Then the cells were washed once with 2 mL cold PBS, 
resuspended in 500 mL PBS and subjected to FACS analysis. Simultaneously unstained 
cells were analyzed. For each diagram 10,000 cells were monitored on a logarithmic scale. 
 
4.2.2.11.2. Ca2+ mobilization analysis  
The Ca2+ response in B lymphocytes after stimulation was determined by flow cytometry 
using the Ca2+-sensitive fluorophors Fluo-3 or Indo-1, respectively. The acetoxymethyl ester 
derivatives of Fluo-3 (Fluo-3-AM) and Indo-1 (Indo-1-AM) are uncharged molecules that 
are capable of permeating cell membranes. Within the cell, the lipophilic blocking groups 
are cleaved by non-specific cytoplasmic esterases, resulting in a charged form which can 
permeate the plasma membrane far more slowly than its parent compound (“dye-trapping”). 
Fluo-3 shows an absorption spectrum compatible with excitation at 488 nm by argon-ion 
laser sources (e.g. FACSCalibur, Becton-Dickinson) and a typically >100 fold fluorescence 
intensity increase in response to Ca2+ binding. Emission is measured at 525 nm. Indo-1 can 
applied for ratio measurements, i.e. the emission shifts from about 475 nm (Indo-blue) 
without Ca2+ to about 400 nm (Indo-violet) with Ca2+ when excited at about 350 nm. The 
use of the 400/475 emission ratio considerably reduces the effects of unequal dye loading, 
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leakage of dye, photobleaching, and problems associated with measuring Ca2+ in cells of 
unequal size/thickness. Cell loading of the fluorophors is facilitated by the non-ionic, 
surfactant polyol Pluronic F-127. The detergent also prevents the compartimentation of the 
fluorophor within the cell membranes. For Ca2+ mobilization analysis, 1 ⋅ 106 cells were 
harvested at 300 g and 4 °C for 5 min. The cell pellet was resuspended in 700 µL of the 
corresponding medium with 5 % FCS. While vortexing mildly, the dye solution was added 
according to table 4.16.  
 
Table 4.16: Loading conditions for Ca2+-sensitive fluorophors 
cell line Pluronic F-127 
(final) 
Fluo-3-AM 
(final) 
Indo-1-AM 
(final) 
DT40 and derivatives 0.015 % 1.5 µM 1 µM 
K46 0.02 % 1 µM not applied 
WEHI-231 0.02 % 1 µM not applied 
 
The cells were loaded for 25 min at 30 °C. Subsequently, the cell suspension was diluted 
with 700 µL of the corresponding prewarmed medium containing 10 % FCS. The cells were 
incubated for 10 min at 37 °C and were washed twice with Ca2+-containing Krebs-Ringer 
solution. The cells were resuspended in Ca2+-containing Krebs-Ringer solution and kept at 
20 °C until measurement. Prior to measurements, cells were resuspended in Ca2+-
free/EGTA-containing Krebs-Ringer solution. The changes in fluorescence intensity of 
Fluo-3 were monitored on a FACSCalibur cytometer (Becton Dickinson), the ratio        
Indo-violet/Indo-blue was measured with an LSR II (Becton Dickinson). After 30 s, 
stimulation was performed with 10 µg/mL M4 (DT40), 20 µg/mL F(ab')2 fragment goat 
anti-mouse IgG (K46), or 20 µg/mL F(ab')2 fragment goat anti-mouse IgG + IgM (H+L) 
(WEHI-231), respectively. The extracellular Ca2+ level was restored to 1 mM after 6 min 
(DT40 cells) or after 5 min (K46, WEHI-231), respectively. Equal Fluo-3 loading of the 
cells was controlled by treatment with 100 nM ionomycin. The Ca2+ mobilization profiles 
were analyzed using FlowJo and Excel software. For comparative Fluo-3 measurements, 
loading levels were normalized if the deviations were <15 %. 
 
Krebs-Ringer solution....................... 10 mM HEPES, pH 7.0; 140 mM NaCl; 4 mM KCl;       
1 mM MgCl2; 10 mM glucose    
Ca2+-containing................................. + 1 mM CaCl2 
Ca2+-free/EGTA-containing.............. + 0.5 mM EGTA  
Material and Methods 
 
 
54
Pluronic F-127 stock......................... 5 % (w/v) 
Fluo-3-AM stock............................... 1 mM in DMSO; store at -20 °C 
Indo-1-AM stock............................... 1 mM in DMSO; store at -20 °C 
 
 
4.2.3.   Biochemical Methods 
 
4.2.3.1. Production of recombinant GST fusion proteins with BL21 E. coli 
Polyclonal antisera against chicken and murine NTAL were obtained by immunization of 
rabbits with recombinant GST fusion proteins. The cDNA sequences encoding the             
49 C-terminal amino acids of chicken and murine NTAL were ligated into the pGEX-3X 
vector (Amersham Biosciences) at the EcoRI site. The resulting vectors pGEX-
3X/chNTAL(aa150-198) and pGEX-3X/mNTAL(aa155-203) encode GST N-terminally 
fused to the 49 C-terminal amino acids of chicken and murine NTAL. These constructs were 
transformed into BL21 E. coli., and 500 mL LB/Amp medium were inoculated with 10 mL 
overnight culture of a single BL21 colony and grown until an OD600 of approximately 0.5 
was reached. Expression of the GST/NTAL fusion proteins was induced with 1 mM IPTG. 
The bacteria was shaken at 37 °C for 2 hours, centrifuged at 3,000 g and 4 °C for 15 min, 
and the supernatant was discarded. The bacterial pellet was resuspended in 20 mL lysis 
buffer without Triton X-100. The bacteria were sonicated six times for 20 s, and Triton X-
100 was added to a final concentration of 1 %. The lysate was incubated on ice for 10 min 
and centrifuged at 6,000 g and 4 °C for 20 min. The supernatant was transferred to two    
15-mL-tubes, and 0.8 mL Glutathione Sepharose® 4B beads (Amersham Biosciences) 
equilibrated with Triton X-100-containing lysis buffer were added per tube. The lysate was 
rotated for 1 h at 4 °C, and the beads were washed two times with 5 mL Triton X-100-
containing lysis buffer. The beads were resuspended with 1 mL Triton X-100-containing 
lysis buffer and transferred to a column. Elution of the GST/NTAL fusion proteins was 
carried out using 5 mL elution buffer and at 4 °C, and the eluate was collected in 10 
fractions à 500 µL in 1.5 mL tubes. As determined by Coomassie staining, typically 
fractions 2 and 3 contained the highest amount of recombinant fusion protein 
(approximately 4-8 mg/mL) and were sent to the antibody production facility Medical & 
Biological Laboratories (MBL, Japan) (see section 4.2.3.2.).    
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lysis buffer (Japan)............................ 25 mM Tris/HCl, pH 8.0; 10 % glycerol; 1 mM EDTA, 
pH 8.0; 100 mM NaCl; 1 mM DTT; 0.5 mM 
benzamidine; 100 ng/mL lysozyme; 0.2 mM PMSF; 
protease inhibitor 
Triton X-100-containing................... to final 1 % 
elution buffer..................................... 50 mM Tris/HCl, pH 8.0; 10 mM Glutathione 
 
Alternatively, GST fusion proteins were used for affinity purification experiments (see 
section 4.2.3.7). BL21(DE3) E. coli harboring the plasmids pGEX-4T-1, pGEX-4T-
1/mGrb2[SH2], or pGEX-4T-1/mGrb2[cSH3], respectively, were kindly provided by Dr. A. 
Grabbe. 500 mL LB/Amp medium were inoculated with 5 mL overnight culture and grown 
until an OD600 of ~0.7 was attained. Expression of GST only or the GST/Grb2 fusion 
proteins was induced with 0.1 mM IPTG. The bacteria was shaken at 37 °C for 3 hours, 
centrifuged at 3,000 g and 4 °C for 20 min, and the supernatant was discarded. The bacterial 
pellet was resuspended in 50 mL lysis buffer without Triton X-100. The bacteria was 
sonicated three times for 30 s, and Triton X-100 was added to a final concentration of       
0.5 %. The lysate was centrifuged at 6,000 g and 4 °C for 20 min. Aliquots of 2 mL were 
flash frozen in liquid N2 until usage in affinity purification experiments.  
 
lysis buffer (Germany)..........................50 mM Tris/HCl, pH 7.4; 150 mM NaCl; 5 mM DTT 
 
4.2.3.2. Immunization of rabbits with GST fusion proteins   
For the generation of polyclonal antibodies, rabbits were immunized with fusion proteins 
containing GST N-terminally fused to the 49 C-terminal amino acids of chicken or murine 
NTAL, respectively (performed by Medical & Biological Laboratories, MBL, Japan). The 
specificity of the obtained antibodies was tested by immunoblot analysis of lysates derived 
from HEK293T cells transfected with pApuroII-DEST/chNTAL or pApuroII-
DEST/mNTAL, respectively (see 4.2.2.8.). 
 
4.2.3.3. Stimulation of B lymphocytes via the BCR 
B cells were harvested and washed once with RPMI 1640 medium without supplements and 
once with cold PBS. The cells were resuspended in RPMI 1640 medium without 
supplements at a density of 1-5 ⋅ 107 cells/mL and incubated at 37 °C for 10-25 min. For 
stimulation via the BCR 10 µg/mL M4 (DT40 cells), 20 µg/mL F(ab')2 fragment goat anti-
mouse IgG (K46/IIA1.6), 20 µg/mL F(ab')2 fragment goat anti-mouse IgG + IgM (H+L) 
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(WEHI-231), or 20 µg/mL F(ab')2 fragment goat anti-human IgM (Ramos) were added to 
the B cells. After vortexing the cell suspension was incubated at 37 °C for the desired time. 
Subsequently the cells were pelleted, 0.2-1 mL lysis buffer per 1 ⋅ 107 cells was added, and 
the lysates were rotated at 4 °C for 30 min. The lysates were cleared from insoluble cell 
debris by centrifugation at maximum speed and 4 °C for 10 min, and finally transferred to a 
fresh 1.5 mL Eppendorf tube. The cleared cellular lysates (CCLs) were mixed with           
1/5 volume of 5x SDS sample buffer and heated to 95 °C for 5 min, or subjected to affinity 
purifications with GST fusion proteins or antibodies, respectively (see 4.2.3.6.).  
 
lysis buffer............................. 20 mM Tris/HCl, pH 7.5; 150 mM NaCl; 0.5 mM EDTA;     
10 mM NaF; 10 µM Na2MoO4; 1 mM Na3VO4; 0.5-1 % 
detergent (see below); protease inhibitor 
detergent................................ NP-40, Triton X-100, or laurylmaltoside 
5x SDS sample buffer........... 156.25 mM Tris/HCl, pH 6.8; 50 mM DTT; 50 % glycerol;   
15 % SDS; 0.05 % bromophenol blue 
 
Alternatively, total cellular lysates were prepared. For that cells were washed once with PBS 
and directly lysed with 2x SDS sample buffer. The lysates were heated to 95 °C for            
8-10 min, subjected to ultrasound for 5 min, and briefly centrifuged. 
 
2x SDS sample buffer........... 62.5 mM Tris/HCl, pH 6.8; 20 mM DTT; 20 % glycerol;         
6 % SDS; 0.02 % bromophenol blue 
 
4.2.3.4. Preparation of membrane fractions 
For the preparation of membrane fractions, DT40 cells were harvested, washed, starved, and 
if desired stimulated as described in 4.2.3.3. Protease inhibitor and 1 mM Na3VO4 were 
added and then the cells were flash frozen in liquid nitrogen. The samples were thawed on 
ice and homogenized with 20 strokes of a dounce homogenizer. The sample was centrifuged 
at 500 g and 4 °C for 5 min. The pellet (nuclei) was discarded and the sample centrifuged at 
20,000 g and 4 °C for 1 h. The supernatant (cytosolic fraction) was placed on ice, and the 
pellet was resuspended with 600 µL 0.1 M Na2CO3. After centrifugation at 20,000 g and     
4 °C for 45 min, the supernatant (membrane-associated fraction) was neutralized with 2 M 
HCl. The pellet (membrane fraction) was lysed with 1 mL lysis buffer (1 % NP-40; see 
4.2.3.3.). After addition of NP-40 (1 % final concentration) to the cytosolic and the 
Material and Methods 
 
 
57
membrane-associated fraction, all three fractions were subjected to immunopurification 
experiments (see 4.2.3.6.). 
 
4.2.3.5. Preparation of lipid rafts 
Lipid rafts were prepared by sucrose density gradient ultra centrifugation (modified from 
ISHIAI et al., 2000). 1 ⋅ 108 DT40 cells/lipid raft preparation were harvested and resuspended 
in 3 mL RPMI w/o supplements. The cells were starved at 37 °C for 5-10 min. If desired, 
stimulation was performed with 10 µg/mL M4. The cells were centrifuged at 500 g and 4 °C 
for 2 min and subsequently washed with 5 mL PBS-PI. After centrifugation at 2,500 g and  
4 °C for 10 s, the supernatant was aspirated and the cells were lysed with 400 µL lysis 
buffer. The lysate was transferred into a homogenizer and homogenized with 20 strokes. 
The homogenate was transferred to a fresh 1.5 mL Eppendorf tube and placed on ice for    
20 min. The samples were centrifuged at 1,500 g and 4 °C for 2 min, and 400 µL 
supernatant were transferred to an ultracentrifuge tube. Then 400 µL 80 % sucrose buffer 
were added and mixed by pipetting. After careful removal of air bubbles, the lysate was 
slowly overlaid with 2 mL 30 % and 1 mL 5 % sucrose buffer, respectively. The samples 
were ultracentrifuged at 200,000 g and 4 °C for at least 16 h. The next day, 12 fractions of 
300 µL were taken from the top of the sample. Lipid rafts are visible as colourless “clouds”, 
usually appearing in fraction 4. After addition of 60 µL 5x SDS sample buffer, the samples 
were heated to 95 °C for 8 min and subjected to SDS-PAGE (see 4.2.3.8.).   
 
PBS-PI................................... 1 mM Na3VO4; 3.75 mM EDTA; 7.5 mM Na4P2O7 x 10 H2O; 
in PBS 
lysis buffer............................. 1 mM Na3VO4; 10 µM Na2MoO4; 5 mM EDTA; 150 mM 
NaCl; 1 % Triton X-100; 25 mM Tris/HCl, pH 7.5; protease 
inhibitor  
sucrose buffers...................... 5, 30 or 80 % (w/v) sucrose; 1 mM Na3VO4; 10 µM Na2MoO4; 
5 mM EDTA; 150 mM NaCl; 25 mM Tris/HCl, pH 7.5; add 
protease inhibitor prior to usage 
 
4.2.3.6. Affinity purification experiments with GST fusion proteins or antibodies  
Affinity purifications of proteins from CCLs were performed with GST fusion proteins 
containing either the murine Grb2 SH2 or the the C-terminal SH3 domain (see 4.2.3.1.). A  
2 mL aliquot of the GST fusion protein was thawed on ice and centrifuged at maximum 
speed and 4 °C for 10 min. Glutathione Sepharose® 4B beads (Amersham Biosciences) 
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were added to the supernatant and rotated at 4 °C for at least 1 h (binding capacity ~10 mg 
recombinant GST/mL medium). The beads were washed three times with lysis buffer (see 
4.2.3.1., lysis buffer Germany). 10-20 µL beads were added to the CCLs of 1-3 ⋅ 107 cells 
and rotated at 4 °C for at least 1 h. Then the beads were washed three times with NP-40- or 
Triton X-100-containing lysis buffer (see 4.2.3.3.). Subsequently 30-100 µL 2x SDS sample 
buffer were added and the samples were heated to 95 °C for 5 min. Purified proteins were 
resolved by SDS-PAGE (see 4.2.3.8.).    
For immunopurifications of proteins from CCLs, 0.5-2 µg of the corresponding antibodies 
were added to the lysates and rotated at 4 °C for at least 1 h. Then 15-20 µL Protein A/G 
Plus Agarose beads (Santa Cruz) were added and proteins were immuno-purified while 
rotating at 4 °C for at least 1 h. Subsequently, the steps as described for affinity purifications 
were followed.  
If necessary, GST fusion proteins or antibodies were covalently linked to glutathione 
sepharose or Protein A/G agarose beads, respectively. For that, GST fusion proteins together 
with glutathione sepharose beads or antibodies together with Protein A/G agarose beads 
were rotated at 4 °C for at least 1 h (usually overnight). Then the beads were washed two 
times with PBS and two times with 0.2 M triethanolamine, pH 8.2. Crosslinking was 
performed by rotating the beads in 0.2 M triethanolamine containing 3 mg/ml dimethyl 
pimelimidate (DMP; Uptima) at 4 °C overnight. To quench unreacted DMP, the beads were 
rotated with 10 mM ethanolamine, pH 8.2, at 4 °C for 30 min. After washing the beads three 
times with PBS, they were used for affinity or immunopurifications. 
 
4.2.3.7. Deglycosylation of N-glycosylated polypeptides 
Deglycosylation of proteins followed immunopurification experiments (see 4.2.3.6.) was 
carried out with PNGase F (NEB). Washed beads were incubated with 15 µL denaturing 
buffer at 95 °C for 15 min. Then the supernantant was transferred to a fresh 1.5 mL 
Eppendorf tube, and 2.5 µL G7 reaction buffer, 2.5 µL 10 % NP-40 and 3.5 µL PNGase F 
were added. The reaction was incubated at 37 °C overnight. After addition of 15 µL 5x SDS 
sample buffer and heating to 95 °C for 5 min, the samples were subjected to SDS-PAGE 
and subsequent western blotting (see 4.2.3.8. and 4.2.3.9.).  
 
4.2.3.8. SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
Separation of proteins was carried out based principally on the method of one-dimensional, 
discontinuous electrophoresis in sodium dodecyl sulphate (WEBER and OSBORN, 1969; 
LAEMMLI, 1970). Laemmli gels are composed of an upper stacking gel, in which the protein 
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sample is concentrated, and a lower separating gel, in which the different proteins of a 
sample are separated. Polyacrylamide gels are an insoluble matrix of acrylamide monomers 
cross-linked with N,N`-methylene-bisacrylamide in the presence of polymerization catalysts 
(i.e. APS and TEMED). The final acrylamide concentration was 8-12.5 % for separating 
gels, and 4.8 % for stacking gels. RainbowTM coloured protein molecular weight markers 
(2.5-45 kDa and 14.3-220 kDa, Amersham Biosciences) or Prestained Protein Marker (6.5-
175 kDa, New England Biolabs) were used as standards. The electrophoretic separation was 
carried out at a constant current of 10-20 mA for stacking gels and 25-35 mA for separating 
gels. Subsequently gels were subjected to Coomassie staining (Coomassie Brilliant Blue    
R-250, Serva), silver staining, or western blot analysis (see section 4.2.3.9.). 
 
separating gel.................................... 375 mM Tris/HCl, pH 8.8; 8-12.5 % acrylamide; 0.1 % 
SDS; 0.25 mM EDTA; 0.1 % TEMED; 0.1 % APS 
stacking gel........................................125 mM Tris/HCl, pH 6.8; 4.8 % acrylamide; 0.1 % 
SDS; 0.25 mM EDTA; 0.1 % TEMED; 0.1 % APS 
SDS running buffer.........................…25 mM Tris; 192 mM glycine; 0.1 % (w/v) SDS 
 
4.2.3.9. Western blotting 
Western blotting was performed with a semidry transfer unit (Bio-Rad or Amersham 
Biosciences). A sheet of transfer buffer-soaked filter paper was put in place on the anode. 
The filter paper was followed by the equilibrated nitrocellulose membrane, the gel and 
finally another sheet of transfer buffer-saturated filter paper. Air bubbles were rolled out as 
each component was added to the stack. The cathode was placed atop of the transfer stack 
and a current of max. 0.8 mA/cm2 gel was applied for 45 min. After transfer the unit was 
dissassembled, and the membrane with transferred proteins was subjected to 
immunoprobing with primary and secondary horseradish-peroxidase (HRPO)-conjugated 
antibodies. The membrane was first incubated in blocking solution at room temperature for 
1h or at 4 °C overnight on a rocking platform, and thereafter briefly washed three times with 
TBST. Specific proteins were detected with a specific primary antibody. The primary 
antibody dilution was typically 1/100 to 1/2000 in TBST with 1 % (w/v) BSA and 0.01 % 
(w/v) NaN3. The membrane was incubated with the primary antibody at 4 °C for 1 h or 
overnight on a rocking platform. The membrane was washed with TBST three times by 
agitation on an orbital shaker, 7 to 10 min each time. The HRPO-conjugated anti-
immunoglobulin antibody was diluted 1/5000 to 1/10,000 in TBST, and the membrane was 
incubated with the secondary antibody at room temperature or 4 °C for 0.5 to 1 h on a 
rocking platform. The membrane was washed with TBST three times by agitation on an 
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orbital shaker, 7 to 10 min each time. The immunoblot was visualized using the ECL® 
detection system (Amersham Biosciences). Detection of specific proteins was carried out by 
either exposure of the membrane to a film with variable exposure times (0.5-15 min) in the 
darkroom and subsequent automated film development (Optimax Typ TR, MS Laborgeräte, 
Germany), or direct exposure of the membrane to a digital imaging system (Chemi Lux 
Imager, Intas). 
 
transfer buffer........................ 39 mM glycine; 48 mM Tris; 0.0375 % (w/v) SDS; 0.01 % 
(w/v) NaN3; 20 % MeOH 
blocking solution................... 5 % (w/v) nonfat dried milk or BSA in TBST 
TBST..................................... 0.1 % (v/v) Tween-20 in TBS 
 
4.2.3.10. Stripping of immunoblot membranes 
If nitrocellulose membranes had to be incubated with an alternative primary antibody 
derived from the same species, bound immunoglobulins were removed by incubating the 
nitrocellulose membranes with stripping buffer at 50 °C for 30 min. Then the membranes 
were washed 6-10 times for 10 min with TBST, followed by incubation in blocking solution 
and probing as described in 4.2.3.11. 
 
Stripping buffer..................................2 % SDS; 0.1 M β-MeOH; 62.5 mM Tris, pH 6.8 
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5.  Results 
 
5.1.  Grb2 and NTAL regulate Ca2+ mobilization in B lymphocytes 
Engagement of antigen receptors on lymphocytes results in the recruitment of adaptor 
molecules and kinases, leading to the activation of PLC-γ and an increase in [Ca2+]i. 
Lymphocytes generate their Ca2+ signals by using both intra- and extracellular sources. The 
first aim of this thesis was to investigate the regulation of Ca2+ mobilization in                     
B lymphocytes and the roles of adaptor proteins in this process. 
 
5.1.1.  Differences in Ca2+ mobilization in immature and mature B lymphocytes 
To discriminate between Ca2+ mobilization from intra- and extracellular sources, B cells 
were loaded with 1 µM Fluo3-AM/0.02% pluronic F127, and BCR stimulation was 
performed for 5 min in the presence of 0.5 mM EGTA to sequester extracellular Ca2+-ions. 
After 5 min the extracellular Ca2+ concentration was restored to 1 mM, and the Ca2+ entry 
via ion channels in the plasma membrane was recorded. To further investigate the 
observation that the extent of extracellular Ca2+ entry depends on the developmental stage of 
the B lymphocyte (KONCZ et al., 2002; KOVESDI et al., 2002), Ca2+ flux was monitored in 
the immature murine B cell line WEHI-231 (figure 5.1, grey line) and the mature murine    
B cell line K46 (figure 5.1, black line). Whereas the Ca2+ release from intracellular stores is 
comparable in these two cell lines, Ca2+ entry across the plasma membrane is significantly 
higher in mature K46 B cells as compared to the immature WEHI-231 B cells. These results 
clearly confirm that the extent of extracellular Ca2+-entry depends on the developmental 
stage of the B lymphocyte.     
 
 
 
Figure 5.1: Ca2+ mobilization in   
B lymphocytes at different 
developmental stages 
Upon loading of the immature B cell line 
WEHI-231 (grey line) and the mature  
B cell line K46 (black line) with 1 µM 
Fluo-3/0.02 % pluronic F127, BCR-
induced release of intracellular Ca2+ was 
monitored for 5 min in the presence of 
0.5 mM extracellular EGTA to sequester 
Ca2+ ions from the medium. 
Subsequently, the extracellular Ca2+ 
concentration was restored to 1 mM, and 
the influx of Ca2+ through plasma 
membrane channels was recorded. Ca2+ 
mobilization in these two cell lines was 
analysed in at least three independent 
measurements. 
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5.1.2.  The adaptor protein Grb2 negatively regulates Ca2+ mobilization in                   
B lymphocytes 
In order to study whether the adaptor molecule Grb2 exhibits a Ca2+-regulating role in        
B lymphocytes similar to the Grb2 family member Gads/GrpL in T lymphocytes, BCR-
induced Ca2+ mobilization was analysed in the immature chicken B cell line DT40 and in 
genetic mutants that were rendered deficient for Grb2 expression by targeted gene 
disruption (HASHIMOTO et al., 1998). Reconstitution of wild-type Grb2 expression was 
achieved by retroviral gene transfer of the parental grb2-/- DT40 cell line with avian grb2 
cDNA. Avian grb2 messenger RNA was isolated from DT40 wild-type cells by RT-PCR 
using the oligonucleotides chGrb2for and chGrb2rev, respectively. In figure 5.2 the deduced 
amino acid sequence of avian Grb2 is aligned to its murine and human orthologues. Grb2 is 
composed of three protein-protein interaction modules, i.e. an N-terminal SH3 domain 
(figure 5.2, amino acids 1-58), a central SH2 domain (amino acids 60-152), and a               
C-terminal SH3 domain (amino acids 156-215). The alignment shows a high degree of 
conservation of the ubiquitously expressed cytosolic adaptor among species with an overall 
identity of 97.2 %.  
 
                     10        20        30        40        50        60 
                      |         |         |         |         |         | 
chicken      MEAIAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPKNYIEMKPHPW 
mouse        MEAIAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPKNYIEMKPHPW 
human        MEAIAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPKNYIEMKPHPW 
             ************************************************************ 
 
                     70        80        90       100       110       120 
                      |         |         |         |         |         | 
chicken      FFGKIPRAKAEEMLGKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFL 
mouse        FFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFL 
human        FFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFL 
             **************.********************************************* 
 
                    130       140       150       160       170       180 
                      |         |         |         |         |         | 
chicken      WVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQALFDFDPQEEGELGFRRG 
mouse        WVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQMPQQPTYVQALFDFDPQEDGELGFRRG 
human        WVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQALFDFDPQEDGELGFRRG 
             *********************************:*****************:******** 
 
                    190       200       210 
                      |         |         | 
chicken      DFIQVLDNSDPNWWKGACHGQTGMFPRNYVTPVNRNI 
mouse        DFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNRNV 
human        DFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNRNV 
             ***:*:******************************: 
 
Figure 5.2: Amino acid alignment of avian, murine, and human Grb2 
The amino acid sequences of avian, murine (accession number NP_032189), and human Grb2 (accession 
number NP_002077) were aligned using the ClustalW algorithm (THOMPSON et al., 1994). Avian Grb2 
amino acid sequence is deduced from multiple cDNA sequences. Amino acids are denoted by using the 
single letter code. Identical amino acids (*) are depicted in red, strongly similar amino acids (:) in green, 
and weakly similar amino acids (.) in blue. 
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Grb2 expression of reconstituted grb2-/- DT40 cells was confirmed by immunoblot analysis 
(see figure 5.4A). All retroviral gene transfers and Ca2+ mobilization measurements 
described in this thesis were performed in cooperation with Dr. M. Engelke (Cellular and 
Molecular Immunology, Georg-August University, Göttingen). 
Wild-type DT40 cells, grb2-/- DT40 cells, and derivatives that upon retroviral gene transfer 
express wild-type Grb2 were loaded with 1.5 µM Fluo3-AM/0.015% pluronic F127. BCR-
induced Ca2+ release from ER stores was monitored for 6 min in the presence of 0.5 mM 
EGTA to remove Ca2+ ions from the medium. Subsequently the extracellular Ca2+ 
concentration was restored to 1 mM and the influx of Ca2+ through plasma membrane ion 
channels was recorded. Wild-type DT40 cells show a response with internal Ca2+ elevation 
but no subsequent Ca2+ influx across the plasma membrane (figure 5.3, green line). The   
grb2-/- DT40 cell line exhibits a completely different Ca2+ signal, as these cells mobilize 
Ca2+ from both intra- and extracellular sources (black line). The Grb2-deficient cells also 
reveal an increased duration of Ca2+ efflux from the ER. It was demonstrated that both the 
prolonged Ca2+ release from intracellular stores, and the Ca2+ entry from extracellular 
sources is due solely to the absence of Grb2 since reconstitution of Grb2 expression results 
in a Ca2+ flux that resembles the signal in wild-type DT40 cells, i.e. shortened duration of 
intracellular Ca2+ release and inhibited Ca2+ influx across the plasma membrane (grey line). 
These experiments reveal a negative regulatory role for Grb2 in BCR-induced Ca2+ 
mobilization.  
 
 
 
 
 
 
 
Figure 5.3: Grb2 negatively 
regulates Ca2+ mobilization in   
B lymphocytes 
Wild-type DT40 B cells (green line), 
grb2-/- mutants (black line), and 
derivatives that upon retroviral gene 
transfer express wild-type Grb2 (grey 
line) were loaded with 1.5 µM   
Fluo-3/0.015 % pluronic F127, and 
BCR-induced Ca2+ release from 
intracellular stores was monitored for  
6 min in the presence of 0.5 mM 
EGTA. Thereafter the extracellular 
Ca2+ concentration was restored to   
1 mM and Ca2+ entry across the 
plasma membrane was recorded. Data 
represent the results obtained from 18 
measurements of four independent 
retroviral infections. 
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5.1.3.  The central SH2 domain and C-terminal SH3 domain are required for the 
inhibitory effect of Grb2 on Ca2+ mobilization       
The contribution of the individual Grb2 domains to the inhibitory effect was investigated by 
mutational analysis. Chicken Grb2 proline 49 was substituted for leucine, arginine 86 was 
substituted for lysine, and tryptophane 193 was substituted for lysine to create SH2 or SH3 
mutants, respectively. It has been previously described that these amino acid exchanges are 
loss-of-function substitutions for the corresponding interaction domain (MCPHERSON et al., 
1994; TANAKA et al., 1995). Grb2 protein expression in wild-type DT40 cells and in grb2-/- 
DT40 cells reconstituted with wild-type Grb2 or non-functional variants was controlled by 
anti-Grb2 immunoblot analysis of total cellular lysates (figure 5.4A). Analysis of BCR-
induced Ca2+ mobilization in grb2-/- DT40 cells reconstituted with these non-functional 
Grb2 variants reveal that the central SH2 domain and the C-terminal SH3 domain are 
required for the inhibitory effect of Grb2 on Ca2+ mobilization (figure 5.4B, blue and orange 
lines, respectively). In these cells, the prolonged Ca2+ release from intracellular stores and 
the increased Ca2+ entry is similar to the fluxes observed for grb2-/- DT40 cells. In contrast, 
the N-terminal SH3 domain is dispensable for this negative regulatory function (figure 5.4B, 
violet line), as the Ca2+ mobilization pattern of this cell line resembles the one observed for 
grb2-/- DT40 cells reconstituted with wild-type Grb2. In figure 5.4C the Ca2+ responses of 
grb2-/- DT40 cells and derivatives that were reconstituted with wild-type Grb2 or 
nonfunctional variants were depicted in one diagram. These measurements show that the 
inhibitory effect of Grb2 on Ca2+ mobilization is mediated by the central SH2 domain and 
the C-terminal SH3 domain. 
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Figure 5.4: The inhibitory effect of Grb2 on Ca2+ mobilization depends on the SH2 and the            
C-terminal SH3 domain 
(A) Grb2 protein expression in wild-type DT40 B cells (lane 1), grb2-/- mutants (lane 2), and derivatives 
that upon retroviral gene transfer express either wild-type Grb2 (lane 3) or variants with non-functional 
N-terminal SH3, central SH2, or C-terminal SH3 domains (lanes 4-6, respectively) was observed by anti-
Grb2 immunoblot analysis of total cellular lysates. Amino acid substitutions present in variant Grb2 
(P49L, R86K, or W193K) are specified by using the single letter code. Molecular mass protein standards 
(kDa) are indicated on the left. (B) Intra- and extracellular Ca2+ mobilization was recorded by flow 
cytometry (for details refer to figure 5.3 legend) in grb2-/- derivatives that upon retroviral infection 
express Grb2 variants with a non-functional N-terminal SH3 (violet line), central SH2 (blue line), or     
C-terminal SH3 domain (orange line). Data represent the results of five independent measurements.     
(C) Overlay of Ca2+ mobilization profiles described in figures 5.3 and 5.4B. Equivalent cellular loading 
with Fluo-3 was controlled by treatment of the cells with 100 nM ionomycin (data not shown). 
 
 
5.1.4. Grb2 also exhibits inhibitory effects on Ca2+ mobilization in mature                   
B lymphocytes 
Thereafter the described negative signalling role of Grb2 was examined to determine if it is 
restricted to immature B lymphocytes such as DT40 since mature B cells show a more 
robust antigen-induced Ca2+ mobilization. Wild-type K46 cells were retrovirally infected 
with murine grb2 cDNA, and overexpression of Grb2 was confirmed by anti-Grb2 
immunoblot analysis of total cellular lysates (figure 5.5A, upper panel). As loading control 
the same membrane was analysed by anti-actin immunoblotting (figure 5.5A, lower panel). 
Analysis of Ca2+ mobilization showed that a moderate overexpression of wild-type Grb2 
results in a significantly attenuated influx of extracellular Ca2+ ions (figure 5.5B, grey line). 
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These results confirm that the function of Grb2 as negative regulator of BCR-induced Ca2+ 
mobilization is not restricted to immature B cells such as DT40 but also plays a role in Ca2+ 
flux regulation in mature B lymphocytes.  
 
 
Figure 5.5: Grb2 also inhibits Ca2+ mobilization in mature B lymphocytes 
(A) Grb2 protein expression in wild-type K46 B cells (lane 1) and derivatives that were retrovirally 
infected with murine grb2 cDNA (lane 2) was observed by anti-Grb2 immunoblot analysis of total 
cellular lysates (upper panel). Anti-actin immunoblotting of the same membrane served as a loading 
control (lower panel). Molecular mass protein standards (kDa) are indicated on the left. (B) Intra- and 
extracellular Ca2+ mobilization was recorded by flow cytometry (refer to figure 5.1 legend for details) in 
wild-type K46 B cells (black line) and derivatives that upon retroviral infection overexpress Grb2 (grey 
line). Data represent the results of four independent measurements. 
 
 
5.1.5.  Grb2 deficiency does not alter the phosphorylation state of SLP-65 or PLC-γ2 
One key hallmark of BCR-induced primary Ca2+ mobilization is the phosphorylation-
dependent assembly of the Ca2+ initiation complex consisting of SLP-65, Btk and PLC-γ2 
(KUROSAKI et al., 2000; WIENANDS, 2000b). In order to determine whether Grb2 directly 
affects the assembly of the Ca2+ initiation complex, the phosphorylation state of SLP-65 and 
PLC-γ2 was analysed. Wild-type and grb2-/- DT40 cells were left untreated or stimulated via 
their BCR with 10 µg/mL M4 antibodies for the indicated times and subjected to 
immunoprecipitation with antibodies to SLP-65 (figure 5.6, left panels) or PLC-γ2 (right 
panels). Purified proteins were analysed by anti-phospotyrosine (α-pTyr) immunoblotting 
(upper panels). It could be shown that Grb2 deficiency does not alter the phosphorylation 
state of SLP-65 or PLC-γ2. This data indicates that Grb2 might not affect the primary Ca2+ 
initiation complex directly.  
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Figure 5.6: Grb2-deficiency does not alter phosphorylation state of SLP-65 or PLC-γ2      
Wild-type and grb2-/- DT40 cells were untreated or stimulated through their BCR for the indicated times, 
and lysed. Following immunoprecipitation with antibodies to SLP-65 (left panels) or PLC-γ2 (right 
panels), the recovered proteins were analysed by anti-phosphotyrosine (α-pTyr) immunoblotting (upper 
panels). Equivalent protein recovery and loading was confirmed by reprobing the membranes with anti-
SLP-65 and anti-PLC-γ2 antibodies (lower panels). Molecular mass protein standards (kDa) are indicated 
on the left. 
 
 
5.1.6.  The expression of the transmembrane adaptor NTAL in B lymphocytes is 
dependent on their developmental stage 
Grb2 is expressed throughout all stages of B cell lymphopoesis. Therefore, it seemed likely 
that the differences in Ca2+ mobilization between immature, and mature B lymphocytes are 
evoked by an upstream regulator of Grb2 that is absent or expressed weakly in immature 
DT40 B cells. This regulator is capable of counter acting the inhibitory effects of Grb2 and 
thus permits a complete biphased Ca2+ response. In T lymphocytes LAT is the central 
transmembrane adaptor, and tyrosine phosphorylated LAT serves as a scaffold organizing 
the translocation of Ca2+-regulating enzymes to the lipid raft fraction (reviewed in 
LINDQUIST et al., 2003; SIMEONI et al., 2005). Brdička et al. reported the identification of the 
non-T cell activation linker NTAL (BRDICKA et al., 2002) (alternatively called LAB, 
JANSSEN et al., 2003), which is closely related to LAT structurally and evolutionarily, and 
reported to bind Grb2 through phosphotyrosine-based binding motifs of the pYxN type 
(where x is any amino acid) in mammalian B cells. Using a panel of cDNAs derived from 
different immunorelevant cells and tissues, the ntal transcription pattern was analysed by 
RT-PCT using the oligonucleotides hNTALfor1 and hNTALrev1 (792 bp amplicon). 
Human ntal transcripts were mainly detected in spleen, lymph nodes, and periphal blood 
leukocytes (figure 5.7A, lanes 1, 2, 4). Gapdh-specific oligonucleotides were used in this 
analysis for normalization (lanes 9 to 16).  
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Figure 5.7: NTAL expression depends on the developmental stage of B lymphocytes 
(A) Normalized first strand cDNA preparations (BD Human Immune System MTCTM Panel) from human 
spleen, lymph node (LN), thymus, peripheral blood leukocytes (PBL), bone marrow (BM), and fetal liver 
were used to analyse NTAL expression by RT-PCR. Oligonucleotides hNTALfor1 and hNTALrev1 are 
expected to yield a 792 bp amplicon (lanes 1-7). First strand cDNA prepared from human Ramos            
B lymphocytes was used as a positive control (lane 7). In addition gapdh-specific oligonucleotides were 
used for normalization (expected transcript size: 983 bp; lanes 9 to 16). Human control cDNA included in 
the panel served as positive control (lane 15), and negative controls (lanes 8 and 16) lacked the template. 
(B) Total cellular lysates were prepared from approximately 1 x 106 cells of B cell lines at various 
developmental stages and were subjected to anti-mouse (lanes 1-6) or anti-chicken NTAL (lane 7) 
immunoblotting. The mature B cell phenotype is represented by murine K46 (lane 1) and the A20-
derivative IIA1.6 (lane 2); the immature phenotype is represented by murine CH31 (lane 3), WEHI-231 
(lane 4), and chicken DT40 (lane 7), while the murine pre-B cell line TKµ+ (lane 5) is a µm-positive 
variant of the pro-B cell line TKµ- (lane 6). Molecular mass protein standards are indicated on the left. 
 
 
The next objective was to analyse the B lymphocyte-specific NTAL expression on the 
protein level. Thus antibodies specific for murine NTAL had to be generated for 
immunoblot analysis. This was achieved by immunization of rabbits with GST fusion 
proteins containing the 49 C-terminal amino acids of murine NTAL. The specificity of the 
antibodies was tested with lysates of HEK293T cells transfected with full length murine ntal 
cDNA (data not shown). Lysates from murine B cell lines representing different 
developmental stages were subjected to anti-mouse NTAL immunoblotting (figure 5.7B, 
maturation stages ascending from the right to the left). This analysis clearly demonstrates 
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that NTAL expression in B lymphocytes increases with maturation, and is expressed in 
mature B cell lines K46 and IIA1.6 at the highest levels (figure 5.7B, lanes 1 and 2, 
respectively).  
 
5.1.7.  Functional analysis of the palmitoylation and Grb2-binding motifs of avian 
NTAL 
Cloning the avian ntal cDNA and subsequently characterizing its functional properties was 
then pursued. Three chicken expressed sequence tags (ESTs) were identified in the 
Biotechnology and Biological Sciences Research Council (BBSRC) repository (BOARDMAN 
et al., 2002; http://www.chick.umist.ac.uk) by a tblastx search with full length murine ntal 
cDNA sequence. These ESTs originated from chicken limbs, small intestine and liver, 
respectively, and displayed a high level of similarity to both the human and murine ntal 
cDNA sequences. Based on the identified chicken ntal sequences gene-specific 
oligonucleotides were designed, and ntal messenger RNA was isolated from wild-type 
DT40 cells by RT-PCR. The full length chicken ntal cDNA (deposited under accession 
number AY743659) was amplified using the oligonucleotides chNTALfor5 and 
chNTALrev2, respectively. Within the amplicon, 9 nucleotides at the 5’end and                 
19 nucleotides at the 3’end of chicken ntal cDNA are derived from the oligonucleotide 
sequences. The amplified avian ntal cDNA encodes a protein containing 198 amino acids 
with a calculated molecular mass of 22.4 kDa. In figure 5.8A the chicken NTAL amino acid 
sequence is aligned with its human and murine orthologues. The schematic representation of 
NTAL from different species and of human LAT depicted in figure 5.8B shows that the 
previously described cystein-containing palmitoylation motifs for raft localization and the 
tyrosine-based Grb2 binding sites (BRDICKA et al., 2002; JANSSEN et al., 2003) are also 
present in avian NTAL. For further functional studies polyclonal antibodies were generated 
in rabbits immunized with GST fusion proteins containing the 49 C-terminal amino acids of 
chicken NTAL. The specificity of the rabbit anti-chicken NTAL antibodies was tested with 
lysates of HEK293T cells transfected with full length chicken ntal cDNA (data not shown). 
The functionality of the cystein-containing palmitoylation motifs of chicken NTAL was 
investigated. Raft localization of chicken NTAL was analysed in DT40 cells overexpressing 
chicken NTAL (transfectant N3-3) by sucrose gradient ultracentrifugation (figure 5.9A, 
upper panel). As a control for the isolated fractions, the same membrane was subjected to 
anti-Lyn immunoblotting (figure 5.9A, lower panel) since Lyn is a permanent resident of 
lipid rafts. These observations prove that chicken NTAL translocates to the lipid rafts since 
it is detected in fraction 4 containing raft-resident proteins.  
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                     10        20        30        40        50        60 
                      |         |         |         |         |         | 
chicken      -MAQPELLWAA--AGLMLLGVAVSACVRCQLYATKRGKDGSQGSRLERPQRFEVIRSCSA 
mouse        MSAELELLWPVSGLLLLLLGATAWLCVHCSRPGVKRNEKIYEQRNRQENAQSSAAAQTYS 
human        MSSGTELLWPG-AALLVLLGVAASLCVRCSRPGAKRSEKIYQQRSLREDQQSFTGSRTYS 
               :  ****.     *:***.:.  **:*.  ..**.:.  :    ..  :  .     : 
 
                     70        80        90       100       110       120 
                      |         |         |         |         |         | 
chicken      VTRRPERIKEPEHLARKAPEELSTSCHVGFESSAEPRYQNFLTEDCLHEDAAYVEPVPLD 
mouse        LARQVWPGPQMDTAPNKSFERKNKMLFSHLEGPESPRYQNFYKGSNQEPDAAYVDPIPTN 
human        LVGQAWPGPLADMAPTR--KDKLLQFYPSLEDPASSRYQNFSKGSRHGSEEAYIDPIAME 
             :. :       :  . :  :      .  :*.. ..***** . .    : **::*:. : 
 
                    130       140       150       160       170       180 
                      |         |         |         |         |         | 
chicken      YYSHNRFFSPPNDEDSHSYQNVIIGDPCSSELDD-------------------------- 
mouse        YYNWGCFQKPSEDDDSNSYENVLVCKPSTPESGV-------------------------- 
human        YYNWGRFSKPPEDDDANSYENVLICKQKTTETGAQQEGIGGLCRGDLSLSLALKTGPTSG 
             **. . * .*.:*:*::**:**:: .  :.* .                            
 
                    190       200       210       220       230       240 
                      |         |         |         |         |         | 
chicken      ------------AEDYENSTAIEVWKVQQAKAMLY--AESQ------DEE---PDYVNTD 
mouse        ----------EDFEDYQNSVSIHQWRESKRTMG----APMS-LSGSPDEE---PDYVNGD 
human        LCPSASPEEDEESEDYQNSASIHQWRESRKVMGQLQREASPGPVGSPDEEDGEPDYVNGE 
                          ***:**.:*. *: .:                  ***   ***** : 
 
                    250 
                      | 
chicken      PTIDAVVLSK 
mouse        VAAAENI--- 
human        VAATEA---- 
              :          
 
 
 
Figure 5.8: Alignments of avian, murine, and human NTAL  
(A) The amino acid sequences of avian, murine (accession number NP_064428), and human NTAL 
(accession number NP_115852) were aligned using the ClustalW algorithm (THOMPSON et al., 1994). 
The avian NTAL amino acid sequence is deduced from multiple cDNA and genomic sequences, and its 
cDNA sequence is catalogued under GenBank accession number AY743659. Amino acids are denoted by 
using the single letter code. Identical amino acids (*) are depicted in red, strongly similar amino acids (:) 
in green, and weakly similar amino acids (.) in blue. Palmitoylation and Grb2 binding motifs are 
indicated in bold letters (B) Avian, murine, and human NTAL are schematically represented and 
compared to human LAT. The amino acid sequences of cystein-containing palmitoylation motifs for raft 
localization and tyrosine-based Grb2 binding sites are indicated above the respective schematics. Human 
LAT possess a unique PLC-γ binding site at amino acid position 132 (YLVV) that is highlighted by a 
black rectangle. TM, transmembrane regions. 
A 
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Thereafter, the functionality of the tyrosine-based Grb2-binding motifs was examined. Four 
Grb2-binding sites are common amongst the  NTAL proteins from different species (see 
figure 5.8A and B). BCR-induced tyrosine phosphorylation of avian NTAL was confirmed 
in two independent NTAL positive DT40 transfectants (transfectants N3-4 and N3-7) by 
immunoprecipitation with antibodies to chicken NTAL and subsequent anti-pTyr 
immunoblotting (figure 5.9B, lanes 4 and 6). The avian NTAL/Grb2 complex could be 
isolated from these two NTAL-positive transfectants following BCR stimulation by co-
immunoprecipitation experiments with anti-Grb2 antibodies (figure 5.9C, upper panel, lanes 
4 and 6).  
 
 
 
 
derived from unstimulated (-) or BCR-stimulated (+) wild-type DT40 cells (lanes 1 and 2) and two 
NTAL-positive transfectants decribed in (B) (lanes 3-6) were analysed by anti-chicken NTAL 
immunoblotting (upper panel). Equivalent protein recovery and co-immunoprecipitation conditions were 
verified by anti-Grb2 (lower panel) and anti-SLP-65 immunoblot analysis (middle panel). Molecular 
mass protein standards (kDa) are indicated on the left in the panels (A-C). 
 
 
Figure 5.9: Raft localization, tyrosine 
phosphorylation, and Grb2-recruitment of 
chicken NTAL 
(A) Isolated sucrose gradient fractions containing 
lipid rafts (JOHMURA et al., 2003) obtained from 
DT40 cells overexpressing chicken NTAL 
(transfectant N3-3) were analysed by anti-chicken 
NTAL immunoblotting (upper panel). Successful 
isolation of lipid rafts (typically fraction 4) was 
confirmed by reprobing the same membrane with 
anti-chicken Lyn antibodies (lower panel).   
(B) Anti-chicken NTAL immunoprecipitates 
derived from unstimulated (-) or BCR-stimulated 
(+) wild-type DT40 cells (lanes 1 and 2) and two 
independently obtained transfectants expressing 
chicken NTAL (clones N3-4 and N3-7, lanes 3-6) 
were subjected to immunoblotting with anti-pTyr 
antibodies. (C) Anti-Grb2 immunoprecipitates 
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In wild-type DT40 cells, NTAL expression is not detectable by immunoblot analysis. The 
efficiency of the co-purification was monitored by reprobing the same membrane with both 
anti-SLP-65 (middle panel) and anti-Grb2 antibodies (lower panel). Together this data 
shows that NTAL is targeted to lipid rafts and recruits Grb2 following BCR engagement.  
 
5.1.8.  Generation of an ntal-/- DT40 cell line 
NTAL function in BCR signalling pathways was further investigated by gene disruption in 
DT40 B lymphocytes. This cell line was employed since targeted integration of homologous 
DNA occurs in these cells at high frequencies (BUERSTEDDE and TAKEDA, 1991). Ntal 
messenger RNA was detected in DT40 B lymphocytes (see section 5.1.7). Therefore the 
generation of an ntal-/- DT40 cell line became necessary to exclude the possibility of 
endogenous NTAL expression dominantly affecting BCR-induced signalling in subsequent 
functional studies. The partial chicken ntal cDNA sequence obtained from the ESTs was 
employed to identify the ntal sequence within the genomic database 
(http://www.ncbi.nlm.nih.gov). The GenBank accession number of the chicken ntal locus is 
AC091726. Like its human and murine orthologues, the genomic locus of chicken ntal 
consists of 11 coding exons. Genomic clones of ntal were obtained by using the 
oligonucleotides genNTALfor and genNTALrev in a long range PCR. The targeting vectors 
pNTAL-neo and pNTAL-hisD were constructed by replacing a 4650 bp genomic fragment 
containing the exons corresponding to chicken NTAL amino acid residues 1-142 with neo 
or hisD cassettes, respectively. These cassettes were flanked by 3.2 and 2.3 kb of genomic 
sequence on the 5’ and 3’ sides, respectively (figure 5.10A). To disrupt one ntal allele, the 
targeting construct pNTAL-neo was transfected into wild-type DT40 cells. Homologous 
recombination was identified by PCR and Southern blot analysis (data not shown), and a 
targeted allele was detected in 13 out of 24 G418-resistant clones. Inactivation of the second 
allele was achieved by introducing pNTAL-hisD into the neo-targeted clone N2, and 
selection with both G418 and histidinol. For Southern blot analysis genomic DNA was 
digested with BglII and probed using a 841 bp fragment located in the 5’ region exterior to 
the site of recombination, allowing a clear distinction between the 13 kb and 14.2 kb 
fragments corresponding to the neo- and hisD-targeted loci and the 5263 bp fragment of the 
wild-type locus. The generation of the ntal-/- DT40 clones N2-1, N2-15, N2-20, and N2-23 
was confirmed by Southern blot analysis (figure 5.10B). The introduction of a single copy 
of each targeting vector was also verified by reprobing the blots with internal neo or hisD 
probes (data not shown).  
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Figure 5.10: Generation of ntal-/- DT40 B lymphocytes 
(A) Schematic representation of the chicken ntal genomic locus and targeting strategy. The targeting 
vectors pNTAL-neo and pNTAL-hisD were constructed by replacing the genomic fragment (4650 bp) 
containing exons corresponding to chicken NTAL amino acids 1-142 with neo, or hisD cassettes. The 
cassettes were flanked by 3236 bp and 2290 bp of genomic sequence on the 5’ and 3’ sides, respectively. 
The transcriptional direction of the resistance cassettes is opposite relative to ntal. Restriction 
endonuclease cleavage sites are denoted above the gene. Red boxes, ntal coding exons; black rectangle, 
probe for Southern blot analysis shown in (B). (B) Homologous recombination of pNTAL-neo and 
pNTAL-hisD at the ntal locus of DT40 B lymphocytes was determined by Southern blot analysis. The 
pNTAL-hisD was introduced into the neo-targeted clone N2 to obtain an NTAL deficient cell line. 
Genomic DNA from 24 selected clones was digested with BglII and probed using an 841 bp fragment 
located 5’ to the targeted region. BglII-digested DNA derived from wild-type DT40 cells and the parental 
clone N2 served as controls. Ntal-/- clones N2-1, N2-15, N2-20, and N2-23 are marked by red arrows. 
DNA size markers (bp) are indicated on the left. 
 
 
5.1.9.  NTAL is a positive regulator of BCR-induced Ca2+ mobilization 
To examine whether NTAL can counter act Grb2 in mature B lymphocytes, the direct 
impact of NTAL expression on the BCR-induced Ca2+ mobilization in DT40 B lymphocytes 
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was monitored. Like wild-type DT40 cells (figure 5.11, green line), the ntal-/- DT40 clone 
N2-1 retrovirally infected with an empty vector lacks Ca2+ influx from extracellular sources 
(blue line). In marked contrast, ntal-/- DT40 cells that express wild-type chicken NTAL 
following retroviral gene transfer (see figure 5.12A) display a prolonged intracellular Ca2+ 
release as well as significant extracellular Ca2+ entry (red line). Hence, the Ca2+ 
mobilization profile of NTAL-positive DT40 cells resembles the signal in Grb2-negative 
DT40 cells. Taken together, NTAL plays a positive regulatory role in BCR-induced Ca2+ 
mobilization. 
 
 
 
 
5.1.10. The positive effect of NTAL on Ca2+ mobilization depends both on cysteine-
containing palmitoylation motifs and tyrosine-based Grb2 binding sites 
The positive regulatory role of NTAL on Ca2+ mobilization was further analysed in DT40 
cells expressing NTAL mutants in which the amino acids responsible for raft localization or 
Grb2 binding were substituted. Alanine substitution of two cysteine residues within the 
NTAL palmitoylation motif (NTAL[C23/26A]) abrogates localization of the protein in lipid 
rafts (data not shown). Plasma membrane localization of this non-raft NTAL variant was 
confirmed by confocal laser scanning microscopy (data not shown). Equivalent expression 
of NTAL and NTAL derivatives in the different transfectants was controlled by anti-HA 
immunoblotting, respectively (figure 5.12A). Ca2+ mobilization analysis of ntal-/- DT40 cells 
reconstituted with NTAL[C23/26A] demonstrates that there is no extracellular Ca2+ influx 
(figure 5.12B). The same observation was made for NTAL mutants in which the four 
consensus Grb2 binding sites were inactivated by tyrosine-to-phenylalanine substitutions 
(figure 5.12B, NTAL[4Y4F]). Single Y-to-F substitutions rendering distinct Grb2 binding 
sites nonfunctional reveal that the membrane-proximal binding site (Y95) is dispensable for 
Figure 5.11: NTAL positively 
regulates BCR-induced Ca2+ 
mobilization 
Intra- and extracellular Ca2+ 
mobilization was recorded by flow 
cytometry (described in figure 5.3 
legend) in wild-type DT40 cells (green 
line) and ntal-/- mutants that were 
retrovirally infected with either empty 
pMSCVpuro vector (blue line) or 
pMSCVpuro containing chicken ntal 
cDNA (red line). Data represent the 
results obtained from 14 measurements 
of two independent retroviral 
infections. 
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the positive effect of NTAL on Ca2+ mobilization (figure 5.12B, NTAL[Y95F]). In contrast, 
the three membrane-distal Grb2 binding sites (Y136, Y155, and Y184) mediate elevated Ca2+ 
entry from extracellular sources (figure 5.12B, NTAL[Y136F], NTAL[Y155F], and 
NTAL[Y184F]). The closely related LAT molecule is capable of substituting NTAL 
function for Ca2+ mobilization in DT40 cells. This could be shown in ntal-/- DT40 cells 
expressing human LAT (figure 5.12B, LAT). Similar results were also obtained in ntal-/- 
DT40 cells expressing a LAT mutant lacking the PLC-γ binding site (figure 5.12B, 
LAT[Y132F]). The above results strongly suggest that raft-targeted NTAL positively 
regulates Ca2+ mobilization in B lymphocytes by means of its three membrane distal Grb2-
binding motifs.  
 
 
 
 
Figure 5.12: Effect of NTAL signalling motifs on the 
Ca2+ responses 
(A) Ntal-/- clone N2-1 was transfected with either the 
empty pMSCVpuro vector or pMSCVpuro containing 
cDNA coding for either HA-tagged wild-type NTAL or 
NTAL variants containing the indicated C-to-A or Y-to-F 
amino acid substitutions. Expression of HA-tagged NTAL 
proteins was confirmed by anti-HA immunoblotting.   
(B) A summary of intra- and extracellular Ca2+ 
mobilization in ntal-/- N2-1 derivatives expressing HA-
tagged NTAL proteins described in (A), wild-type human 
LAT, or a LAT Y-to-F mutant lacking the PLC-γ1 binding 
site (LAT[Y132F]). The control represents the Ca2+ 
response of empty pMSCVpuro vector control 
transfectants. Standard deviations were calculated for the 
maximal signal following restoration of extracellular Ca2+ 
(n = 4-17). 
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5.1.11. NTAL exerts its positive regulatory role on Ca2+ flux via phosphorylation-
dependent Grb2 binding 
The fact that the YxN motifs in NTAL are essential for Ca2+ regulation suggests a Grb2-
dependent regulatory mechanism. To further analyse the role of NTAL/Grb2 interaction for 
the regulation of the Ca2+ response, single tyrosine residues were reintroduced into the 
NTAL[4Y4F] mutant. Phosphorylation of the four add-back mutants was analysed by anti-
pTyr immunoblotting. In parallel the phosphorylation of wild-type NTAL, non-raft 
NTAL[C23/26A], NTAL[4Y4F], and human LAT was examined. Both wild-type NTAL 
and LAT are readily tyrosine phosphorylated upon BCR stimulation (figure 5.13A, lanes     
2 and 18). However, tyrosine phosphorylation is not detectable for the non-raft mutant 
NTAL[C23/26] and the variant lacking the Grb2 binding sites (NTAL[4Y4F]) (lanes 5-8). 
Similarly, and in accordance with its less important role for NTAL-mediated Ca2+ elevation, 
tyrosine phosphorylation at the single Grb2 binding site Y95 is not observed (lanes 9 and 
10). In marked contrast, tyrosine phosphorylation is readily detectable on the single        
add-back mutants Y136, Y155, and Y184, which is consistent with their prominent role for Ca2+ 
mobilization (lanes 11-16). 
Co-immunoprecipitation experiments were carried out in order to further assess the 
correlation between the tyrosine-phosphorylated Grb2 binding sites and the Grb2 SH2 
domain. As shown above (figure 5.9C), wild-type Grb2 associates with NTAL in a 
stimulation-dependent manner (figure 5.13B, lanes 1 and 2). In contrast, wild-type Grb2 
cannot be recruited by the phosphorylation-deficient NTAL mutants 4Y4F or C23/25A 
(figure 5.13B, lanes 3-6). Conversely, a Grb2 mutant with defective SH2 domain 
(Grb2[R86K]) does not bind to HA-tagged NTAL (lanes 9 and 10).  
Taken together these observations clearly identify raft-localized NTAL and Grb2 as a 
stimulation-dependent regulatory module for Ca2+ mobilization in B lymphocytes. This 
function appears to be accomplished by SH2-mediated recruitment of Grb2 to tyrosine-
phosphorylated NTAL, simultaneously preventing Grb2 from exerting its inhibitory effect 
on Ca2+ elevation.  
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Figure 5.13: Tyrosine phosphorylation and Grb2 binding analysis of avian NTAL 
(A) Unstimulated (0’) or BCR-stimulated (1’) ntal-/- DT40 (clone N2-1) transfectants expressing wild-
type NTAL (lanes 1-2), no NTAL (empty pMSCVpuro vector transfectants, lanes 3-4), NTAL mutants as 
indicated (lanes 5-16), or wild-type human LAT (lanes 17-18) were subjected to immunoprecipitation 
experiments with anti-chicken NTAL (lanes 1-16) or anti-LAT (lanes 17-18) antibodies. The isolated 
proteins were analysed by immunoblotting with antibodies to phosphotyrosine (upper panel) or NTAL 
and LAT (lower panel). (continued on next page) 
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(legend to figure 5.13 continued) NTAL variants lack either a functional lipid raft targeting signal      
(C-to-A substitutions at positions 23 and 26, lanes 5-6) or one of the four Grb2 binding motifs (Y-to-F 
substitutions at positions 95, 136, 155, or 184, lanes 7-16). The amino acid positions refer to chicken 
NTAL protein sequence and are indicated on the left. (B) Anti-HA immunoprecipitates derived from 
unstimulated (0’) or BCR-stimulated (2’)  ntal-/- (lanes 1-6) and grb2-/- (lanes 7-10) DT40 mutant cells 
that upon retroviral infection express HA-tagged versions of either wild-type NTAL (lanes 1-2 and lanes 
7-8), 4Y4F NTAL (lanes 3-4), C23/26A NTAL (lanes 5-6), or wild-type NTAL plus SH2-domain-
defective Grb2[R86K] (lanes 9-10) were analysed by immunoblotting with anti-Grb2 antibodies (upper 
panel). The faint background band visible in all lanes that nearly co-migrates with Grb2 emanates from 
the light chains of the precipitating antibodies. Equivalent NTAL protein recovery was confirmed by 
anti-HA immunoblot analysis (lower panel). Molecular mass protein standards (kDa) are indicted on the 
left (A-B), and data represent the results of three independent experiments. 
 
 
5.1.12. Lipid raft targeting of Grb2 is sufficient for the inactivation of its negative 
regulatory role on Ca2+ mobilization 
A transmembrane Grb2 fusion protein was generated to further investigate the model 
suggesting that NTAL/Grb2-mediated regulation of Ca2+ flux in B lymphocytes is 
dependent on subcellular re-localization of Grb2. By SOE-PCR using the oligonucleotides 
NTALfor, bridge2for, bridge2rev, and Grb2rev the cDNA fragment encoding the first       
94 amino acids of chicken NTAL was added to the 5’ end of the full length chicken grb2 
cDNA (see Materials and Methods, section 4.2.1.16.). By this method Grb2 was                
N-terminally equipped with the transmembrane region and the cyteine-containing 
palmitoylation motif (TM-Grb2). The fusion protein was expressed in grb2-/- DT40 cells in 
the absence of NTAL and was detected as a protein doublet of 35 and 36 kDa, respectively 
(figure 5.14A, lane 3). Multiple protein bands are typical for lipid raft residents such as 
NTAL (e.g. figures 5.9, 5.12, and 5.13) and LAT (ZHANG et al., 1998a). The chimeric    
TM-Grb2 is permanently targeted to lipid rafts as opposed to Grb2 which is isolated in the 
cytosolic fraction (figure 5.14B, upper and lower panel, compare figure 5.9A). The 
biochemical functionality of the fusion protein was confirmed by co-immunoprecipitation 
experiments performed by S. Laing. TM-Grb2 could be co-purified with endogenously 
expressed c-Cbl, and it also bound to a SLP-65-derived peptide encompassing the Grb2 
binding site indicating that at least the C-terminal SH3 domain of the fusion protein is 
properly folded and functional (data not shown). However, the BCR-induced Ca2+ 
mobilization in TM-Grb2 transfectants is similar to the one observed for grb2-/- DT40 cells 
(figure 5.14C, orange and black line) indicating that unlike cytosolic wild-type Grb2      
TM-Grb2 cannot suppress Ca2+ elevation (grey line). These experiments demonstrate that 
lipid raft localization is sufficient to prevent Grb2 from exerting its inhibitory function.     
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Figure 5.14: Lipid raft targeting of Grb2 inactivates its negative regulatory role on Ca2+ 
mobilization 
(A-B) Grb2 protein expression and its subcellular localization were analysed, respectively by anti-Grb2 
immunoblotting of (A) total cellular lysates and (B) isolated sucrose gradient fractions (JOHMURA et al., 
2003) obtained from grb2-/- DT40 cells and transfectants reconstituted with either wild-type Grb2 or a 
Grb2 fusion protein constitutively targeted to lipid rafts (TM-Grb2). In TM-Grb2, the first 94 N-terminal 
amino acids of NTAL including the NTAL transmembrane region and the palmitoylation motif are fused 
to full length chicken Grb2. Molecular mass protein standards (kDa) are indicated on the left. (C) BCR-
induced Ca2+ mobilization of DT40 cells described in (A-B) was analysed by flow cytometry (refer to 
figure 5.3 legend for details). Data represent the results of four independent measurements. 
 
 
5.1.13. The NTAL/Grb2 module influences plasma membrane recruitment of PLC-γ2 
To further elucidate the molecular mechanism of Grb2 action, K. Neumann in our group 
demonstrated that increased Ca2+ elevation in NTAL-positive or Grb2-negative DT40         
B lymphocytes can be attributed to an increased intracellular IP3 concentration (PhD thesis 
in progress, unpublished results). Possible explanations for this observation are an 
enhancement of PLC-γ2 activity and/or an altered translocation of the lipase to the plasma 
membrane where its substrate resides. To further investigate this issue, plc-γ2-/- DT40 cells 
(TAKATA et al., 1995) were transfected with cDNA encoding a transmembrane PLC-γ2 
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chimera (TM-PLC-γ2) consisting of the extracellular CD16 domain (amino acids 1-208; 
RAVETCH and PERUSSIA, 1989), transmembrane CD3ζ domain (amino acids 31-58; 
WEISSMAN et al., 1988), and cytosolic full length rat PLC-γ2 (1265 amino acids; EMORI et 
al., 1989) (ISHIAI et al., 1999b). PLC-γ2 protein expression was confirmed by anti-PLC-γ2 
immunoblot analysis (data not shown). Plc-γ2-/- DT40 B cells expressing TM- PLC-γ2 show 
a comparatively higher Ca2+ influx across the plasma membrane (figure 5.15, right panel). 
Interestingly, NTAL expression does not enhance Ca2+ mobilization in these cells upon the 
unique engagement of the BCR (figure 5.15), nor BCR/CD16 co-crosslinking (data not 
shown). In marked contrast, NTAL expression in cells reconstituted with cDNA encoding 
the wild-type cytosolic PLC-γ2 led to a slightly prolonged intracellular Ca2+ release, and a 
significantly elevated Ca2+ flux across the plasma membrane (figure 5.15, left panel). This 
set of experiments was conducted in collaboration with S. Alers and are part of his diploma 
thesis. 
Collectively, during the work for this thesis a novel Ca2+-regulating signalling pathway in   
B lymphocytes could be identified and characterized. This regulatory module is composed 
of the adaptor proteins NTAL and Grb2. It seems that the NTAL/Grb2 module influences 
the membrane localization of PLC-γ2 or its retention time at the membrane. This function is 
abolished in DT40 B lymphocytes expressing a PLC-γ2 chimeric protein that is 
constitutively associated with the plasma membrane. 
 
 
Figure 5.15: The NTAL/Grb2 module influences plasma membrane recruitment of PLC-γ2 
Plc-γ2-/- DT40 cells were reconstituted with either wild-type rat PLC-γ2 (left panel), or the 
transmembrane PLC-γ2 chimera (TM-PLC-γ2, right panel) consisting of the extracellular CD16 domain 
(amino acids   1-208), transmembrane CD3ζ domain (amino acids 31-58) and cytosolic full length rat 
PLC-γ2 (1265 amino acids) (ISHIAI et al., 1999b). Intra- and extracellular Ca2+ mobilization was recorded 
by flow cytometry (refer to figure 5.3 legend for description) in these reconstituents that were retrovirally 
infected with either empty pMSCVpuro vector (blue line) or pMSCVpuro containing chicken ntal cDNA 
(red line). 
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5.2.  Grb2 regulates tyrosine phosphorylation of p50/Dok-3  
As shown in the first part of this thesis, the cytosolic adaptor molecule Grb2 acts as a central 
component of B cell signalling pathways. The grb2-/- DT40 B cell line represents an ideal 
tool to further elucidate the role of Grb2 in BCR signalling in general and to analyse the 
mechanism(s) underlying its negative regulatory function for Ca2+ mobilization in 
particular. As described above, a complex network of tyrosine phosphorylation and 
dephosphorylation catalyzed by specific kinases and phosphatases precedes the elevation of 
the intracellular Ca2+ concentration. Therefore, the second aim of this thesis was to analyse 
the role of Grb2 in BCR-induced tyrosine phosphorylation processes and how its 
involvement might contribute to the observed regulation of Ca2+ mobilization.   
 
5.2.1.  Tyrosine phosphorylation of p50 is dependent on Grb2 in DT40 B lymphocytes 
Stimulation of the B cell antigen receptor initiates a biochemical cascade in which PTK 
acitivity is one of the earliest known events (WIENANDS, 2000b). Numerous cellular proteins 
become tyrosine phosphorlyated upon BCR engagement, many of which have yet to be 
chararacterized at the molecular level. 
During the analysis of SLP-65 tyrosine phosphorylation upon BCR stimulation in wild-type 
and grb2-/- DT40 cells (see figure 5.6), the precipitating anti-SLP-65 antibodies cross-
reacted with a tyrosine phosphorylated protein with a molecular weight of approximately  
50 kDa (p50) (figure 5.16A, lower left panel, lane 2). Interestingly, tyrosine phosphorylation 
of p50 is only detectable in wild-type DT40 cells, indicating that this modification is 
dependent on Grb2 (lanes 2 and 4). The differences in the phosphorylation state of p50 
between wild-type and grb2-/- DT40 cells were also demonstrated by immunoprecipitation 
experiments with anti-pTyr antibodies (figure 5.16A, lower right panel, lanes 6 and 8). 
Detection of phospho-SLP-65 served in each case as a loading control (upper panels). To 
further verify whether the absence of p50 tyrosine phosphorylation is solely due to the lack 
of Grb2, wild-type grb2 cDNA was re-introduced into grb2-/- DT40 cells by retroviral gene 
transfer (compare figures 5.3 and 5.4). Indeed, reconstitution of wild-type Grb2 expression 
recapitulated tyrosine phosphorylation of p50 (figure 5.16B, lower panel, lane 10). 
Furthermore, p50 could also be purified from cleared cellular lysates of BCR-stimulated  
slp-65-/- DT40 cells (lane 6), demonstrating that the purification of p50 is due to the cross-
reactivity of the anti-SLP-65 antibodies rather than a direct association with SLP-65. In 
marked contrast, tyrosine phosphorylation of p50 was not detected in lyn-/- DT40 cells   
(lane 4). P50 is one of the major tyrosine-phosphorylated proteins in DT40 B lymphocytes 
after BCR engagement, since it is prominently detected in cleared cellular lysates by anti-
pTyr immunoblotting (figure 5.16C, lane 2). To summarize, p50 is a major substrate for 
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tyrosine kinases in DT40 B lymphocytes after BCR engagement, and tyrosine 
phosphorylation is dependent on the presence of the cytosolic adaptor molecule Grb2. 
 
 
 
 
Figure 5.16: Grb2 regulates tyrosine phosphorylation of p50 in DT40 B cells 
(A) Anti-chicken SLP-65 (left panels, lanes 1-4) and anti-pTyr immunoprecipitates (right panels, lanes  
5-8) derived from unstimulated (-) or BCR-stimulated (+) wild-type (lanes 1-2 and lanes 5-6) and grb2-/- 
DT40 cells (lanes 3-4 and lanes 7-8) were analysed by anti-pTyr immunoblotting (lower panels). 
Equivalent protein recovery was confirmed by anti-SLP-65 immunoblot analysis (upper panels). 
Purification of p50 by anti-chicken SLP-65 antibodies is due to cross-reactivity. (B) Anti-chicken SLP-65 
immunoprecipitates prepared from unstimulated (-) or BCR-stimulated (+) wild-type (lanes 1-2), lyn-/- 
(lanes 3-4), slp-65-/- (lanes 5-6), grb2-/- (lanes 7-8), and grb2-/- DT40 cells reconstituted with wild-type 
Grb2 (lanes 9-10) were analysed by anti-pTyr immunoblotting (lower panel). As a control for equal 
protein recovery anti-SLP-65 immunoblot analysis was performed (upper panel). (C) Cleared cellular 
lysates (CCLs) obtained from unstimulated (-) or BCR-stimulated (+) wild-type (lanes 1-2) and grb2-/- 
DT40 cells (lanes 3-4) were analysed by anti-pTyr immunoblotting. Molecular mass protein standards 
(kDa) are indicated on the left (A-C), and data represent the results of at least three independent 
experiments. 
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5.2.2.  p50 is a cytosolic protein 
The next aim was to further characterize p50 regarding its subcellular localization. Since the 
eukaryotic cell is a multicompartmental structure, it has to be ensured that newly 
synthesized proteins reach their ultimate destination. Protein targeting is achieved by a 
sophisticated system of labelling and sorting. N-glycosylation is one of the cotranslational 
modifications that distinguishes for proteins destined for cellular membranes, lysosomes, or 
secretion, and following glycosylation initiation in the lumen of the rough ER it proceeds 
throughout the smooth ER and various cisternae of the Golgi apparatus. To investigate 
whether N-linked oligosaccharides are attached to p50, cleared cellular lysates from grb2-/- 
and wild-type DT40 cells were treated with Peptide:N-glycosidase F (PNGase F) prior to 
immunoprecipitation with anti-SLP-65 antibodies. It appears that p50 does not aquire        
N-glycans since its mobility observed by SDS-PAGE is not altered by PNGase F treatment 
(figure 5.17A, lanes 5 and 6). Therefore, this suggests that p50 is neither a secreted nor an 
integral membrane protein. Detection of p50 was carried out by anti-pTyr immunoblotting. 
The subcellular localization of p50 was alternatively analysed by anti-pTyr immunoblot 
analysis of cytosolic, membrane-associated and membrane protein fractions subjected to 
immunoprecipitation experiments with anti-SLP-65 antibodies (figure 5.17B, lower panels). 
Detection of phospho-SLP-65 served as control for the enrichment of the cytosolic fraction 
(upper panels). P50 is prominently detected in the cytosolic protein fraction (lane 4). Taken 
together, these experiments indicate that p50 is likely to be a cytosolic protein. 
 
 
 
 
 
Figure 5.17 (legend see next page) 
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Figure 5.17: p50 is mainly localized in the cytosolic compartment  
(A) Anti-chicken SLP-65 immunoprecipitates were prepared from unstimulated (-) or BCR-stimulated 
(+) grb2-/- DT40 cells transfected with either empty pMSCVpuro vector (left panels, lanes 1-3) or 
pMSCVpuro containing cDNA coding for wild-type Grb2 (right panels, lanes 4-6). N-linked 
oligosaccharides were removed from proteins in cleared cellular lysates from BCR-stimulated cells by 
treatment with Peptide:N-glycosidase F (PNGase F) prior to immunoprecipitation (lanes 3, 6). 
Immunoblot analysis was carried out with anti-pTyr (lower panels) and anti-SLP-65 antibodies (upper 
panels). (B) Cytosolic, membrane-associated and membrane protein fractions derived from BCR-
stimulated grb2-/- (left panels, lanes 1-3), and wild-type DT40 cells (right panels, lanes 4-6) (as described 
in Material and Methods section 4.2.3.4.) were subjected to immunoprecipitation experiments with anti-
SLP-65 antibodies, and analysed by anti-pTyr immunoblotting (lower panels). Detection of phospho-
SLP-65 served as control for enrichment of the cytosolic fraction (upper panel). Molecular mass protein 
standards (kDa) are indicated on the left (A-B). 
 
 
 
5.2.3.  Tyrosine phosphorylation of p50 depends on both the Grb2 SH2 domain and 
the C-terminal SH3 domain 
To further dissect the function of Grb2 in the regulation of p50 tyrosine phosphorylation, the 
importance of the three distinct Grb2 domains was analysed. The above described 
nonfunctional Grb2 mutants (see section 5.1.3) were tested for their capacity to support p50 
tyrosine phosphorylation. Cleared cellular lysates from BCR-stimulated wild-type DT40 
cells, grb2-/- DT40 cells, and derivatives reconstituted with either wild-type Grb2 or a 
nonfunctional variant were analysed by anti-pTyr immunoblotting (figure 5.18, lower 
panel). Detection of phospho-SLP-65 served as a loading control (upper panel). It appears 
that the N-terminal SH3 domain of Grb2 exhibits no influence on the phosphorylation state 
of p50 (lane 8). In marked contrast, the central SH2 domain and the C-terminal SH3 domain 
are mandatory for a maximal tyrosine phosphorylation of p50 (lower panel, lanes 10 and 
12). A similar result indicating the importance of the three Grb2 interaction domains was 
obtained by purification of p50 with antibodies to SLP-65 (data not shown).  
These results reveal that maximal tyrosine phosphorylation of p50 depends on both the 
central SH2 and the C-terminal SH3 domain of Grb2. It is noteworthy that both of these 
Grb2 domains are also responsible for the inhibitory effect of Grb2 on Ca2+ mobilization 
(see figure 5.4).  
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Figure 5.18: Tyrosine phosphorylation of p50 depends on both the Grb2 SH2 domain and the       
C-terminal SH3 domain 
Cleared cellular lysates derived from unstimulated (-) or BCR-stimulated (+) wild-type DT40 cells (lanes 
1-2), grb2-/- mutants (lanes 3-4) and derivatives that upon retroviral gene transfer express either wild-type 
Grb2 (lanes 5-6) or variants with a non-functional N-terminal SH3, central SH2, or C-terminal SH3 
domain (lanes 7-12, refer to figure 5.4 legend) were subjected to anti-pTyr immunoblot analysis (lower 
panel). Equivalent protein loading was controlled by anti-SLP-65 immunoblotting (upper panel). 
Molecular mass protein standards (kDa) are indicated on the left. These results were confirmed by anti-
pTyr immunoblot analysis of anti-SLP-65 precipitates obtained from cells described above (data not 
shown). 
 
 
5.2.4.  Tyrosine-phosphorylated p50 associates with the SH2 domain of Grb2 
The next question was whether one of the two Grb2 domains directly associates with p50. 
Therefore, cleared cellular lysates from grb2-/- and reconstituted DT40 cells were subjected 
to affinity purification experiments with GST fusion proteins containing either the central 
SH2 domain or the C-terminal SH3 domain of Grb2. Subsequent anti-pTyr immunoblot 
analysis indeed revealed that p50 directly associates with the Grb2 SH2 domain (figure 
5.19, lanes 7 and 15). Relatively lower levels of tyrosine-phosphorylated p50 were also 
purified from grb2-/- DT40 B lymphocytes by this method (lane 7). 
These affinity purification experiments indicate that tyrosine phosphorylated p50 directly 
associates with the Grb2 SH2 domain. This observation strongly suggests the existence of at 
least one YxN phosphoacceptor site within the amino acid sequence of p50 (refer to section 
5.1.6.). The direct interaction of the Grb2[SH2] domain with p50 must be emphasized since 
this domain is also required for p50 tyrosine phosphorylation (see section 5.2.3).  
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Figure 5.19: Tyrosine phosphorylated p50 associates with the central Grb2 SH2 domain 
Cleared cellular lysates (CCL) prepared from unstimulated (-) or BCR-stimulated (+)  grb2-/- DT40 
mutant cells that were retrovirally infected with either empty pMSCVpuro vector (lanes 1-8) or 
pMSCVpuro containing wild-type chicken grb2 cDNA (lanes 9-16) were subjected to affinity 
purification experiments with either GST (lanes 2, 6, 10, 14; GST) or GST fusion proteins containing the 
central SH2 (lanes 3, 7, 11, 15; SH2) or the C-terminal SH3 domain of murine Grb2 (lanes 4, 8, 12, 16; 
cSH3). Purified proteins were analysed by anti-pTyr immunoblotting. Molecular mass protein standards 
(kDa) are indicated on the left. Data represent the results of four independent affinity purification 
experiments. 
 
 
5.2.5.  PTK Lyn is mandatory for p50 tyrosine phosphorylation 
PTK Lyn is expressed in two isoforms due to two alternative splicing variants, with 
molecular weights of 53 and 56 kDa in mice and humans (YI et al., 1991; YAMANASHI et al., 
1989). Tyrosine phosphorylation of p50 does not occur in lyn-/- DT40 cells (figure 5.16C, 
lower panel). To exclude the possibility that the observed protein is Lyn itself, endogenous 
Lyn was purified from grb2-/- DT40 cells and derivatives expressing wild-type Grb2 with 
anti-Lyn antibodies (figure 5.20A, lanes 4-7). By immunoblot analysis with anti-pTyr 
antibodies it could be shown that the phospo-Lyn isoform doublet does not co-migrate with 
p50 purified from wild-type DT40 cells with anti-SLP-65 antibodies (lane 1). Furthermore, 
no differences in overall Lyn tyrosine phosphorylation are detectable in grb2-/- and 
reconstituted DT40 cells. Subsequently, lyn-/- DT40 cells were transfected with cDNA 
coding for murine Lyn with EGFP fused to its C terminus. This EGFP-tagged Lyn has a 
molecular weight of approximately 75 kDa (figure 5.20B, lane 2) and is located at the 
plasma membrane (figure 5.20C). Expression of the Lyn/EGFP fusion protein is capable of 
reconstituting tyrosine phosphorylation of p50 in lyn-/- cells (figure 5.20D, lane 6). Analysis 
of tyrosine phosphorylation in syk-/- and btk-/- DT40 B lymphocytes revealed that these two 
PTKs are dispensable for this process (data not shown). Taken together these observations 
clearly indicate that the Src kinase family member Lyn is obligatory for tyrosine 
phosphorylation of p50. 
 
Results 
 
 
87
 
 
 
gene transfer express C-terminally EGFP-tagged murine Lyn were subjected to anti-Lyn immunoblot 
analysis. (C) Expression of C-terminally EGFP-tagged murine Lyn in lyn-/- DT40 B lymphocytes was 
analysed by confocal laser scanning microscopy (kindly performed by I. Goldbeck). (D)  Cleared cellular 
lysates prepared from unstimulated (-) or BCR-stimulated (+) wild-type DT40 cells (lanes 1-2), lyn-/- 
DT40 mutant cells (lanes 3-4) and derivatives that upon retroviral gene transfer express C-terminally 
EGFP-tagged murine Lyn (lanes 5-6) were subjected to affinity purification experiments with GST-
Grb2[SH2] fusion proteins. Purified proteins were analysed by anti-pTyr immunoblotting. Molecular 
mass protein standards (kDa) are indicated on the left (A, B, D). 
 
Figure 5.20: Lyn is mandatory for 
complete p50 tyrosine phosphorylation 
(A) Anti-chicken SLP-65 
immunoprecipitates prepared from BCR-
stimulated (+) wild-type DT40 cells 
(lane 1), and anti-chicken Lyn 
immunoprecipitates obtained from 
unstimulated (-) or BCR-stimulated lyn-/- 
DT40 mutants (lanes 2-3), grb2-/- DT40 
mutants (lanes 4-5), and grb2-/- DT40 
mutants reconstituted with wild-type 
Grb2 (lanes 6-7) were analysed by anti-
pTyr immunoblotting. (B) Cleared 
cellular lysates obtained from lyn-/- DT40 
cells and derivatives that upon retroviral 
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5.2.6.  Kinetics of p50 phosphorylation  
Following the identification of PTK Lyn as the kinase responsible for p50 tyrosine 
phosphorylation, the kinetics of this process were further analysed to determine whether the 
reduced tyrosine phosphorylation of p50 in grb2-/- DT40 cells is caused by either decreased 
phosphorylation, or increased dephosphorylation reactions. Therefore, wild-type and Grb2-
deficient DT40 cells were stimulated with M4 antibodies for varying periods of time. P50 
was purified by Grb2[SH2] affinity purification and tyrosine phosphorylation was analysed 
by anti-pTyr immunoblot analysis. It was shown that strong tyrosine phosphorylation of p50 
is initiated after 30 s, lasting for 5-10 min (figure 5.21, upper panel, lanes 1-5). After 10 min 
p50 gradually becomes dephosphorylated (lanes 6-9). For grb2-/- DT40 cells, a clearly 
reduced tyrosine phosphorylation could be observed at all time points (figure 5.21, lower 
panel).  
These results strongly suggest that the reduced p50 tyrosine phosphorylation in grb2-/- DT40 
cells is due to a decreased phosphorylation rate in these cells and not caused by an increased 
and/or de-regulated dephosphorylation rate. 
 
 
 
 
Figure 5.21: Kinetics of p50 tyrosine phosphorylation 
Wild-type (upper panel) and grb2-/- DT40 cells (lower panel) were left untreated or stimulated through 
their BCR for the indicated times, lysed, and subjected to affinity purification with GST-mGrb2[SH2] 
fusion proteins. Purified proteins were analysed by anti-pTyr immunoblotting. Molecular mass protein 
standards (kDa) are indicated on the left. Data represents observations made in three independent 
experiments. 
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5.2.7.  Identification of p50 by mass spectrometry and western blot analysis 
The affinity purification with the GST-mGrb2[SH2] fusion protein was perfectly suitable 
for a large scale purification of p50 and subsequent analysis by mass spectrometry (kindly 
performed by Dr. T. Kähne, Institute of Experimental Internal Medicine, Otto-von-Guericke 
University, Magdeburg). P50 was purified from approximately 5 x 108 BCR-stimulated 
wild-type DT40 cells by GST-mGrb2[SH2] affinity purification. In parallel, p50 was 
purified from an identical number of unstimulated grb2-/- and wild-type DT40 cells as 
controls. The samples were separated by SDS-PAGE and purified proteins were visualized 
by silver staining (figure 5.22A, lanes 1-3). A prominent protein migrating at approximately 
50 kDa was purified from the lysates of stimulated wild-type DT40 cells (lane 3, black 
arrow). Since lower levels of the protein were purified from unstimulated grb2-/- and wild-
type DT40 cells (lanes 1 and 2, respectively) the association of this protein with the 
mGrb2[SH2] domain is stimulation-dependent. This observation is in accordance with the 
anti-pTyr immunoblotting data obtained for p50. The protein band was excised from the gel, 
and subsequently the samples were digested with trypsin. The resulting digest mixture was 
analysed by ESI-Ion Trap mass spectrometry including MS/MS analysis (Dr. T. Kähne, 
Magdeburg). An instrument with MS/MS capability can additionally provide structural 
information by monitoring the fragment ion spectrum of a peptide. The Mascot search 
engine (www.matrixscience.com) was searched with the fragment ion spectra of the 
obtained peptides, and the mass spectrometry data were matched to a partial chicken amino 
acid sequence (GenBank accession number: XP_427516). Subsequent database tblastx 
searches revealed that this protein is homologous to the mammalian Dok-3 adaptor protein. 
This adaptor belongs to the downstream of kinase (Dok) family, consisting so far of six 
members. Dok-3 was identified in 1999 (LEMAY et al., 2000) (Dok-L, CONG et al., 1999), 
and contains an N-terminal PH domain, followed by a PTB domain and a C-terminus with 
multiple phosphoacceptor sites. Since Dok-3 is a cytosolic adaptor protein, the identification 
of p50 as Dok-3 is in accordance with the data obtained for the subcellular localization of 
p50 (see section 5.2.2). Furthermore, Dok-3 also possess the above proposed YxN 
phosphoacceptor site (see section 5.2.4), which upon tyrosine phosphorylation is 
preferentially bound by the Grb2 SH2 domain. 
To ultimately verify that p50 is chicken Dok-3, anti-Dok-3 immunoblot analysis was 
performed using antibodies to murine Dok-3 kindly provided by Dr. A. Veillette (Clinical 
Research Institute of Montréal, Canada). Unfortunately, these antibodies were not 
applicable for direct immunoblot detection of chicken Dok-3 (data not shown). Thus to 
determine if the antibodies recognize native chicken Dok-3, cleared cellular lysates from 
unstimulated and BCR-stimulated grb2-/- and wild-type DT40 cells were incubated with 
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Figure 5.22: Identification of p50 by mass spectrometry and western blot analysis 
(A) Approximately 5 x 108 grb2-/- (lane 1) and wild-type DT40 cells (lanes 2-3) were left untreated (-) or 
stimulated through their BCR (+), lysed, and subjected to affinity purifications with GST-mGrb2[SH2] 
fusion proteins. The samples were separated by SDS-PAGE and purified proteins were visualized by 
silver staining. A prominent protein migrating at approximately 50 kDa was purified from lysates of 
BCR-stimulated wild-type DT40 cells (lane 3, black arrow). Less of this protein was purified from 
unstimulated grb2-/- and wild-type DT40 cells (lanes 1 and 2). The protein band of interest was excised 
from the gel and subjected to mass spectrometric analysis (kindly performed by Dr. T. Kähne, 
Magdeburg). (B) Cleared cellular lysates prepared from unstimulated (-) or BCR-stimulated (+) wild-type 
DT40 cells and grb2-/- mutants were subjected to affinity purification experiments with GST-
mGRB[SH2] fusion proteins (lanes 5-8), or rabbit-anti-Dok-3 antibodies (lanes 9-12). As control, 
purifications were performed with GST only (lanes 1-4) or non-relevant anti-mouse NTAL antibodies 
(lanes 13-16). Purified proteins were analyzed by immunoblotting with antibodies to pTyr (upper panels) 
or Grb2 (lower panels). (C) Cleared cellular lysates derived from unstimulated (-) or BCR-stimulated (+) 
murine WEHI-231 (lanes 1-2), K46 (lanes 3-4), IIA1.6 (lanes 5-6), and human Ramos B lymphocytes 
(lanes 7-8) were subjected to affinity purifications with GST-mGrb2[SH2] fusion proteins, and purified 
proteins were analyzed by rabbit-anti-Dok-3 immunoblotting. Molecular mass protein standards (kDa) 
are indicated on the left (A-C). 
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anti-mouse Dok-3 antibodies or GST-mGrb[SH2] fusion proteins, and affinity complexes 
were purified with glutathione-sepharose and ProteinA/G-agarose beads, respectively 
(figure 5.22B). Affinity purifications with irrelevant anti-mouse NTAL antibodies or GST 
only served as negative controls. Immunoblot analysis with anti-pTyr antibodies indeed 
revealed that p50 purified by the Grb2 SH2 domain co-migrates with a prominent tyrosine 
phosphorylated protein purified by anti-mouse Dok-3 antibodies from BCR-stimulated wild-
type DT40 cells (figure 5.22B, upper middle panel, lanes 6 and 10). Reprobing the 
membrane with antibodies to Grb2 clearly shows that the protein purified by anti-mouse 
Dok-3 antibodies interacts with Grb2 in a stimulation-dependent manner (lower middle 
panel, lane 10). Interestingly Grb2 cannot be detected in the Grb2[SH2] affinity 
purifications (lanes 5-8), suggesting that the stoichiometry of the Grb2-Dok-3 interaction is 
1:1. 
To clarify whether the Grb2-Dok-3 association is a general mechanism in BCR-stimulated 
B lymphocytes, the formation of this complex was investigated in the three murine B cell 
lines WEHI-231, K46, and IIA1.6, and in the human B cell line Ramos (figure 5.22C). By 
affinity purification experiments with the Grb2 SH2 domain and subsequent anti-mouse 
Dok-3 immunoblotting it could indeed be demonstrated that Dok-3 is bound by the Grb2 
SH2 domain in a stimulation-dependent manner in B lymphocytes originating from different 
species (lanes 2, 4, 6, and 8, respectively). 
In summary, these observations show that Grb2 is obligatory for a complete Dok-3 tyrosine 
phosphorylation and that the Grb2-Dok-3 interaction is mediated via the Grb2-SH2 domain. 
The latter observation was confirmed in B lymphocytes of various species. 
 
5.2.8.  Cloning of chicken dok-3 cDNA and generation of dok-3-/- DT40 cells 
Isolation of the cDNA encoding full length chicken Dok-3 was then pursued since it is a 
major tyrosine phosphorylated protein and Grb2 interaction partner in activated DT40         
B lymphocytes. The cDNA encoding the partial chicken Dok-3 protein described above 
included the coding exons 2, 3, and 4 of the chicken dok-3 mRNA. Chicken dok-3-specific 
oligonucleotides, chDok-3cDNAfor3 and chDok-3cDNArev1, in combination with the 
oligonucleotides pJG4-5for and pJG4-5rev were used to amplify the missing 5’ and 3’ 
cDNA regions from the plasmid-based DT40 cDNA library pJG4-5/DT40 (kindly provided 
by Dr. T. Kurosaki). Oligonucleotides annealing in the 5`-UTR and the 3`-UTR of chicken 
dok-3 were subsequently designed and used to amplify the full length chicken dok-3 cDNA 
by RT-PCR. In figure 5.23A the deduced chicken Dok-3 amino acid sequence is aligned 
with its murine and human orthologs. Similar to its mammalian orthologs, chicken Dok-3 
harbors an N-terminal PH domain followed by a PTB domain. The C-terminus contains two 
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PTB domain proximal tyrosines representing potential Csk and Grb2 binding motifs 
(Y307ASI and Y331ENI, repectively). The two distal tyrosines described for human and 
murine Dok-3 are not present in chicken Dok-3. Two tyrosines within the PH domain (Y11 
and Y96) and a single tyrosine between the PH and the PTB domain (Y140) are predicted to 
be phosphorylated by an artificial neural network method (NetPhos 2.0 Server, BLOM et al., 
1999). This method also predicts 17 serines/threonines of chicken Dok-3 are 
phosphoacceptor sites. Four core PxxP motifs exist in the C-terminal part of avian Dok-3 
(see figure 5.23A; P296VEP299EAP, P322GQP, and P398SRP). These motifs represent 
potential SH3 domain binding sites, and two of them (RFPP296VEP and RPCP322GQP) 
conform to a class I ligand motif for SH3 domains, and share the consensus sequence 
(R/K)xxPxxP (FENG et al., 1994, 1995; SPARKS et al., 1996, 1998; MAYER, 2001; JIA et al., 
2005).  
Due to a single nucleotide polymorphism (SNP), the amino acid at position 122 of chicken 
Dok-3 can be either glutamate or alanine, as determined by analysis of multiple cDNA and 
genomic sequences.   
The level of chicken dok-3 messenger RNA in DT40 B lymphocytes was analysed by RT-
PCR using the oligonucleotides chDok-3cDNAforSTART and chDok-3cDNArev1 (figure 
5.23B; expected transcript size: 618 bp). The cDNA was synthesized from oligo-dT- or 
random hexamer-primed DT40 total RNA. It was shown that chicken dok-3 transcripts are 
detectable after 22-26 cycles from both oligo-dT- and random hexamer-derived cDNA, and  
reach similar transcript levels as observed for chicken gapdh. The faint RT-PCR product 
running below the fragment corresponding to the main transcript may represent an 
alternative splice variant. For the human and murine orthologs indeed different isoforms 
were identified (www.expasy.org). Taken together, these RT-PCR experiments suggest a 
comparatively high concentration of chicken dok-3 messenger RNA in DT40                       
B lymphocytes.   
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                     10        20        30        40        50        60        70        80 
                      |         |         |         |         |         |         |         | 
chicken      -----------------------------------------------------------MERPVKDGIIYVQHCKFGKRT 
mouse        --------------------------------------------------------MESVEPPVKDGILYQQHVKFGKKC 
human        MTRGARLRSDARAQLNQLSLDGGTGSGQKGKCEEFPSSLSSVSPGLEAAALLLAVTMDPLETPIKDGILYQQHVKFGKKC 
                                                                        :* *:****:* ** ****:  
 
                     90       100       110       120       130       140       150       160 
                      |         |         |         |         |         |         |         | 
chicken      WRKIRAQLFAASPFGVARMEKFDARD--HGTVSDISL---QRCARRVIRLSDCVSVGPMGTESCPKATAAFYLTTTEKNY 
mouse        WRKVWALLYAGGPSGVARLESWDVRDGGLGPAGDRSTGPSRRGERRVIRLADCVSVLPADGESCPRDTGAFLITTTERSH 
human        WRKVWALLYAGGPSGVARLESWEVRDGGLGAAGDRSAGPGRRGERRVIRLADCVSVLPADGESCPRDTGAFLLTTTERSH 
             ***: * *:*..* ****:*.::.**   *...* *    :*  ******:***** * . ****: *.** :****:.: 
 
                    170       180       190       200       210       220       230       240 
                      |         |         |         |         |         |         |         | 
chicken      VLAAEQRDEWIEQLCQLAFQGKKEAEQSSSTGLQP----IPMEENCLYSSWQDLTEFPVLVLRTEAAARCELHGHYVLAA 
mouse        LLAAQHRQSWVDPICQLAFPGTGECSSGSGQAESPKRGFVPMEENSIYSSWQEVTEFPVIVQRTEATSRCQLKGPYLLVL 
human        LLAAQHRQAWMGPICQLAFPGTGEASSGSTDAQSPKRGLVPMEENSIYSSWQEVGEFPVVVQRTEAATRCQLKGPALLVL 
             :***::*: *:  :***** *. *....*  . .*    :*****.:*****:: ****:* ****::**:*:*  :*.  
 
                    250       260       270       280       290       300       310       320 
                      |         |         |         |         |         |         |         | 
chicken      LPHSLTLKDAQSQQPLLTWPYPFLRKFGQDQNIFSFEAGRRSDSGEGTFTFSTPRAAELCRAVAAAIACQQQ-----GQE 
mouse        GQDDIQLRETSKPQACFSWPYRFLRKYGSDKGVFSFEAGRRCDSGEGLFAFSSPRAPDICGVVAAAIARQRERLPELAMS 
human        GPDAIQLREAKGTQALYSWPYHFLRKFGSDKGVFSFEAGRRCHSGEGLFAFSTPCAPDLCRAVAGAIARQRERLPELTRP 
               . : *:::.  *.  :*** ****:*.*:.:********..**** *:**:* *.::* .**.*** *::         
 
                    330       340       350       360       370       380       390       400 
                      |         |         |         |         |         |         |         | 
chicken      SPQPSAQGLSNQPWGAEAEDPQCSPTLGRAHSGSHSASYP---SLNLLRFPPVEPEAPAPIVYASIARGQQPHFRPCPGQ 
mouse        PPCPLPRALSLPSLEPPGELREVAPGFELPTPRKLPLTDPGPQSLPLLLSP--TQEGPASGLYASVCK----QTSKHTGT 
human        QPCPLPRATSLPSLDTPGELREMPPGPEPPTSRKMHLAEPGPQSLPLLLGP--EPNDLASGLYASVCK----RASGPPG- 
              * * .:. *  .  . .*  : .*    . . .   : *   ** **  *    :  *. :***:.:    :    .*  
 
                    410       420       430       440       450       460       470       480 
                      |         |         |         |         |         |         |         | 
chicken      PLPEHLYENIFTAQPRP-LAEEEAEEEEGR-WELGCRQAPEGHSS-EAAVPYPARSAPQPHTQRWAPGGSRGGAEEPSRP 
mouse        --AEHLYENVCMLEASPGLTNGGPEAQEGPPGGRSPLGSPIYHNTEDLSWPGSAQDSNLEAQYRRLLELELDEAGSAGRS 
human        --NEHLYENLCVLEASPTLHGGEPEPHEGP-GSRSPTTSPIYHNGQDLSWPGPANDSTLEAQYRRLLELDQVEG--TGRP 
                ******:   :. * *    .* .**     .   :*  *.  : : * .*..:      *     .   .  ..*. 
 
                    490       500 
                      |         | 
chicken      KPQRTLRAKLVRLLSRD---GPGARDWS 
mouse        GAQAGIKAKLVTLLTRERKKGPAPCDRP 
human        DPQAGFKAKLVTLLSRERRKGPAPCDRP 
              .*  ::**** **:*:   **.. * .                                                     
 
 
 
 
Figure 5.23: Avian Dok-3 amino acid sequence and messenger RNA levels in DT40 cells 
(A) The amino acid sequences of avian, murine (accession number NP_038767), and human Dok-3 
(accession number Q7L591) were aligned using the ClustalW algorithm (THOMPSON et al., 1994). The 
avian Dok-3 amino acid sequence is deduced from multiple cDNA and genomic sequences. Amino acids 
are described by using the single letter code. Identical amino acids (*) are denoted in red, strongly similar 
amino acids (:) in green, and weakly similar amino acids (.) in blue. Putative phosphoacceptor-tyrosines 
and class I ligand motifs for SH3 domains are indicated in bold letters (B) DT40 cDNA was synthesized 
from oligo-dT- (upper panels) or random hexamer-primed (lower panels) DT40 total RNA by reverse 
transcription. Chicken dok-3 cDNA was amplified by PCR using the oligonucleotides chDok-
3cDNAforSTART and chDok-3cDNArev1 (618 bp transcript), and amplicons were analyzed after the 
indicated number of cycles (right panels). As a control chicken gapdh cDNA was amplified (564 bp 
transcript; left panels). 
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For further functional analysis of Dok-3 in B lymphocyte signal transduction, the next aim 
was to generate a dok-3-/- DT40 cell line by gene targeting experiments. The genomic locus 
of chicken dok-3 was identified by blastn searches of the chicken genomic database 
(www.ensembl.org) using the full length chicken dok-3 cDNA sequence. The so far 
unidentified chicken dok-3 locus was mapped to chicken chromosome 13 (Gga 13) (figure 
5.24A). Two strategies were pursued in parallel for the gene targeting constructs (figure 
5.24A). The first construct was designed as insertion vector, introducing the resistance 
encoding cassettes into intron 1 of chicken dok-3 genomic sequence. Alternatively, a second 
targeting vector was generated by which 621 bp of intron 1 and the first 65 bp of exon 2 
coding for chicken Dok-3 amino acids 19-40 were replaced upon homologous 
recombination. Exon 1 of chicken dok-3 could not be inactivated by insertion or 
replacement since it is part of the 3`-UTR of the upstream chicken ddx41 gene (figure 
5.24A). Both the insertion and the replacement vector contain the functional 
polyadenylation site for chicken Ddx41 within intron 1 of the chicken dok-3 genomic 
sequence. However, for both targeting approaches the ATG translation initiation codon of 
chicken dok-3 was mutated to TTG, and a stop codon (TAG) was introduced immediately 
following the last in frame ATG of chicken dok-3 coding sequence located within exon 3 
(figure 5.24A). The neo and hisD cassettes were flanked by 1132 bp (replacement vector, 
REP) or 1798 bp (insertion vector, INS) at the 5`-site, and by 2858 bp at the 3`-site. To 
disrupt the dok-3 locus, the targeting constructs pDok-3-neo(REP) and pDok-3-neo(INS) 
were transfected into wild-type DT40 cells. Homologous recombination was identified by 
PCR (data not shown). A targeted allele was detected in 4 out of 25 G418-resistant clones, 
i.e. clone D12 for the replacement vector, and clones D23, D27, and D28 for insertional 
inactivation. The pDok-3-hisD(REP) was introduced into the neo-targeted clone D12, and 
pDok-3-hisD(INS) was transfected into clones D23, D27, and D28, respectively. 
Transfectants were selected with both G418 and histidinol, and the generation of the dok-3-/- 
DT40 clones D12-15, D12-67, D12-90, D23-34, D23-38, and D27-30 was confirmed by 
PCR (figure 5.24B). The successful generation of dok-3-/- DT40 cells was also confirmed by 
immunoblot analysis (figure 5.24, C and D) 
Taken together, the chicken dok-3 cDNA was cloned and dok-3 transcripts were detectable 
at relatively high levels in DT40 B lymphocytes. To exclude that the high expression of 
endogenous Dok-3 may dominantly affect signal transduction pathways in functional 
studies, dok-3-/- DT40 cells were generated by gene disruption experiments. 
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Figure 5.24: Generation of dok-3-/- DT40 B lymphocytes 
(A) Schematic representation of the chicken dok-3 genomic locus and targeting strategy. For gene 
disruption, two alternative targeting constructs were generated. The insertion vector (INS) introduces the 
resistance encoding cassettes into intron 1 of the chicken dok-3 genomic sequence. The replacement 
vector (REP) deletes 621 bp in intron 1 and 65 bp in exon 2 (coding for amino acids 19-40) of the 
chicken dok-3 genomic sequence. Exon 1 of chicken dok-3 could not be inactivated by insertion or 
replacement since it is part of the 3`-UTR of the upstream chicken ddx41 gene. (continued on next page) 
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(legend to figure 5.13 continued) Both the insertion and the replacement vector contain the functional 
polyadenylation site of chicken Ddx41 within intron 1 of the chicken dok-3 genomic sequence. For both 
targeting vectors the ATG translation initiation codon of chicken dok-3 was mutated to TTG, and 
immediately following the last in frame ATG within the chicken dok-3 coding sequence (exon 3) a stop 
codon (TAG) was introduced. The neo and hisD cassettes were flanked by 1132 bp (replacement vector) 
or 1798 bp (insertion vector) at the 5`-site, and by 2858 bp at the 3`-site. Annnealing sites for the 
screening oligonuclotides are depicted as red half-arrows. (B) Homologous recombination of pDok-3-
neo(REP/INS) and pDok-3-hisD(REP/INS) at the dok-3 locus. The generation of dok-3+/- clones D12, 
D23, and D27 (lanes 2-4), and of dok-3-/- DT40 clones D12-15, D12-67, D12-90, D23-34, D23-38, and 
D27-30 (lanes 5-10) was confirmed by PCR. For the wild-type dok-3 allele, the oligonucleotides 
screenLAfor2 and chDok-3rev2 were used. Neo- and HisD-targeted alleles were amplified using the 
oligonucleotides screenLAfor2 and Neo_rev or HisD_rev, respectively. Genomic DNA dervied from 
wild-type DT40 cells and dH20 served as controls (lanes 1 and 11, respectively). (C) Cleared cellular 
lysates prepared from unstimulated (-) or BCR-stimulated (+) wild-type (lanes 1-2), dok-3+/- (clone D12; 
lanes 3-4), or dok-3-/- DT40 cells (clone D12-15, lanes 5-6) were subjected to affinity purification 
experiments with GST-mGRB[SH2] fusion proteins. Purified proteins were analyzed by immunoblotting 
with antibodies to pTyr. (D) Cleared cellular lysates of unstimulated (-) or BCR-stimulated (+) wild-type 
DT40 cells (lanes 1-2), dok-3+/- clones D12, D23, and D27 (lanes 3-8), and dok-3-/- clones D12-15, D12-
67, D12-90, D23-34, D23-38, and D27-30 (lanes 9-20) were analyzed by anti-pTyr immunoblotting. 
Molecular mass protein standards (kDa) are indicated on the left (C, D). 
 
 
5.2.9.  Dok-3 negatively regulates BCR-induced Ca2+ mobilization 
To elucidate whether Dok-3 is the downstream mediator of Grb2 in the negative regulation 
of BCR-induced Ca2+ mobilization, Ca2+ flux was analysed in dok-3-/- DT40 lymphocytes 
(clone D23-38). These cells show a prolonged intracellular Ca2+ release and a marked 
increase in extracellular Ca2+ entry (figure 5.25B, black line). In contrast, derivatives that 
were reconstituted with wild-type chicken Dok-3 (figure 5.25A, lane 6) display a Ca2+ flux 
profile similar to wild-type DT40 cells (figure 5.25B, grey and orange line, respectively). 
Hence, Ca2+ mobilization in Dok-3-deficient DT40 cells resembles that of Grb2-deficient 
DT40 cells (see figure 5.3). Taken together, Dok-3 appears to be the downstream mediator 
of Grb2 in the negative regulation of BCR-induced Ca2+ mobilization. 
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In summary, the studies presented in this thesis identify and characterize a novel Ca2+-
regulating signalling pathway in B lymphocytes. This pathway involves the transmembrane 
adaptor NTAL and the cytosolic adaptors Grb2 and Dok-3. Grb2 exhibits an inhibitory 
effect on BCR-induced Ca2+ elevation. This negative regulatory role is abolished by NTAL-
mediated, phosphorylation-dependent recruitment of Grb2 to lipid rafts. Although the 
biochemical data does not reveal any differences in tyrosine phosphorylation of the Ca2+ 
flux regulators SLP-65 and PLC-γ2, the NTAL/Grb2 module appears to influence the 
activation and/or the membrane targeting of PLC-γ2. Dok-3, which is the major tyrosine 
phosphorylated protein in DT40 cells, was identified as the downstream mediator of Grb2 in 
the negative regulation of BCR-induced Ca2+ mobilization. It was shown that tyrosine 
phosphorylated Dok-3 is directly bound by the Grb2 SH2 domain, and the Ca2+ flux profiles 
in Grb2- and Dok-3-deficient DT40 cells are similar. Lyn-mediated tyrosine 
phosphorylation of Dok-3 depends on the presence of Grb2, whose central SH2 and           
C-terminal SH3 domain are a stringent requirement for maximal Dok-3 tyrosine 
phosphorylation. Notably, these two Grb2 domains are also responsible for the inhibitory 
Figure 5.25: Enhanced Ca2+ 
mobilization in dok-3-/- DT40 cells 
(A) Dok-3 protein expression in 
unstimulated (-) or BCR-stimulated (+) 
wild-type DT40 B cells (lanes 1-2), 
dok-3-/- mutants (lanes 3-4), and 
derivatives that upon electroporation 
express wild-type Dok-3 (lanes 5-6) 
were compared by anti-pTyr 
immunoblot analysis of cleared 
cellular lysates. Molecular mass 
protein standards (kDa) are indicated 
on the left. 
(B) Wild-type DT40 B cells (orange 
line), dok-3-/- mutants (black line), and 
derivatives that were reconstituted 
with wild-type Dok-3 (grey line) were 
loaded with 1 µM Indo-1/0.015 % 
pluronic F127, and BCR-induced Ca2+ 
mobilization was monitored as 
described in the figure 5.3 legend. 
Data represent the results obtained 
from 3 independent measurements. 
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effect of Grb2 on Ca2+ mobilization. The direct association of the Grb2 SH2 domain with 
tyrosine phosphorylated Dok-3 is especially striking considering that in absence of a 
functional Grb2 SH2 domain tyrosine phosphorylation of Dok-3 is severely reduced. 
Chicken dok-3 cDNA and dok-3-/- DT40 B lymphocytes are useful tools for the 
investigation of the mechanistic background of the Grb2-dependent Dok-3 phosphorylation 
and the involvement of Dok-3 in the Grb2-regulated Ca2+ mobilization in future 
experiments. 
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6.  Discussion 
 
B-cell signalling through the BCR occurs via a complex and highly regulated network of 
cytoplasmic protein tyrosine kinases and phosphatases, adaptor proteins and further effector 
enzymes. The BCR signal transduction is counterbalanced by an equally sophisticated 
inhibitory machinery. Inhibitory mechanisms involve a similar set of proteins, i.e. receptors, 
protein tyrosine kinases and phosphatases, lipid phosphatases, ubiquitin ligases, and 
inhibitory adaptor molecules.  
Ca2+ is a universal second messenger and its concentration is precisely controlled within all 
cell types. A large electro-chemical gradient is maintained across the plasma membrane, and 
dynamic changes in intracellular Ca2+ release and Ca2+ entry through plasma membrane 
channels lead to broad range of short- and long-term cellular responses, e.g. secretory 
processes, cytoskeletal reorganizations, altered gene transcription, proliferation, and 
apoptosis. Key components of Ca2+ signalling pathways are members of the PLC 
superfamily. The PLC-catalyzed generation of the second messengers IP3 and DAG initiates 
the Ca2+-signal cascade. Downstream of the BCR, this process is coordinated by 
phosphorylation-dependent and successive recruitment of PLC-γ2 and Btk by the 
scaffolding molecule SLP-65.  
Presently, one of the main questions in BCR signal transduction is how activation 
mechanisms and the inhibitory apparatus are choreographed for a dynamic Ca2+ 
mobilization in the cell. Intensive investigation is underway to determine (1) which 
mechanisms regulate membrane recruitment of the Ca2+ initiation complex comprised of 
PLC-γ2, SLP-65, and Btk, (2) what is the detailed mechanism of BCR-initiated PLC-γ2 
activation, (3) how the intracellular Ca2+ release is connected to Ca2+ entry across the 
plasma membrane, and (4) how Ca2+ mobilization is differentially regulated in                     
B lymphocytes of different developmental stages. 
The above stated questions were addressed in this thesis by using the chicken DT40 B cell 
line and derivatives which were rendered deficient for central components of the Ca2+ 
mobilization machinery. The objective was to determine the role of the cytosolic adaptor 
molecule Grb2 in the regulation of BCR-induced Ca2+ signals.  
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The main findings of this thesis are:  
1.) The adaptor molecule Grb2 is a negative regulator of BCR-induced Ca2+ mobilization, 
affecting both the Ca2+ release from intracellular stores, and the Ca2+ entry through 
plasma membrane channels. The central SH2 domain and the C-terminal SH3 domain 
are obligatory for this inhibitory role. This Grb2 function is controlled by its subcellular 
localization. 
2.) The transmembrane adaptor molecule NTAL is a positive regulator of BCR-induced 
Ca2+ mobilization. Upon BCR engagement the three membrane-distal YxN sites of 
NTAL are tyrosine phosphorylated and are bound by the Grb2 SH2 domain. NTAL 
counter acts Grb2 by the stimulation-dependent recruitment of Grb2 to the lipid rafts. 
The NTAL/Grb2 module does not influence the phosphorylation state of central 
components of the Ca2+ initiation complex such as SLP-65 or PLC-γ2. There are 
indications that PLC-γ2 retention at the plasma membrane is prolonged in NTAL-
positive cells.  
3.) The tightly regulated expression of NTAL during B cell lymphopoiesis may explain the 
specificity of Grb2-regulated Ca2+ mobilization profiles at different stages of B cell 
development. 
4.) In searching for Grb2 effector proteins, it was shown that the major tyrosine 
phosphorylated protein in DT40 B lymphocytes requires Grb2 for its phosphorylation. 
This protein was identified as the inhibitory adaptor molecule Dok-3, and was shown to 
bind to the Grb2 SH2 domain in a stimulation-dependent manner. The SH2 and the      
C-terminal SH3 domain of Grb2 are strictly required for complete Dok-3 tyrosine 
phosphorylation following BCR engagement.  
5.) It was demonstrated that Dok-3 negatively regulates Ca2+ mobilization in                       
B lymphocytes. Probably this function of Dok-3 is modified by the NTAL/Grb2 module 
through a competetive binding mechanism. It seems that NTAL promotes Ca2+ 
mobilization by SH2-mediated relocalization of Grb2 in order to prevent its 
phosphorylation-dependent interaction with Dok-3.   
 
Collectively, in this scenario Grb2 seems to be a molecular switch of BCR-induced Ca2+ 
mobilization. The SH2-domain dependent binding of Grb2 to either tyrosine phosphorylated 
NTAL or Dok-3 ultimately results in positive or negative fine-tuning of antigen receptor-
induced Ca2+ mobilization in B lymphocytes. Both the expression levels of NTAL and  
Dok-3 during B cell lymphopoiesis and the Grb2-dependent tyrosine phosphorylation of 
Dok-3 are critical factors in this mechanism.       
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6.1.  Grb2 is a negative regulator of Ca2+ mobilization in B lymphocytes 
The work presented in this thesis identifies Grb2 as a negative regulator of BCR-induced 
Ca2+ mobilization, both in immature and mature B lymphocytes. Grb2 deficiency affects 
both the release from intracellular stores and the Ca2+ entry across the plasma membrane. 
This negative regulatory function of Grb2 depends on the SH2 and the C-terminal SH3 
domain. Interestingly, the overall tyrosine phosphorylation of the Ca2+ initiation complex 
components SLP-65 and PLC-γ2 was unaffected. This is supported by the observation that 
SLP-65 and Grb2 independently translocate to signalling competent lipid rafts (JOHMURA et 
al., 2003). It will be important to further address this question with phospho-specific 
antibodies to components of the Ca2+ initiation complex. It was previously suggested that 
Grb2 can indeed fulfill a role in PLC-γ regulation. Choi et al. reported that Grb2 directly 
binds phospho-Tyr783 of PLC-γ1 (rat sequence) in a HEK-293 cell-based system (CHOI et 
al., 2005). Downregulation of Grb2 in HEK-293 cells by RNA interference enhanced 
epidermal growth factor (EGF)-induced PLC-γ1 enzymatic activity and subsequent Ca2+ 
mobilization, while Grb2 overexpression inhibited PLC-γ1 activity. Interestingly, the EGF-
induced tyrosine phosphorylation state of PLC-γ1 was unaffected (CHOI et al., 2005). In 
addition, it was reported that there is some level of association between PLC-γ1 and Grb2 
which is independent of tyrosine phosphorylation, and probably mediated by a proline-rich 
motif of PLC-γ1 and one of the two SH3 domains of Grb2 (PEI et al., 1997). This data 
suggests that Grb2 directly influences PLC-γ recruitment and/or activity. However, it seems 
unlikely that similar interactions between Grb2 and PLC-γ2 are the cause of the observed 
negative regulation of Ca2+ mobilization in B lymphocytes. In our system, inducible or 
constitutive interactions between Grb2 and PLC-γ2 were not detected by immuno- or 
affinity purifications (I. Goldbeck, PhD thesis in progress). Furthermore, in PLC-γ2 neither 
Y753 nor Y759 are located within a motif similar to the postulated Grb2-binding motif in 
PLC-γ1 (Y783). 
Grb2 was shown to be a central component of many inhibitory signalling pathways by 
serving as scaffold for different negative regulators (reviewed in DIKIC and GIORDANO, 
2003). The data reported herein is complementary to those studies and reveal for the first 
time a regulatory role of Grb2 for the essential process of Ca2+ mobilization in                     
B lymphocytes. 
 
6.2.  NTAL positively regulates Ca2+ mobilization in B lymphocytes 
Ca2+ mobilization differs significantly at different stages of B cell development. Since Grb2 
is expressed throughout all stages of B cell lymphopoiesis, the requirement of an upstream 
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Grb2 regulator that may be differentially expressed during B cell maturation appeared to be 
obligatory. We focussed on the transmembrane adaptor NTAL, since it was previously 
shown that NTAL is capable of binding Grb2 through phosphotyrosine-based binding 
motifs of the pYxN type (BRDICKA et al., 2002; JANSSEN et al., 2003). The deduced amino 
acid sequence of avian NTAL indicates the importance of Grb2 binding since the 
evolutionary conservation is essentially restricted to these motifs. In this thesis it was 
demonstrated that tyrosine phosphorylation of the three membrane-distal YxN sites of 
NTAL leads to Grb2 recruitment via its SH2 domain. Thus, NTAL is a positive regulator of 
BCR-induced Ca2+ mobilization.  
The results presented in this thesis clearly show that NTAL is not the B-cell homolog of 
LAT as previously assumed based on their structural similarity. NTAL lacks critical 
functional properties of LAT, most importantly it fails to recruit PLC-γ isoforms (BRDICKA 
et al., 2002; JANSSEN et al., 2003). Nevertheless, NTAL has been shown to activate Erk 
(BRDICKA et al., 2002) or to induce Ca2+ mobilization via an unknown pathway (JANSSEN et 
al., 2003). The hypothesis that NTAL does not exert its positive role in Ca2+ mobilization 
via a direct interaction with PLC-γ2 was further supported by the observation that a LAT 
variant which is incapable of binding PLC-γ (human LAT [Y132F]) still leads to an increase 
in Ca2+ mobilization when expressed in DT40 B lymphocytes. Evidence for the functional 
equivalence of NTAL and the LAT [Y132F] mutant was also obtained in other cell lines and 
mouse models. Both NTAL and LAT [Y132F] were able to restore Ca2+ mobilization in 
LAT-deficient J.Cam2.5 Jurkat T cells, albeit to a reduced extent than variants expressing 
wild-type LAT (ZHANG et al., 2000; JANSSEN et al., 2004). In other studies both LAT 
[Y136F] knock-in mice (murine LAT Y136 is the equivalent of human LAT Y132) and lat-/- 
mice reconstituted with an ntal transgene under the control of the CD2 promotor show a 
TH2 lymphoproliferative disorder characterized by a massive T cell infiltration and 
organomegaly (AGUADO et al., 2002; SOMMERS et al., 2002; JANSSEN et al., 2004), clearly 
emphasizing the importance of the association of LAT with PLC-γ1. It seems that this 
association determines the signalling threshold within the cells. If NTAL does not interact 
with PLC-γ isoforms, what is its function in B cells in general and how does it regulate Ca2+ 
mobilization in particular? 
Mast cells isolated from ntal-/- mice show increased PLC-γ activity, increased IP3 
production, and increased Ca2+ mobilization probably caused by enhanced LAT tyrosine 
phosphorylation (VOLNA et al., 2004; ZHU et al., 2004). Additionally, ntal-/- mice reveal 
slightly increased BCR-induced Ca2+ mobilization (ZHU et al., 2004; WANG et al., 2005). 
Thus, genetic deletion in mice reveals primarily an inhibitory function of NTAL. However, 
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a partial contributory role for NTAL in Ca2+ signalling has been deduced from studies in 
both T and B lymphocytes (BRDICKA et al., 2002; JANSSEN et al., 2003; 2004). Therefore, 
the increased LAT phosphorylation in ntal-/- mast cells might mask the positive regulatory 
role of NTAL in Ca2+ mobilization (VOLNA et al., 2004; ZHU et al., 2004). It must be noted 
that ntal-/- lat-/- mast cells are even less responsive than lat-/- mast cells (ZHU et al., 2004), 
clearly suggesting a stimulatory role for NTAL which could be mediated through its role in 
Ca2+ mobilization. Tkaczyk et al. indeed found a positive regulatory role for NTAL in Ca2+ 
signalling by using an RNAi approach in human mast cells (TKACZYK et al., 2004).    
Further investigation is required to ultimately determine the redundancy (Grb2 binding) 
and/or difference (PLC-γ binding) of LAT and NTAL in immune cell signalling. The 
influence of other transmembrane adaptors capable of Grb2 recruitment (i.e. LAX and SIT) 
on NTAL-regulated signalling pathways has yet to be assayed. It must be considered that 
the genetic deletion of one transmemebrane adaptor may significantly alter the membrane 
distribution of the remaining transmembrane adaptors. The final assessment of overlapping 
functions of transmembrane adaptors is yet to come. Furthermore, the potential signalling 
capabilities of the highly conserved tyrosine motifs in NTAL, which are not Grb2-binding 
sites remains to be elucidated (Y110, Y118, and Y119 in avian NTAL).   
Collectively, the data presented in this thesis lead to a bidentated model for Ca2+ 
mobilization in B lymphocytes. First, tyrosine phosphorylated SLP-65 serves as scaffold for 
the recruitment of PLC-γ2 and Btk, resulting in the formation of the Ca2+ initiation complex 
and the activation of PLC-γ2. Second, the tyrosine phosphorylated YxN sites of NTAL 
recruit Grb2 to the lipid rafts, thereby inactivating its negative regulatory role on Ca2+ 
mobilization and preventing a premature stop of the Ca2+ signal. This model is supported by 
the fact that a constitutive recruitment of Grb2 to the lipid rafts by virtue of a palmitoylated, 
transmembrane anchor leads to increased Ca2+ mobilization.  
It appears that the NTAL/Grb2 module is one pathway to fine-tune the BCR-induced Ca2+ 
signal, allowing for specific cellular responses. Since both NTAL and Grb2 are expressed in 
various hematopoietic lineages, it can be assumed that the NTAL/Grb2 module also 
operates in the context of other receptor systems. The expression of other Grb2-recruiting 
transmembrane adaptors and their distribution in distinct plasma membrane microdomains 
are likely to be important factors influencing NTAL function. 
 
6.3.  The NTAL/Grb2 module: a regulator of PLC-γ2 function? 
Over the course of this project it was demonstrated that the enhanced Ca2+ mobilization in 
NTAL-positive or Grb2-negative DT40 cells can be attributed to increased intracellular IP3 
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concentration (K. Neumann, PhD thesis in progress). This observation led to the assumption 
that the NTAL/Grb2 module affects PLC-γ2 activity. As outlined in the introduction,    
PLC-γ2 activity is regulated by tyrosine phosphorylation and its translocation to the plasma 
membrane. To further elucidate that hypthesis, the effect of NTAL overexpression was 
analysed in plc-γ2-/- DT40 cells reconstituted with either wild-type rat PLC-γ2 or a 
transmembrane chimera (diploma thesis S. Alers). Strikingly, forced expression of NTAL 
had no enhancing effect on Ca2+ mobilization in plc-γ2-/- DT40 cells expressing the 
transmembrane variant of PLC-γ2. Thus it appears that the NTAL/Grb2 module directly 
influences the membrane localization of PLC-γ2 or its retention time at the membrane. This 
function is abolished in DT40 B lymphocytes expressing a PLC-γ2 chimeric protein which 
is constitutively targeted to the plasma membrane. Collectively, these studies reveal a role 
of the NTAL/Grb2 module in the regulation of PLC-γ2 function. As demonstrated by the 
IP3 production assays discussed above and the data for the Ca2+ release from intracellular 
stores in NTAL-positive and Grb2-negative cells (shown in this thesis), it might be possible 
that the NTAL/Grb2 module directly affects PIP2 hydrolysis by an altered retention time of 
PLC-γ2 at the plasma membrane.  
Although extensively studied, the regulation of Ca2+ permeable ion channels in the plasma 
membrane and exactly how receptor activation leads to channel activity remain obscure. 
Currently it seems to be evident that the same proteins participate in both Ca2+ release from 
intracellular stores and Ca2+ entry across the plasma membrane (PATTERSON et al., 2005). 
For example, this could be shown for IP3R (FURUICHI et al., 1989; VAN ROSSUM et al., 
2004), calmodulin (MICHIKAWA et al., 1999; ORDAZ et al., 2005), PKC (FERRIS et al., 1991; 
VENKATACHALAM et al., 2003), homer (TU et al., 1999; YUAN et al., 2003), and PLC-γ 
(SUGAWARA et al., 1997; PATTERSON et al., 2002).  
B lymphocytes signal Ca2+ in response to antigen receptor engagement exclusively via  
PLC-γ2 (TAKATA et al., 1995; KUROSAKI et al., 2000; REBECCHI and PENTYALA, 2000; 
RHEE, 2001; WILDE and WATSON, 2001), and this is also the only isoform of PLC-γ 
expressed in DT40 B cells (TAKATA et al., 1995; REBECCHI and PENTYALA, 2000). Evidence 
is accumulating that PLC-γ2 has both lipase-dependent and lipase-independent functions in 
Ca2+ entry across the membrane (see introduction; BERRIDGE et al., 2000; PATTERSON et al., 
2002; CLAPHAM, 2003; NISHIDA et al., 2003; PATTERSON et al., 2005; VAN ROSSUM et al., 
2005). Nishida et al. convincingly demonstrated that PLC-γ2 acts to amplify the BCR-
evoked Ca2+ signal. The amplification mechanism is a positive feedback cycle, in which the 
key event is the Ca2+ entry-mediated, lipase-independent translocation of PLC-γ2 towards 
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the plasma membrane via its C2 domain leading to PLC-γ2 activation, IP3/DAG production, 
and finally to Ca2+ release and entry (NISHIDA et al., 2003). Interestingly, three recent 
reports provide clear evidence that PLC-γ also has a functional role in Ca2+ entry 
independent of its enzymatic activity. Patterson et al. reported experiments clearly showing 
that a lipase-inactive mutant of PLC-γ2 can elicit Ca2+ entry (PATTERSON et al., 2002). Yu et 
al. identified a point mutation in the murine plc-γ2 gene leading to the gain-of-function 
substitution D993G (YU et al., 2005). The ability of this PLC-γ2 variant to interact and to 
remain at the plasma membrane is affected, and in turn causes an increased and sustained 
external Ca2+ entry (YU et al., 2005). Finally, van Rossum et al. reported that the C-terminal 
half of the split PH domain of PLC-γ1 interacts with a complementary partial PH-like 
domain in TRPC3, thereby eliciting lipid binding and cell-surface expression of TRPC3 
(VAN ROSSUM et al., 2005). With regard to the data described above, one might speculate 
that the comparatively high Ca2+ influx from extracellular sources in DT40 cells expressing 
the transmembrane PLC-γ2 variant might be due to an increased cell-surface expression of 
Ca2+ channels. Collectively, as NTAL/Grb2 seem to control PLC-γ2 localization, it is likely 
that this module also regulates lipase-independent activities of PLC-γ2 in BCR-induced 
Ca2+ mobilization.  
One important regulator of PLC-γ activation is PI3K, which plays a role in both Ca2+ release 
(BAE et al., 1998; BOLLAND et al., 1998; FALASCA et al., 1998; RAMEH et al., 1998; 
SCHARENBERG et al., 1998; SCHARENBERG and KINET, 1998; CLAYTON et al., 2002; JOU et 
al., 2002; OKKENHAUG et al., 2002; DONAHUE and FRUMAN, 2004) and Ca2+ influx (CHING 
et al., 2001; MACREZ et al., 2001; KAWANABE et al., 2003; LE BLANC et al., 2004; TSENG et 
al., 2004). However, the NTAL/Grb2 module seems to act independently of PI3K as 
concluded from three lines of evidence. First, Grb2-deficient DT40 cells continue to exhibit 
increased Ca2+ mobilization in the presence of the PI3K inhibitor wortmannin as compared 
to DT40 cells expressing Grb2. Second, forced expression of NTAL in vav3-/- DT40 cells 
similarly caused an augmentation in Ca2+ mobilization. Vav-3 was shown to modulate BCR 
responses as an upstream regulator of PI3K (INABE et al., 2002). Third, an enhanced Ca2+ 
flux was also observed in p110α-/- DT40 cells expressing either NTAL or the dominant 
negative Grb2 variant W193K (all data by K. Neumann, PhD thesis in progress). One major 
antagonist of PI3K activity is the 5´-phosphatase SHIP. However, the NTAL/Grb2 module 
seems to exert its function also in absence of SHIP, as deduced from an increased Ca2+ 
mobilization in ship-/- DT40 cells expressing NTAL (K. Neumann, PhD thesis in progress). 
Taken together, it seems that the role of the NTAL/Grb2 module in BCR-induced PLC-γ2 
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activation and subsequent Ca2+ mobilization cannot solely be attributed to an altered 
phosphoinositide metabolism catalyzed by PI3K and/or SHIP. 
Since neither Grb2 nor NTAL directly associate with PLC-γ2 in B lymphocytes, the 
necessity of a further downstream effector molecule is apparent. Such a molecule might 
affect both the lipase-dependent and -independent activities of PLC-γ2. During the course of 
this project, different molecules known to interact with Grb2 and to be components of 
inhibitory signalling pathways in B lymphocytes were analysed for their sensitivity to the 
NTAL/Grb2 module. This was achieved by NTAL overexpression in DT40 cell lines 
rendered deficient for the corresponding negative regulators, i.e. ship-/-, shp1-/-, shp2-/-, and 
cbl-/- DT40 cells (K. Neumann, PhD thesis in progress). However, in all these cell lines 
NTAL expression still led to an enhanced Ca2+ mobilization. Two conclusions may be 
drawn from these results. First, neither the lipid phosphatase SHIP, the tyrosine 
phosphatases SHP-1/-2 nor the ubiquitin ligase Cbl are the inhibitory molecule whose 
function is regulated by presence or absence of NTAL/Grb2. Rather an inhibitor that 
remains to be identified is controlled by the NTAL/Grb2 module. Second, the observed Ca2+ 
signal in NTAL-positive or Grb2-negative DT40 cells is composed of multiple Grb2-
dependent pathways. Therefore, small differences might not be detectable in DT40 cells 
deficient for a single, Grb2-bound negative regulator. 
 
6.4.  Does the NTAL/Grb2 module influence store-operated Ca2+ entry? 
In this thesis it was shown that the absence of Grb2 or the presence of NTAL increase the 
extent of Ca2+ entry across the plasma membrane. Some experiments not shown provided 
evidence that the NTAL/Grb2 module affects store-operated Ca2+ entry in DT40                  
B lymphocytes. Store-depletion with thapsigargin led to identical Ca2+ entry in Grb2-
negative and Grb2-positive DT40 cells (data not shown). Identical Ca2+ mobilization from 
the extracellular space was also observed when BCRs were crosslinked after thapsigargin-
mediated store-depletion (K. Neumann, PhD thesis in progress), indicating that a potential 
direct BCR-dependent coupling to the channels is unaffected by presence or absence of 
Grb2. This data agrees with the observation that PLC-γ depletion by RNAi or knockout in 
DT40 cells has no effect on Ca2+ entry following thapsigargin-induced store emptying 
(PATTERSON et al., 2002). It must be stated that the global store depletion induced by 
thapsigargin treatment may represent a pathophysiological state, bypassing important 
physiological regulatory elements (PATTERSON et al., 2002). However, it was shown that 
store depletion with thapsigargin results in the activation of ICRAC in DT40 cells (PRAKRIYA 
and LEWIS, 2001). Interestingly, thapsigargin-induced Ca2+ entry is indeed potentiated upon 
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PLC-γ1 overexpression, suggesting that PLC-γ isoforms can indeed fulfill a functional role 
in SOC activation (PATTERSON et al., 2002).  
Analogous to the lipase-dependent and -independent activity of PLC-γ2 in Ca2+ release and 
Ca2+ entry, evidence is accumulating that IP3Rs have both release-dependent and release-
independent functions in Ca2+ entry across the membrane. IP3Rs are important components 
of the conformational/secretion-like coupling model for SOC-mediated Ca2+ entry. It could 
be shown that the IP3R-mediated gating of TRPC3, an ion channel that is controversially 
disputed to be store-operated or not (see introduction; PAREKH and PUTNEY, 2005), is 
dependent on IP3, but independent of Ca2+ release (KISELYOV et al., 1998; 1999). A similar 
dependence of endogenous SOCs on IP3/IP3R was reported in A431 cells (ZUBOV et al., 
1999). Another group could demonstrate that capacitative Ca2+ entry could be rescued in 
ip3r-/- DT40 B cells reconstituted with a pore-dead mutant of IP3R that is capable of binding 
IP3. In marked contrast, Ca2+ entry could not be rescued using a mutant with a functional 
Ca2+ pore but defective IP3 binding, simply suggesting that IP3-binding to IP3Rs, and not ER 
Ca2+ release triggers Ca2+ entry (VAN ROSSUM et al., 2004). Therefore, the possibility exists 
that increased IP3 levels in NTAL-positive and Grb2-negative DT40 cells also directly 
influence IP3R-gated Ca2+ entry channels, allocating the NTAL/Grb2 module an indirect 
role in the secretion-like coupling model. This could be further elucidated using ip3r-/- DT40 
cells which are reconstituted with the IP3R mutants described above and which are either 
positive for NTAL expression or deficient for Grb2. However, other studies do not support a 
requirement for IP3 in TRPC3 and/or SOC gating (SUGAWARA et al., 1997; HOFMANN et al., 
1999; BROAD et al., 2001; MA et al., 2001; VENKATACHALAM et al., 2001; TREBAK et al., 
2003). It has been demonstrated that TRPC3 could be activated not by store-depletion but 
by DAG analogs (HOFMANN et al., 1999; VENKATACHALAM et al., 2001; TREBAK et al., 
2003). In this scenario, channels would be activated contemporaneously with an increase in 
IP3 and subsequent Ca2+ release, but it is the DAG produced as a result of PLC-γ activity 
and neither store depletion nor liganded IP3Rs that opens the channels. Naturally, increased 
IP3 levels in NTAL-positive or Grb2-negative DT40 cells are likely to reflect 
concomittantly increased DAG levels.  
Physiologically, an increase in IP3 or other Ca2+ mobilizing signals and subsequent Ca2+ 
release from the stores are the sine qua non of store-operated Ca2+ entry. Therefore, gating 
mechanisms for SOCs might differ between BCR signalling and pharmacological induced 
responses, e.g. the former might require IP3/IP3Rs whereas the latter does not. For example, 
receptor-mediated store depletion is spatially localized and temporally restricted, whereas 
thapsigargin globally depletes stores leading to an overriding stimulus independent of   
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PLC-γ2 activity. Further experiments will be necessary to determine the role of PLC-γ 
and/or IP3 liganded IP3Rs in gating Ca2+ channels of DT40 B lymphocytes and how the 
NTAL/Grb2 module may regulate this function. 
Taken together, the studies and experiments described above allow for a refinement of the 
general principles underlying Ca2+ mobilization in B lymphocytes (figure 6.1; compare 
figure 2.2). (1) The BCR transmits information to the ER-resident IP3Rs via the production 
of IP3. This is mainly mediated by the Ca2+ initiation complex, and possibly fine-tuned by 
the NTAL/Grb2 module and further Grb2-dependent inhibitory effector molecule(s).         
(2) The ER transmits information back to the plasma membrane Ca2+ entry channels, e.g. 
via IP3-liganded IP3Rs or close interactions between the two membranes. (3) BCR 
engagement can also result in a “direct” modification of Ca2+ entry channels within the 
same membrane, e.g. via conformational changes. Alternatively, this “direct” modification 
is a result of lipase-dependent or -independent PLC-γ2 activities, e.g. via PLC-γ/TRP 
interactions or lipid mediators such as DAG. The last two steps might also be affected by 
the NTAL/Grb2 module and Grb2-dependent inhibitor(s), allowing for a dynamic Ca2+ 
signalling in response to antigen binding.  
 
 
 
 
 
 
Figure 6.1: Ca2+ mobilization in B lymphocytes 
Principle steps of the BCR-induced Ca2+ 
mobilization from intra- and extracellular sources 
(also refer to figure 2.1). (1) Antigen-binding by 
the BCR leads to the assembly of the Ca2+ 
initiation complex, PLC-γ2 activation, and 
subsequent IP3 production. This is possibly fine-
tuned by the NTAL/Grb2 module and its 
downstream effector molecules. (2) The ER 
transmits information back to the plasma 
membrane Ca2+ entry channels, i.e. via a 
diffusible messenger, coupling processes   
(e.g. involving IP3-liganded IP3Rs), vesicular 
trafficking, or removal of Ca2+ inhibition.   
(3) BCR engagement can also lead to a direct 
activation of the Ca2+ entry channels. This may 
involve conformational changes or signalling 
molecules, e.g. PLC-γ2 itself or DAG. The last 
two steps could also be influenced by the 
NTAL/Grb2 module and Grb2-dependent 
inhibitor(s). (Modified from PATTERSON et al., 
2005) 
Discussion 
 
109
6.5.  Dok-3 tyrosine phosphorylation is regulated by Grb2 in B lymphocytes 
To achieve a deeper understanding of Grb2-dependent signalling pathways in DT40            
B lymphocytes global tyrosine phosphorylation was analysed in Grb2-positive and -negative 
cells. Strikingly, the major tyrosine phosphorylated protein could not be detected by anti-
pTyr immunoblot analysis in grb2-/- DT40 cells. During the course of this project, this 
protein was identified as Dok-3. Its complete tyrosine phosphorylation critically depends on 
the presence of Grb2, and the central SH2 domain and the C-terminal SH3 domain are 
particularly required.  
The Grb2-dependent phosphorylation of Dok-3 was also confirmed in the murine system, 
using Grb2-deficient BAL17.TR mature B cells and variants in which wild-type Grb2 
expression was reconstituted (HARMER and DEFRANCO, 1999; K. Neumann, PhD thesis in 
progress). Furthermore, it seems that Grb2 function concerning Dok-3 phosphorylation 
cannot be compensated by other members of the Grb2 adaptor family expressed in DT40 
cells, e.g. Grap (HASHIMOTO et al., 1998) although Grb2 and Grap have highly related 
structures (59 % identity), and associate with the same proteins (FENG et al., 1996; TRUB et 
al., 1997). Dok-3 was reported to bind SHIP and Csk upon BCR stimulation, thus playing a 
role in the negative regulation of antigen receptor signalling in B cells (LEMAY et al., 2000). 
It has been proposed that the Dok-3/SHIP complex suppresses B-cell activation by 
selectively inhibiting the BCR-evoked activation of the Jun N-terminal protein kinase (Jnk) 
cascade (ROBSON et al., 2004).  
The use of lyn-/- DT40 cells confirmed that PTK Lyn is capable of phosphorylating Dok-3 as 
reported previously (LEMAY et al., 2000). Lyn activity itself is regulated by various 
molecules. The best studied regulation mechanism involves the kinase-phosphatase pair 
Csk/CD45 that regulates the phosphorylation state of the C-terminal inhibitory tyrosine of 
Lyn. Yanagi et al. reported the generation of chptpl-/- DT40 cells which is the chicken 
homolog of CD45 (FANG et al., 1994; YANAGI et al., 1996). In these cells, BCR-induced 
tyrosine phosphorylation is almost completely abolished and resembles the pattern observed 
for lyn-/- cells (this thesis; TAKATA et al., 1994). Dok-3, the major tyrosine phosphorylated 
protein, also could not be detected by anti-pTyr immunoblot analysis in chptpl-/- DT40 cells 
(figure 3 in YANAGI et al., 1996). This observation provides further evidence that Lyn is the 
kinase responsible for Dok-3 phosphorylation along with the fact that Lyn is the only Src 
kinase expressed in DT40 B lymphocytes (TAKATA et al., 1994). Additionally, Dok-3 
tyrosine phosphorylation was not altered in syk-/- or btk-/- DT40 cells (data not shown). 
Collectively, one might speculate that the Dok-3 phosphorylation by Lyn, the Csk binding 
by Dok-3 and the regulation of Lyn activity by Csk (see below) constitute a negative 
feedback loop in B lymphocytes which is independent of the transmembrane adaptor 
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PAG/Cbp. However, more experiments have to be performed to substantiate this hypothesis. 
Similar mechanisms were proposed for Dok-1 in the negative regulation of platelet-derived 
growth factor (PDGF)-induced mitogenesis (ZHAO et al., 2006) and Dok-2 in the attenuation 
of EGFR signalling (VAN SLYKE et al., 2005). Interestingly, these two reports revealed 
constitutive interactions between c-Src and Dok-1, and in greater detail between the c-Src 
SH3 domain and PxxP motifs in the C-terminal part of Dok-2 (VAN SLYKE et al., 2005; 
ZHAO et al., 2006). Whether such an association holds true for Lyn and Dok-3 in DT40       
B lymphocytes awaits further clarification, but four core PxxP motifs also exist in avian 
Dok-3 (P296VEP299EAP, P322GQP, and P398SRP). Two of them (RFPP296VEP and 
RPCP322GQP) are indeed located within a class I ligand motif for SH3 domains, sharing the 
consensus motif (R/K)xxPxxP (FENG et al., 1994, 1995; SPARKS et al., 1996, 1998; MAYER, 
2001; JIA et al., 2005). This is even more notable with regard to reports convincingly 
showing that Src family PTK activity is itself regulated by interactions with its SH3 domain, 
e.g. with the HIV accessory protein NEF, SHP-2 or UNC119 (MOAREFI et al., 1997; 
WALTER et al., 1999; CEN et al., 2003; GORSKA et al., 2004). This possibly suggests an even 
greater level of Dok-3-mediated regulation of Lyn activity. The SH3 domains of Src family 
PTKs bind preferentially to the (R/K)xxPxxP motif (RICKLES et al., 1994; 
ALEXANDROPOULOS et al., 1995), such as those found in avian Dok-3. The SH2-kinase 
linker region of Lyn has the canonical PxxP motif (amino acids 211-214) but lacks the 
flanking arginine. Therefore, this “imperfect” SH3 motif with low affinity binding can be 
easily displaced by a high affinity SH3 ligand (CEN et al., 2003). However, it seems that 
Grb2/Dok-3 complexes do not regulate Lyn activity by an all-or-nothing mechanism, since 
overall tyrosine phosphorylation patterns are not altered in grb2-/- or dok-3-/- DT40 cells. 
Interestingly, only two core PxxP motifs are present in the murine Dok-3 amino acid 
sequence and are not located within classical class I or II SH3 ligand motifs. Whether this 
difference contributes to the strong tyrosine phosphorylation of chicken Dok-3 in DT40 
cells has to be investigated.   
In summary, extensive Dok-3 tyrosine phosphorylation in DT40 B lymphocytes could be 
caused by two mechanisms, which are not mutually exclusive. First, Dok-3 is brought in 
perfect proximity to Lyn, e.g. via Grb2-supported plasma membrane recruitment (see 
below), direct interaction involving the Dok-3 PxxP motifs, or homotypic oligomerization 
processes. Homo- and heterotypic oligomerization processes were also described for Dok-1 
and Dok-2 (SONGYANG et al., 2001; BOULAY et al., 2005). Second, the intense tyrosine 
phosphorylation signal is due to the massive expression of Dok-3 in DT40 cells, e.g. as 
indicated by the high levels of dok-3 messenger RNA. Further experiments are currently 
underway to answer this question.  
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6.6.  The phosphorylation-dependent Grb2-Dok-3 interaction: the hen-egg problem 
and beyond 
In this thesis it was shown that the central SH2 domain of Grb2 binds to tyrosine 
phosphorylated Dok-3 upon BCR engagement in chicken, murine, and human B cells. This 
observation was somewhat unexpected since the SH2 domain itself together with the         
C-terminal SH3 domain are stringently required for Dok-3 tyrosine phosphorylation. The 
Grb2-dependent tyrosine phosphorylation of Dok-3 and the stimulation-dependent 
Grb2/Dok-3 interaction represent a typical hen-egg-problem. 
In avian Dok-3 only two of the four tyrosines described for human and mouse amino acid 
sequences exist, i.e. the PTB domain proximal tyrosines Y307 and Y331. The functional 
significance of the two PTB domain distal tyrosines is unclear, since substitution of these 
two residues with phenylalanine in murine Dok-3 had no impact on BCR-mediated 
signalling (ROBSON et al., 2004). Tyrosine Y331 represents a potential Grb2 SH2 domain 
binding site of the YxN type (Y331ENI). Mutational analysis of this motif will ultimately 
determine if indeed it is the Grb2 interacting site (in progress). Weak Dok-3 tyrosine 
phosphorylation is also observed in grb2-/- DT40 cells. This Grb2-independent 
phosphorylation might occur at Y331 since the partially tyrosine phosphorylated Dok-3 is 
purified by GST-Grb2[SH2] fusion proteins. Robson et al. reported that the presence of the 
potential Grb2 binding site Y331ENI is mandatory for Dok-3 phosphorylation (ROBSON et 
al., 2004). This was confirmed by overexpression studies of the chicken Dok-3 Y331F 
variant in wild-type DT40 cells. In these cells, phosphorylation of the HA-tagged Dok-3 
Y331F variant was clearly diminished. A reduction in Dok-3 tyrosine phosphorylation was 
also observed in a derivative with a defective PTB domain (R197A). A complete lack of 
tyrosine phosphorylation was detected for a Dok-3 variant with deleted PH domain (ΔPH 
Dok-3), suggesting that the major contribution to subcellular localization is likely to be 
made by the Dok-3 PH domain (all data by K. Neumann, PhD thesis in progress).  
A slightly increased tyrosine phosphorylation was seen in the Y307F variant (K. Neumann, 
PhD thesis in progress). This is particularly notable with regard to the fact that an 
orthologous murine Dok-3 variant seemed to augment the inhibitory capacity in an 
interleukin (IL)-2 production assay in A20 cells (ROBSON et al., 2004). One might speculate 
that inhibition of the Dok-3/Csk interaction evoked by substitution of Y307 leads to enhanced 
Dok-3 global phosphorylation due to increased Lyn activity. The motif Y307ASI reveals 
striking similarity to the Csk SH2 domain binding sites of SIT (YASV in human) and 
PAG/Cbp (YSSV in human) (BRDICKA et al., 2000; KAWABUCHI et al., 2000; PFREPPER et 
al., 2001). Previously it was shown by affinitiy purification experiments with GST Csk 
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[SH2] fusion proteins that the equivalent residue of murine Dok-3 (YASV) is necessary for 
Csk-Dok-3 interaction (ROBSON et al., 2004). It was also suggested that this interaction is 
enhanced by a functional Csk SH3 domain (LEMAY et al., 2000). Indeed it is necessary to 
note the striking similarities in the functional activities of the transmembrane adaptor SIT 
and the cytosolic adaptor Dok-3. Both molecules inducibly associate with Grb2 and Csk, 
and both molecules negatively regulate BCR-induced activation of the transcription factor 
NFAT (LEMAY et al., 2000; PFREPPER et al., 2001). Further studies are required to confirm 
whether these two adaptors fulfill overlapping or different functions in BCR-induced 
signalling. Both PTB domain proximal tyrosine residues of murine Dok-3 were shown to be 
bound by the SH2 domain of SHIP (ROBSON et al., 2004). A bidentated mechanism of   
Dok-3-SHIP interaction was suggested, since tyrosine phosphorylated SHIP could also be 
purified with GST-Dok-3 [PTB] fusion proteins (LEMAY et al., 2000). The exact interaction 
modes with known and possibly unknown binding partners are currently under investigation 
using wild-type Dok-3 and derivatives in immuno- and affinity purification experiments.  
Interestingly, tyrosine phosphorylation is predicted by an artificial neural network method 
(NetPhos 2.0 Server, BLOM et al., 1999) for two tyrosines within the PH domain (Y11 and 
Y96) and one tyrosine located in the PH-PTB interdomain (Y140). It has been postulated that 
post-translational modifications (such as serine/threonine or tyrosine phosphorylation) or 
oligomerization might enable low affinity PH domain-containing molecules to bind 
membranes with more avidity (LEMMON and FERGUSON, 2000). Thus, Y11 and Y96 could 
regulate the affinity of the Dok-3 PH domain for membrane lipids. Phosphorylation of the 
tyrosine within the PH-PTB interdomain was proposed to be a critical step in hetero- and 
homotypic oligomerizations of the paralogs Dok-1 and Dok-2 (SONGYANG et al., 2001; 
BOULAY et al., 2005). Accordingly, Y140 might promote maximal Dok-3 tyrosine 
phosphorylation by supporting oligomerization processes. Recently it was reported that a 
pYxxY/F/W motif is bound by a C2 domain in a sequence-specific manner (BENES et al., 
2005). Whether the putative pY140SSW motif associates with molecules containing SH2, 
PTB or possibly C2 domains remains to be demonstrated. The relevance of these tyrosines 
for maximal Dok-3 tyrosine phosphorylation and for potential interactions with other 
molecules is also currently under study.   
To shed light on the hen-egg-problem of the Grb2-dependent Dok-3 tyrosine 
phosporylation, the following mechanism is proposed. BCR engagement leads to tyrosine 
phosphorylation of Dok-3 at tyrosine Y331. This site is then bound by the Grb2 SH2 domain, 
leading to a conformational “opening” of Dok-3. This in turn enables Dok-3 to localize at 
the plasma membrane probably via its PH domain and/or its PTB domain. Finally, 
membrane recruitment leads to complete tyrosine phosphorylation of Dok-3 catalyzed by 
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Lyn. Alternatively, the Grb2-mediated conformational “opening” of Dok-3 may only occur 
following its localization to the plasma membrane since tyrosine phosphorylation is 
completely abolished in the ΔPH Dok-3 variant (see above). It is likely that a Grb2-induced 
conformational “opening” of Dok-3 additionally facilitates homotypic oligomerization 
processes, leading to the maximal Dok-3 tyrosine phosphorylation observed in Grb2-
positive cells. The C-terminal Grb2 SH3 domain may stabilize the association of Dok-3 
with Lyn and/or the plasma membrane. This hypothesis is supported by several 
observations. First, Grb2 recruitment to the membrane according to this mechanism would 
depend on Dok-3 bringing Grb2 to the plasma membrane via a piggyback mechanism. 
Preliminary data reveals that recruitment of Grb2-EGFP is tremendously impaired in      
dok-3-/- DT40 cells (I. Goldbeck, PhD thesis in progress). Second, it was shown that a   
Dok-3-EGFP fusion protein is constitutively and Grb2-independently phosphorylated and 
permanently located at the plasma membrane (I. Goldbeck, PhD thesis in progress). This 
observation suggests that EGFP fusion to the C-terminus of chicken Dok-3 mimics binding 
of Grb2, thereby leading to membrane recruitment and complete tyrosine phosphorylation. 
Third, inducible plasma membrane recruitment via the PH domain was previously reported 
for Dok-1 (ZHAO et al., 2001). Collectively, the above hypothesis would explain the 
importance of Dok-3 Y331 and the SH2 domain of Grb2 for complete Dok-3 tyrosine 
phosphorylation. Intriguingly, this proposed mechanism represents a slight modification of a 
model published in 1995 (MAYER et al., 1995). The authors report that the substrate 
specificity of a non-receptor tyrosine kinase is dependent on the binding specificity of its 
associated SH2 domain. In this case, the SH2 domain binds to a subset of proteins tyrosine 
phosphorylated by its own catalytic domain, finally leading to a processive phosphorylation 
of those substrates. Strikingly, it was demonstrated that the non-receptor tyrosine kinase Abl 
can aquire an additional SH2 domain in trans by binding to the adaptor Crk through the Crk 
SH3 domain. In this case the bound adaptor serves as processivity factor initiating the 
processive phosphorylation (MAYER et al., 1995). The Grb2 SH2 domain binds with high 
affinity to partially tyrosine-phosphorylated Dok-3, and it could be shown that the              
C-terminal SH3 domain is also required for maximal Dok-3 tyrosine phosphorylation. It is 
tempting to speculate that Grb2 serves as processivity factor for Lyn-catalyzed Dok-3 
tyrosine phosphorylation with the Grb2 SH3 domain holding Dok-3 in the vicinity of Lyn. 
In this scenario, the Grb2 SH3 domain may bind to Lyn directly or via further mediators, 
e.g. the Grb2-associated binder (Gab) family. It was shown that the C-terminal Grb2 SH3 
domain can bind to sites containing either the canonical PxxP motif (e.g. present in Lyn) or 
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the atypical Px3Rx2KP motif (e.g. present in Gab proteins) (LOCK et al., 2000; SCHAEPER et 
al., 2000; LEWITZKY et al., 2001). 
 
6.7.  Do the Grb2-interacting adaptors Dok-3 and Shc have redundant functions in  
B cell signalling? 
The next question that arises is the immunological relevance of the Grb2/Dok-3 interaction 
in B lymphocytes. To answer this question the scaffolding properties of Dok-3 and its 
interaction with catalytically active molecules have to be elucidated. Interestingly, Dok-3 is 
not the only molecule in B lymphocytes which is bound by the Grb2 SH2 domain upon 
BCR stimulation and whose tyrosine phosphorylation depends on Grb2. Both of these 
properties also apply to the adaptor molecule Shc (HARMER and DEFRANCO, 1999). 
Additionally, it was shown that Shc tyrosine phosphorylation strongly depends on Shc 
having a functional PTB domain, and the presence of SHIP (INGHAM et al., 1999). Harmer 
and DeFranco claimed that efficient binding of tyrosine phosphorylated SHIP and the Shc 
PTB domain requires Grb2, with Grb2 binding to Shc via its SH2 domain and to SHIP via 
its SH3 domains (HARMER and DEFRANCO, 1999). A ternary SHIP/Grb2/Shc complex 
would be analogous to the SOS/Grb2/Shc complex, which has been implicated in the 
regulation of the Ras/MAPK pathway (SAXTON et al., 1994; NAGAI et al., 1995; CROWLEY 
et al., 1996; HARMER and DEFRANCO, 1997). It has been proposed that SHIP may indirectly 
inhibit Ras activation by competing with SOS for binding to Shc and Grb2 (CHACKO et al., 
1996; TRIDANDAPANI et al., 1997). However, whether SHIP may be involved in this 
function still remains unclear since the activation of the MAPK cascade seems to be 
unaffected in ship-/- DT40 cells (OKADA et al., 1998). Furthermore, it could be shown that 
Shc is not required for BCR-induced ERK response (HASHIMOTO et al., 1998). However, 
Hashimoto et al. suggested that Grb2 plays an important role in Ras activation, since the 
extent of ERK inhibition was comparable in DT40 cells expressing a dominant negative 
variant of Ras (RasN17) and in grb2-/- DT40 cells. Oh-hora et al. subsequently presented 
data that RasGRP3 couples PLC-γ2 to Ras after BCR engagement (OH-HORA et al., 2003). 
Therefore, it seems that the SOS/Grb2/Shc complex is not required for BCR-induced 
Ras/ERK activation. However, in the case of EGFR-mediated Ras activation it could indeed 
be demonstrated that the Grb2/SOS pathway also operates in the DT40 system (OH-HORA et 
al., 2003). Interestingly, the Dok family members Dok-1, Dok-2, and Dok-3 were all 
implicated in the regulation of Ras/ERK signalling (CONG et al., 1999; JONES and DUMONT, 
1999; WICK et al., 2001; VAN SLYKE et al., 2005). This was also confirmed in vivo by using 
mice deficient for Dok-1 and/or Dok-2 (YAMANASHI et al., 2000; NIKI et al., 2004; YASUDA 
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et al., 2004; SHINOHARA et al., 2005). Both Dok-1 and Dok-2 have been shown to inducibly 
interact with p120 RasGAP via C-terminal phosphotyrosines (CARPINO et al., 1997; DI 
CRISTOFANO et al., 1998; NELMS et al., 1998; WICK et al., 2001). Dok-3 does not harbor a 
RasGAP-binding motif nor bind p120 RasGAP (CONG et al., 1999; LEMAY et al., 2000). Yet 
a role for Dok-3 in the activation of the Ras/ERK pathway was deduced from the following 
two observations. First, forced expression of Dok-3 in 293 cells inhibits ERK activation 
(CONG et al., 1999). Second, in a recent study using 293T cells it was suggested that Dok-3 
sequesters Grb2 and SOS from Shc and thereby inhibits the Ras/ERK pathway downstream 
of PTKs (HONMA et al., 2006). Whether this mechanism functions in BCR-induced 
Ras/ERK activation in B lymphocytes is at best questionable for the reasons stated above. 
Nonetheless, given the fact that Grb2 plays a role in both BCR- and EGFR-induced 
Ras/ERK activation (HASHIMOTO et al., 1998; HASHIMOTO et al., 1999), it will be 
interesting to analyse these processes in the dok-3-/- DT40 cell lines. This is of particular 
importance in regard to the potential involvement of Dok-3 in the recruitment of Grb2 to the 
plasma membrane (see above).  
It is tempting to speculate that a putative SHIP/Grb2/Dok-3 complex might play a similar 
functional role in B lymphocytes. However, several differences between Shc and Dok-3 
must be considered. One important aspect is that Dok-3 becomes readily tyrosine-
phosphorylated in ship-/- DT40 cells (data not shown). Efficient BCR-induced tyrosine 
phosphorylation of Shc requires kinase activity of Syk (NAGAI et al., 1995; RICHARDS et al., 
1996), whereas Dok-3 phosphorylation is independent of Syk (this thesis; LEMAY et al., 
2000). It seems that the Dok-3/SHIP interaction is mainly mediated by binding of the SHIP 
SH2 domain to phosphotyrosines of Dok-3 (LEMAY et al., 2000). The Dok-3 PTB domain 
binds phospho-SHIP only to a minor extent especially compared to the Shc PTB domain 
(LEMAY et al., 2000). Nevertheless, it is well accepted that the increase in BCR, FcεRI, or 
FcγR signalling observed in SHIP-deficient cells implies that SHIP can inhibit 
immunoreceptor signalling without the deliberate co-aggregation of the immunoreceptors 
with ITIM-bearing receptors like FcγRIIB (SAXTON et al., 1994; CROWLEY et al., 1996; 
BOLLAND et al., 1998; VEILLETTE et al., 2002). One might speculate that Dok-3 is involved 
in this FcγRIIB-independent process, e.g. by recruiting SHIP via its SH2 domain to the 
plasma membrane. In this scenario, it would be interesting to analyse whether membrane 
recruitment of SHIP is altered in dok-3-/- cells compared to wild-type DT40 cells. It is 
known that the 5’-phosphatase activity of SHIP is not regulated by tyrosine phosphorylation 
or interaction with adaptor proteins. Rather, it is commonly believed that its activity is 
determined by its localization (ROHRSCHNEIDER et al., 2000). Intriguingly, a 
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SHIP/Grb2/Dok-1 complex was proposed to play a role in FcεRI-mediated signalling in 
human mast cells (KEPLEY et al., 2004). However, the authors do not comment on the mode 
of Grb2-Dok-1 interaction. This would be interesting to elucidate, since Dok-1 lacks a 
classical YxN site for the interaction with the Grb2 SH2 domain. 
Collectively, further studies are required to ultimately determine the interplay between the 
cytosolic adaptor molecules Grb2, Dok-3, and Shc. It is possible that both the Grb2/Shc 
complex and the Grb2/Dok-3 complex fulfill some redundant functions, but this is not 
necessarily the case. Current experiments are focused on the known Dok-3-bound effector 
molecules SHIP and Csk, but other unknown molecules may also participate in              
Dok-3-regulated pathways in B lymphocytes. In the future affinity purification experiments 
with GST fusion proteins containing either the PTB domain of Dok-3, or its tyrosine 
phosphorylated C-terminal part will hopefully give new insights how Dok-3 exerts its 
function in DT40 B lymphocytes. In this thesis it could be demonstrated that the negative 
regulation of BCR-induced Ca2+ mobilization belongs to those functions.    
 
6.8.  The NTAL/Grb2 module and Dok-3: shaping Ca2+ signals in B lymphocytes 
The inhibitory adaptor molecule Dok-3 was demonstrated to negatively regulate Ca2+ 
mobilization in B lymphocytes. Dok-3 tyrosine phosphorylation depends on the central SH2 
and the C-terminal SH3 domain of Grb2. Together with the fact that Dok-3 is also a major 
interacting partner for the Grb2 SH2 domain, it is likely that the NTAL/Grb2 module is 
connected to Dok-3. In this scenario, Grb2 seems to be a molecular switch in BCR-induced 
Ca2+ mobilization. The SH2-domain-dependent association of Grb2 with either tyrosine 
phosphorylated NTAL or Dok-3 ultimately leads to a positive or negative fine-tuning of 
antigen receptor-induced Ca2+ mobilization in B lymphocytes. Both the expression levels of 
NTAL and Dok-3 during B cell development and the Grb2-dependent tyrosine 
phosphorylation of Dok-3 are crucial parameters in this pathway. 
Although more experiments are needed to confirm this hypothesis, some striking 
observations indicate a connection between these three adaptor molecules in BCR-induced 
Ca2+ mobilization. Firstly, for both the negative regulation of Ca2+ mobilization and Dok-3 
tyrosine phosphorylation, the demands on Grb2 domains are identical, i.e. the central SH2 
domain and the C-terminal SH3 domain are obligatory for both processes. Secondly, it 
seems that Dok-3 tyrosine phosphorylation is reduced in NTAL-overexpressing DT40 cells, 
whereas tyrosine phosphorylation of other PTK substrates is unaffected (data not shown). 
Third, in prelimenary experiments it was shown that forced expression of NTAL had no 
enhancing effect on BCR-induced Ca2+ mobilization in dok-3-/- DT40 cells (data not shown). 
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This is probably the strongest evidence for the assumption that Dok-3 is indeed the 
downstream inhibitory element which is regulated by the NTAL/Grb2 module.  
Dok-3 tyrosine phosphorylation cannot be rescued in cells expressing the chimeric         
TM-Grb2 (data not shown and I. Goldbeck, PhD thesis in progress). These results were 
somewhat surprising since both TM-Grb2 and Lyn are located in lipid rafts. These 
observations indicate that enhanced Ca2+ mobilization in NTAL-positive DT40 cells may 
not be due to the sequestration of Grb2 to the lipid rafts, but as a consequence of the 
inability of this chimeric protein to support a conformational “opening” of Dok-3 and 
subsequent tyrosine phosphorylation. This could be due to restricted degrees of freedom in 
the chimeric protein. Therefore, to investigate if the targeting of Grb2 to lipid rafts causes 
the observed phenotypes, it could be useful to express a soluble form of NTAL consisting 
only of the cytoplasmatic domain and thus incapable of localizing in lipid rafts. A tyrosine 
phosphorylated soluble form of NTAL should be bound by the Grb2 SH2 domain with the 
same affinity as wild-type NTAL. A similar variant of LAT indeed became phosphorylated 
upon TCR stimulation and inhibited T-cell activation by recruiting PLC-γ1 and Grb2 
(TORGERSEN et al., 2001). It might be that Grb2 sequestration by a soluble form of NTAL is 
sufficient to positively regulate BCR-induced Ca2+ mobilization. 
Current experiments are aiming at the downstream effector molecule of Dok-3. As stated 
previously, Dok-3 associates with both SHIP and Csk (LEMAY et al., 2000). Intriguingly, a 
similarly increased Ca2+ mobilization from intra- and extracellular sources can be observed 
in ship-/-, grb2-/-, and dok-3-/- DT40 cells suggesting that SHIP is at least part of the effector 
machinery regulated by Grb2/Dok-3. Since NTAL expression in ship-/- DT40 cells still 
results in an enhanced BCR-induced Ca2+ mobilization (see section 6.3), it appears that this 
effect cannot solely be attributed to SHIP. The expression of dominant negative variants of 
Dok-3 in ship-/- DT40 cells will shed further light on other Grb2/Dok-3 regulated pathways 
influencing BCR-induced Ca2+ mobilization (K. Neumann, in progress). Alternatively, with 
the dok-3 targeting constructs prepared during this thesis the generation of dok-3-/- ship-/- 
DT40 cells is possible. The double-deficient cell line and ship-/- DT40 cells could then be 
used to identify Dok-3-dependent, but SHIP-independent regulatory pathways.  
As described above, the second known effector molecule bound by Dok-3 is Csk. It is 
reasonable to assume that Csk influences the extent of Ca2+ mobilization in B lymphocytes 
via the regulation of Lyn activity. However, to date csk-/- DT40 cells were not reported to 
reveal an altered Ca2+ mobilization (HATA et al., 1994). Definitely, these studies have to be 
extended. Interestingly, Ca2+ elevation was enhanced in primary B cells obtained from lyn-/- 
mice, although the initiation of the response showed a slightly longer delay (CHAN et al., 
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1998). In lyn-/- DT40 cells, IP3 production was slightly increased (TAKATA et al., 1994). 
However, crosslinking of BCR on lyn-/- DT40 cells evoked a considerably delayed and slow 
Ca2+ mobilization (TAKATA et al., 1994). Surprisingly, primary B cells expressing a gain-of-
function Lyn tyrosine kinase mutant (Y508F) show constitutive phosphorylation of Syk and 
PLC-γ2 and also a heightened Ca2+ mobilization in response to BCR stimulation (HARDER 
et al., 2001; HIBBS et al., 2002). As stated above, Lyn activity is regulated by multiple 
mechanisms, both tyrosine phosphorylation-dependent and -independent. Future 
experiments aiming at the phosphorylation state of the regulatory tyrosine residue of Lyn in 
dok-3-/- cells and also in vitro Lyn kinase assays will elucidate the importance of Dok-3/Csk 
complexes or even Lyn-Dok-3 associations (as discussed above) in BCR-induced Ca2+ 
mobilization. 
However, SHIP and/or Csk may not be the only effector molecules regulated by Dok-3 and 
affecting BCR-induced Ca2+ mobilization. A connection between PTK Tec and Dok-1 or 
Dok-2 was reported in various cell lines (VAN DIJK et al., 2000; YOSHIDA et al., 2000; 
LIANG et al., 2002). Tec was shown both to associate with and to phosphorylate Dok-1 in 
Ramos B lymphocytes (VAN DIJK et al., 2000; YOSHIDA et al., 2000). It was further 
demonstrated that both the Tec/Dok-1 complex formation and Tec-dependent Dok-1 
phosphorylation require PI3K activity (VAN DIJK et al., 2000). All of these characteristics 
were shown to be specific for Tec, since none of the other Tec family members (Btk, Bmx, 
Itk) phosphorylated Dok-1 as efficiently (YOSHIDA et al., 2000). This agrees with the 
observation that Dok-3 phosphorylation is not affected in btk-/- DT40 cells. However, a 
thorough assessment of the interplay of Dok-3 and Tec family PTKs in DT40                      
B lymphocytes has not yet come. Furthermore, the involvement of PI3K activity in Dok-3 
tyrosine phosphorylation or in Dok-3-regulated pathways remains to be analysed.  
The data obtained for the TM-PLC-γ2 chimera suggests an even more direct involvement of 
Dok-3 in the PLC-γ-Ca2+ pathway. A direct interaction between the PLC-γ1 SH2 domain 
and Dok-1 was demonstrated by affinity purification experiments (VAN DIJK et al., 2000). 
Dok-1-mediated inhibition of Ca2+ mobilization was observed upon CD2 crosslinking in 
Jurkat T cells and upon FcεRI-FcγRIIB coaggregation in RBL-2H3 cells (NEMORIN et al., 
2001; OTT et al., 2002). A significant influence of Dok-3 on Ca2+ mobilization was also 
shown in A20 cells, albeit neglected by the authors (ROBSON et al., 2004). Forced 
expression of a murine Dok-3 variant in which all four PTB-domain distal tyrosines were 
replaced by phenylalanine caused an increased Ca2+ mobilization, suggesting a dominant 
negative effect of that derivative (figure 6F in ROBSON et al., 2004). However, 
overexpression of wild-type Dok-3 similarly led to an enhanced Ca2+ mobilization (figure 
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6F in ROBSON et al., 2004). These observations were confirmed in DT40 B cells by 
overexpression of the corresponding avian derivatives (K. Neumann, PhD thesis in 
progress). Interestingly, the overall phosphorylation state of PLC-γ2 seemed to be altered in 
A20 cells overexpressing wild-type or dominant negative Dok-3, but again the authors 
deemed it significance (figure 6C in ROBSON et al., 2004). Whether Dok-3 can indeed fulfill 
a direct regulatory role on PLC-γ2 activity remains to be proved. However, the observations 
that forced expression of wild-type Dok-3 can lead to enhanced Ca2+ mobilization suggest 
the importance of a tightly regulated Dok-3 expression level. Taken together, it is tempting 
to speculate that Dok-3 directly influences membrane recruitment or retention time of   
PLC-γ2 in DT40 B lymphocytes. A complete biochemical characterization of the dok-3-/- 
DT40 cell lines will hopefully give new insights into these functions. 
In figure 6.2 the “revised Ca2+ signalling toolkit” of B lymphocytes is summarized. During 
this thesis new pathways fine-tuning the BCR-induced Ca2+ mobilization were identified 
and characterized. BCR crosslinking leads to the activation of PTKs and the subsequent 
assembly of the Ca2+ initiation complex. PLC-γ2-mediated IP3 production leads to Ca2+ 
release from intracellular stores. Ca2+-permeable channels in the plasma membrane are 
opened and allow for Ca2+ entry from extracellular sources. The regulation of those plasma 
membrane resident Ca2+ channels awaits further clarification. However, store depletion 
and/or “direct” modifications, e.g. by conformational changes and/or as a result of PLC-γ2 
or lipid mediators, are likely to be involved in the regulated gating of the channels (see 
figure 6.1). In this revised model, BCR engagement and PTK activation also result in 
tyrosine phosphorylation of Dok-3, and plasma membrane recruitment of Dok-3/Grb2 
complexes. Tyrosine phosphorylated Dok-3 exerts its inhibitory function via the previously 
described effector molecules SHIP and/or Csk, or possibly via so far unidentified           
Dok-3-associated molecule(s). Alternatively, Dok-3/Grb2 complexes directly influence the 
activity and/or membrane localization of components of the Ca2+ initiation complex (figure 
6.2, left panel). The extent of this inhibitory regulation orchestrated by Dok-3 critically 
depends on the expression of NTAL. The presence of constitutively plasma membrane 
localized NTAL leads to tyrosine phosphorylation-dependent sequestration of Grb2, thereby 
preventing the association of Grb2 with Dok-3 and the subsequent membrane recruitment 
and tyrosine phosphorylation of Dok-3 (figure 6.2, right panel). The removal of these 
inhibitory elements in NTAL-positive cells ultimately results in enhanced Ca2+ 
mobilization, resembling the profiles observed for SHIP-, Grb2-, or Dok-3-negative cells. 
Obviously the balanced expression levels of NTAL and Dok-3 during B cell lymphopoiesis 
allow for a specific regulation of pathways dependent on the ubiquitous second messenger 
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Grb2. The revised BCR-induced Ca2+ mobilization model presented once again emphasizes 
the importance of a coordinated interplay of positive and negative signalling pathways.    
 
 
 
 
Figure 6.2: The “Ca2+ signalling toolkit” of B lymphocytes 
BCR engagement leads to the activation of PTKs and the assembly of the Ca2+ initiation complex.    
PLC-γ2-mediated IP3 production leads to Ca2+ release from intracellular stores. Additionally, Ca2+-
permeable channels in the plasma membrane are opened and allow for Ca2+ entry from extracellular 
sources. BCR crosslinking and PTK activation also result in tyrosine phosphorylation of Dok-3 and 
plasma membrane recruitment of Grb2/Dok-3 complexes. Tyrosine phosphorylated Dok-3 exerts its 
inhibitory function via SHIP and/or Csk, or possibly via so far unknown Dok-3-associated molecule(s). 
Alternatively, Grb2/Dok-3 complexes directly influence the activity and/or membrane localization of 
components of the Ca2+ initiation complex (left panel). The presence of NTAL leads to tyrosine 
phosphorylation-dependent sequestration of Grb2. The formation of Grb2/NTAL complexes prevents 
the association of Grb2 with Dok-3 and the subsequent membrane recruitment and tyrosine 
phosphorylation of Dok-3. The removal of these inhibitory elements in NTAL-positive cells ultimately 
causes an enhanced Ca2+ mobilization (right panel). 
 
 
6.9.  Conclusions and outlook 
In my opinion, two major fields are of particular interest to elucidate the biological 
relevance of the pathways described in this thesis. The first critical factor that should be 
considered is the connection between Ca2+ signalling and the cytoskeleton. There already 
exist many overlaps between components of the Ca2+ mobilization machinery and the 
cytoskeleton. For example, Grb2 was shown to bind dynamin via its SH3 domain (GOUT et 
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al., 1993; MIKI et al., 1994; SEEDORF et al., 1994). Members of the dynamin superfamily of 
large GTPases essentially participate in clathrin-mediated endocytosis (ORTH and 
MCNIVEN, 2003). Dynamin was also shown to interact with the SH3 domain of PLC-γ 
(SEEDORF et al., 1994; CHOI et al., 2004). Choi et al. could show that PLC-γ1 is a GEF for 
dynamin-1 and enhances dynamin-1-dependent EGFR endocytosis (CHOI et al., 2004). Vice 
versa, dynamin-2 is required for efficient Ca2+ mobilization and PLC-γ1 tyrosine 
phosphorylation in T cells (GOMEZ et al., 2005). PLC-γ isoforms were also reported to 
associate with the actin cytoskeleton during their translocation to the plasma membrane 
(REBECCHI and PENTYALA, 2000; RHEE, 2001). Close structural and functional links 
between PLC-γ and the Rho/Rac/Cdc42 family of GTPases, which participate in secretion 
and trafficking processes, were revealed (ARRIEUMERLOU et al., 2000; HONG-GELLER and 
CERIONE, 2000; ZENG et al., 2000). Strikingly, results obtained by Piechulek et al. suggest a 
novel mechanism of PLC-γ2 activation by Rac GTPases involving neither tyrosine 
phosphorylation nor PI3K-mediated PI(3,4,5)P3 generation (PIECHULEK et al., 2005). 
Finally, it is known that store-operated Ca2+ channels are GTPase-dependent and are 
affected by actin cytoskeletal rearrangements (FASOLATO et al., 1993; FERNANDO et al., 
1997; PATTERSON et al., 1999; YAO et al., 1999; ROSADO et al., 2000). All of the data 
described above indicate the importance of the cytoskeleton for Ca2+ mobilization, and 
future experimental set-ups should focus on the inputs that the Ca2+ signalling machinery 
receive from cytoskeletal components, and vice versa. 
The second major issue is the role of Ca2+ signalling in B cell fate decision. Given the 
tightly regulated expression levels of NTAL during B cell development and the 
fundamentally different biological responses of immature and mature B lymphocytes to 
BCR stimulation (i.e. apoptosis versus activation), it is tempting to speculate that 
Grb2/NTAL/Dok-3-regulated Ca2+ signalling may be involved in processes such as 
tolerance induction. This is supported by the differences in Ca2+ mobilization between 
anergic and naïve B cells described in the introduction. Generally, Ca2+ responses can be 
subdivided into short-term, rapid responses and long-term modifications. The latter requires 
changes in gene expression, which ultimately govern B cell development and 
differentiation. Increased intracellular Ca2+ concentrations support nuclear translocation of 
two important sets of transcription factors, i.e. the NFAT and the NF-κB family 
(DOLMETSCH et al., 1997; HIKIDA and KUROSAKI, 2005). NF-κB activation occurs after a 
large transient Ca2+ rise, and NFAT activation is promoted by a slow but sustained Ca2+ 
elevation (DOLMETSCH et al., 1997; HIKIDA and KUROSAKI, 2005). The requirement for 
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differential Ca2+ signals for these two sets of transcription factors once again underlines the 
importance of adaptor-mediated regulation of Ca2+ mobilization in B lymphocytes. 
In this thesis it was demonstrated that the adaptor molecules Grb2, NTAL, and Dok-3 are of 
particular importance for the modulation of BCR-induced Ca2+ mobilization. It will be 
fascinating to analyse whether this novel Ca2+ signalling pathway also functions in other 
immune cells. For example, all three adaptors are also expressed in myeloid lineages. The 
impact of this Ca2+ signalling pathway on the outcome of humoral immune responses must be 
supported by further experiments with currently available and future mouse models. 
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